key: cord-1041948-4fzvmp0q authors: nan title: Cumulative general subject index volumes 1-30 date: 2005-12-31 journal: Studies in Natural Products Chemistry DOI: 10.1016/s1572-5995(05)80099-7 sha: 3549df51a2aae3cc1a6e775f0bbfd1386334665c doc_id: 1041948 cord_uid: 4fzvmp0q Publisher Summary This chapter lists the important subjects that are discussed in the publication Studies in Natural Products Chemistry, Volumes 1–30, such as abdominal pain, acaricidal activities, acanthenes, gibberellins, glucoamylases, macarpine, and quercetin. The terms are mentioned along with the page numbers in which they are discussed in the publication. , 8,11,13-tetraen-7- one 29:100 activity in EBV assay system 29:100 Ent- , 13(15)-dien-16,12- olide (jolkiolide E) 9:283, 284, 11, activity in EBV assay system 29:99 18-nor- 11, 7c~, triol 29:99 activity in EBV assay system 29:99 Abieta- 8,11,13-triene-7cz, 15,18-triol 29:99 activity in EBV assay system 29:99 Abieta- 8,11,13-triene-7c~,l 5,18-triol 7- 816 from (15R)-I 5-acetoxy-15,20dihydro catharanthine 14:815,816 1 ot-Acetoxy-20Ctv-hydroxy-24tx,25 c~epoxywitha-5-ene-22,26-olide-413-0glucopyranoside 4, trien-3-one 11:398 (+)-1-Acetoxy-2-epipinoresinol 5:538-540 1 ct-Acetoxy-2ct,6 [3,9[3-trifuroyloxy-4[3- hydroxy-dihydro- [3-agarofuran 29 :87 4-Acetoxy-3 [ 1 '-tert-butyldimethylsilyloxy) ethyl]-2-azetidinone 4:448 20S-Acetoxy-3 [3-16-dihydroxylanost-7- en-18-oic acid-18,16-1actone 7:~269 3-Acetoxy-4-hydroxybenzaldehyde 8:166,167 9ot-Acetoxy-4 [3,15- 8ot-Acetoxy-6-epi-tannunolide A 27:583 1-Acetoxy-6cx-hydroxy-germacran-1(10), 3(4)-dien-8,12-olide 27:561 16-Acetoxy -7,8-epoxy-3,12- dolabelladien-13-one 20:491 2-Acetoxy-8,13-dihydroxy-11-epi APO 13:522 12-Acetoxy-8,13-dihydroxy-11-epiapotrichothec-9-ene 9:20 7fl-Acetoxy-8,13-epoxy-1 a,6/3,9 atrihydroxylabd-14-en-11-one 25:256 1 , 7-diene-8-12-olide 20:660 3 [3-A c etoxy-8 [3-i s obutyrylo xy-re ynos in 29:87 activity in Mam-2 assay system 29:87 activity in DIF assay system 29:87 15-Acetoxy-9ct-hydroxy-8 [3-methacryl- oyloxy-14-oxo-acanthospermolide 29:89 activity in NFkB assay system 29:89 15-Acetoxy-9cz-methacryloyloxy-8 f3hydroxy-14-oxo-acantho-spermolide 29:89 activity in NFkB assay system 29:89 5-Acetoxyarctigenin monoacetate 18:601 6'-Acetoxyavarol 15:301 1-Acetoxybutadiene 1:571 l'-Acetoxychavicol acetate 23:800 25-Acetoxycholesta-1,4,6-trien-3-one 11:385 2tx-Acetoxycholestanone 18:888 2[3-Acetoxycholestanone 18:888 3-Acetoxycostunolide 29:89 activity in NFkB assay system 29:89 (+)-Acetoxycrenulide 18:22-28 15-Acetoxy-eremantholide B 29:89 activity in NFkB assay system 29:89 activity in TNFet assay system 29:89 l'-Acetoxyeugenol 23:800 12-Acetoxyfamesol acetate 27:586 3-Acetoxyflavanones 30:729 structure of 30:729 tx-Acetoxyfuranone 12:14 3-Acetoxyguaiazulene 14:321 23S-Acetoxyholost-7-en-3 [3-ol 7:273 613-A cetoxyho lo sta-7,24-dien-3 [3-ol 7 :275 23 S-Ace to x yho losta-7,25 -dien-313-o 1 7:273 16otAcetoxy-holosta-7-en-3b-ol 7:277-1-Acetoxyisocomene 3:6,60 6-Acetoxyldihydrochelerythrine 27:168 313-Acetoxymalabarican-14(26), 17E,21triene 27:591 ent-13-epi-12a-Acetoxymanoyl oxide 25:273 10-Acetoxymenthol 25:160 6-Acetoxymethyl-2,6-dimethyl-9methoxy tricyclo [5.3.01'5] undec-9en-8,11-dione 8:163 5-Acetoxymethyltrachelogenin 18:602 5-Acetoxymethyltrachelogenin monoacetate 18:602 9a-Acetoxy-miller-1 (10)-Z-enolide 29:89 activity in NFkB assay system 29:89 13-Acetoxymodhephene 3:6,61 18-Acetoxy-Na-deacetylisoretuline 1:38-39 18-Acetoxynorfluorocurarine 1:38-39 (+)-1-AcetoxypinoresinoI- [3-D- 3 ", 2', 3', 6', 2, 4:306 Aminoalkylindoles 30:196, 197, 198 as cannabinoid receptors ligands 30:197 Aminoalkylindoles 30:196, 197, 6:551,7:32-36,39;10:496-498; 8:343 ;24:995-998;25 :719 enzymatic activity of 24:995-998 a- 10:242, 243, [504] [505] [506] [507] 514, 13:195; 16:8622:622; 27:330, 331 in aleurone protoplasts 27:331 13-Amylase 7 :33,58,59,10:497;16 :86 ~-Amylase inhibitor 13:189 acarbose as 13:189 Amyloglucosidase 7:13, 10:567, 357, in starch 7 :6 Amylose 5:288, 291, 292, 7:6, 10:496, 497 Amylostatins GXGGG 10:509 inhibitory activity of 10:509 Amylostatins GXG 10:509 inhibitory activity of 10:509 Amylostatins GXGG 10:509 inhibitory activity of 10:509 Amylostatins XG 10:509 inhibitory activity of 10:509 synthesis of 10:507-511 Amylostatins XGG 10:509 inhibitory activity of 10:509 Amylostatins XGGG 10:509 inhibitory activity of 10:509 (x- 633;30:193,194,204,799 alkaloid 30 673 ;23:153, 180;26:32,56;30:195,198-201,817 ofbarbatosides A and B 30:191, 192, 203 development of 30:192, 203 use of 30:191 Analgesic effects 26:401, 403, 404, 406, 416, 418; 30:205, 208 1, 4:5, 6:5,6,29 ,30 of cyclopentane ring system 6:6-8,30 ,31 of enolate 10:414,415 of methylenecyclohexane 6:21, 856,857 ;26:226,1002;28:140,688; 30:328,738 of 1,2,3- 11:130;12:192; 17:283 ;21:188,202,223,239,364,437; 23:649;24:953-954 21:186,192,197, 203,206,213,214,218,221,226,227, 233-235,223,238,240,389,391,399, 404,405,435,599-662 ;22:626;23:3,4, 271,341,344,348,468,473,798,801, 354,368 ;26:227,228,553,1098 ;28:4; 66,473,475,686;30:327,738,629 against Candida albicans 30:327,629 from Hypericum roeperanum 30:629 of (E)-8(17), 12-1abdadiene-15,16-dial 23:798 47 of (E)-8b, 17-epoxylabd-12-ene-15,16-deol 23:798 of (E)-813,17-epoxylabol-12-ene-15,16-dial 23 :798 of 2-hydroxynagilactone F 28:475 of 2-thioxopyrrolidines 26:1098 of 3,4,3 ',4'-tetramethoxylignan-7-ol 26:228 of 3,5'-diallyl-2'-hydroxy-4- methoxybiphenyl 24:861 of 3,5- 132, 133,149,252,269,664,665 ;23:316, 533,534,687,704 ;24:742,743 ;30:226, 396,397 Anti-lactose antibodies 29:538 Antileishmanial activity 21:674,744; 26:229,790,813,887,789,790,791, 800,805,807,810,811,821,828,830 5:752;10:443; 15:327-339;18:776-778;21:153, 235,257,401,571,573,591,596,597, 599,606;22:626;23:94,153,180,233, 237,249,262,268,267,346,353,522; 24:64,69,206,330,331-334,402,403, 404,406,417,418,443,470,485,859, 1091,1092,1189;26:64,330,401,402, 1189;27:807;28:62,224,257,293,698, 671 against Candida albicans 5 21:599,600,618; 22:308,321,345;23:395,534,535,742, 772,773,845 ;25:59;26:250,255,509,5 56,672,763,768,887,1005,1006;28:4, 16,17,63,179,257,293,773 ;30:173, 224,225,289,320,321,524,561, 5:461,563;10:608, 609,619,620;17:146;21:132,148, 150,393,435,600,615,662,690,718; 22:307,361 ;23:233,268,233,346,395, 473,512,531,703;25:114;26:169,222, 224,226,344,452,741,759;27:482; 28:257,293 ;30:224,324-326,393,394, 395,398,401-405,407,410-412,627 of (-)-aristeromycin 10:609 of (+)-C-2'-ara-fluoroguanosine 10:609 of 2-amino oxetanocin-A 10:620,621 of 3',4-O-dimethylcedrusin 61 22:361 of 3'-azido-3'-deoxythymidine 10:585 of aciclovir (9-[2-hydroxyethoxy) 7:136,139;22:312;23:163; 30:433 reaction of 30:433 L- Arabinose 7:144, 181, 294, 298; 11:7, 8; 30 21:657,744;25:66, 263,274,275,333,596,597,616,66; 26:758,759;27:422;30:192,225 6:153;20:577,578,588, 607;21:298,299,304,305;30:518,520, 533,538 7:288;15:58,69;28:718 Asterias rubens 6:151, 152, 156, 161; 7:288, 294, 304, 306; 15:48 Asterias vulgaris 7:288,291,304;15:59; 28:718 Asterina pectinifera 7:289;15:44,48,55; 25:698 Asterinic acid 6:161 Asterogenol (20R-5c~-pregn-9(11)-ene-3~,6c~,20-triol) 7:288, 291 Asteroidea 7:265, (11)-en-20-one) 7:290,291 (+)- Asterosaponin 7:285, 288, 290, 291, 294, 7: 303,304 Asterosaponin 1 (forbeside C) 7:287, 288,293 Asterosaponin A and B 7:286,303 from Asterias amurensis 7:286,303 Asuka [744] [745] [746] [747] [748] [749] [750] [751] [752] [753] [754] 761, 766, 767, 772, 773, 775, 777, 780, 781 by diastereofacial selection 13:62-70 by enantiofacial selection 13:70-73 by enantiotopic discrimination 13:60-62 of (+)-azaisopicrostegnane 24:775,777 of conidendrin 24:772,773 of 2,3-dibenzylbutyrolactones 24:744-754 of(+)-gomisin A 24:775-777 of (+)-isolarresinal 24:767 of (+)-isoschizandrin 24:775,777 of (-)-isoschizandrin 24:780,781 of (+)-paulownin 24:761,766 of (-)-podophyllotoxin 24:767, 775 of (+)-schizandrin 24:775-777 of (-)-schizandrin 24:780,781 of paraherquamide A 28:331,367 of carbaoxirose/carbaoxetoses 29:490 of (-)-ajmalicine 14:563,564 of (-)-sibirine 14:539-544 of (+)-(S,S)-solenopsin A 6:431, 432 of (+)-castanospermine 12:346 of(+)-elaeokanine A 12:351,352 of (+)-elaeokanine C 12:351,352 of (R)-muscone 14:490 of (R/S)-1,6-dioxaspiro [4.5] decane 14:523,524 of (R/S)-1,7-dioxaspiro [5.5] of cy-symmetric ketones 11:241, 242 AT2433-AI 12:366,368 from Actinomadura melliaura 12:366,368 AT2433-A2 12:366,368 from Actinomadura melliaura 12:366,368 AT2433-BI 12:366,368 from Actinomadura melliaura 12:366,368 AT2433-B2 12:366,368 from Actinomadura melliaura 12:366,368 Atalantia ceylanica 13:348,349,356 1,5-dihydroxy-3-methoxy-10methylacridin-9-one from 13:348,350 11-hydroxynoracronycine from 13 :830 Attanuatoside C 7:295, 296, 300 Atta-ur-Rahman synthesis 14:850 of (+)-16-hydroxydihydrocleavamine 14:850 of (+)-16-methoxycarbonyldihydrocleavamine 14:850 of (+)-coronaridine 14:850 of (+)-dihydrocatharanthine 14:850 of (+)isovincadifformine 14:850 of (+)-c~-dihydrocleavamine s 14:850 of (+)- [3-dihydrocleavamine s 14:850 of anhydrovinblastine 14: [857] [858] [859] from Hacelia attenuata 7:295 Attenuatoside A- 299, 296, 296, 296 ,300 Attenuatoside C 15:61 from Hacelia attenuata 15:61 Atuna racemosa 29:708 Aucubigenin 7:478 Aucubin 7:440, 455, 465, 472, 473, 476, 478, 479, 480, [481] [482] [483] 29 7:90 Avarol 5:430, 431, 438, 439; 9:30, 31; 15:238, 252; 21:252; 25:697; 29:111 activity in CRG bioassay system 29:111 activity in TPA bioassay system 29:111 Avarol monoacetate 15:300 Avarone 5:430, 431, 434, 438, 439; 15:301, 314; 21:252; 25:697; 29 13:87;4:437,441,448,450, 452-454,457,458,461-466;8: 25:95, 104, 105, 115, 116, 118, 203, 226 Azukisaponin V 25:104, 115, 116, 118, 120, 203 :4, 9; 12:179 Baccatin III 11:3, 4, 179, 180; 12:179, 180; 20:81 ; 22:218; 23:490, 491 ; 25:245 (5,7dihydroxy-6,4'-dimethoxy- flavone) from 30:725 pe dunletin (5,4 '-dihydro x y-3,6,7- trimethoxyflavone) from 30:725 salvigenin (5-hydroxy-6,7,4 'trimethoxyflavone) 5:302,304,368,418, 308,353;8:353;10:117,104,400,345, 692,290,556,559;18:778;21:237,262, 266,267,284,610;22:627,628;23:41, 344,473 ;24:713;25:220,258-260,765, 770,776-779,782,789,792,863 ;26:79, 333,334,1093 ;28:223,693 ;29:272; 30:629,693, 4:158, 263, 324, 325, 340, 341, 410, 542, 543, 552, 553 ; 6:13; 10:410; 13:58, 59, 307, 309; 20:573, 593, 818, 820; 25:143, 145 Baker's yeast reduction 13:662, 176 Balaenonol 5:744, [747] [748] [749] 149, 150, 152 trans-BC-ring fusion 12:205 stereochemistry of 12:205 BCA method 25:433 BCAs 21:182, 191, 193, 202, 203, 218, 224, 226, 229, [190] [191] 195, [196] [197] [198] [199] [200] [201] [202] [203] [204] [205] [206] [207] 195, 196 DIM2BOA 27:191 DIMBOA 27:191, 195, 196 HBoA 27:191 HDMBoA 27:191 synthesis of 25:128,129, 294,300,329,401,659,661,662 Biogeneration 13:295-345 of flavors 13:295-345 Biogenesis 23:204,211,253,255,395-453 ; 26:141,142,313,314,405,465, 552,1054 132,148,162, 223,236,23 8,263,265,269,284,297, 366,388,390,410,419,421,431,571, 578,591,598,601,603,620,694;23:63, 93,95,108,111,129,126,107-152,153, 158,179,267,271,285,395-453, 455-485,491,497,642-643 ;739;24:25, 353-376;799,845;27:178,185-225, 332,377,431,421,443,659693,778, 801,924;28:109,212,228,229,340; 29:743 ;30:4,26,172,175,200,224, 303,310,395,404,483,484,485,495, 496,497,499,562,588,603,637,831, 840,843 (ABI-I) as 29:598 I-A, I-B, I-A', II, II', I I-A (7R,8S,7'R,8'R) - 195, 509, 599; 26:321, 324, 326, 329 5:467,469,474,479,111, 119,579,36;22:126,346,645,663; 23:537,551,740,744 ;25:655,657,663, 671,919,920,922-927,932-934, 936-938;28:262;29 3-epi-2-deoxy-20-hydroxyecdysone activity in 29:26 25-deoxy-7,8-dihydro-ecdysone activity in 29:26 2f3,14c~,-dihydroxy-5 a-cholest-7en-6-one activity in 29:27 6-oxo-3 c~, 14ot-dihydroxy-5 [3- cholenoic acid methyl ester activity in 29: 27 3-oxocholest-dihydroxy-cholest-4,7-dien-6-one activity in 29:27 313,14c~-4,6,8(14) -triene activity in 29:27 3 [~, 7 e-dihydroxychole st-5-ene activity in 29:27 ( 2 5 R/S) 2 0,2 6-dih ydro x yecd yso ne activity in 29:26 20-(2',2'-dimethyl-(22R)furanyl) ecdysone activity in 29:26 6,24-dioxo-3 [3,14t~-dihydroxy-513-chol-7-en-24 -dimethylamine activity in 29:27 ecdysone activity in 29:26,28 3 [3-ethoxy-14 ot-hydroxy-5 ~-cholest-7-en-6-one activity in 29:26 for Bombyx mori pupae's ecdysone 29:25 for Calliphora erythrocephala 29:25 14c~-hydroxy-3c~,5 ~cyclocholest-7-en-6-one activity in 29:27 3-oxo-14~-hydroxy-5 f3-cholest-7-en-6-one activity in 29:26 14~-hydroxy-5 [3-cholest-7-en-6one activity in 29:26 3 [3-hydroxy-5 ~-cholest-7-en-6- one activity in 29:26 3 ~-hydroxy-5 [3-cholest-8,14dien-6- [3-methoxy-14c~-hydroxy-5 [3- cholest-7-en-6-one activity in 29:26 24R-methyl-2 [3,14c~-dihydroxy-5~-cholest-7,22-dien-6-one activity in 29:27 3 ct-methyl-3 ~, 14c~-dihydroxy-5[3-cholest-7-en-6-one activity in 29:26 5 [3-methyl-3 [3,14~-dihyroxy- cholest-7-en-6-one activity in 29:27 2ct,3 ~, 14ot,20R,22R-pentahyd-roxy-5 [3-cholest-7-en-6-one activity in 29:26 213,313,20R,22R,25-pentahydroxy-5 [3 - 4-nor-3 [3,14ot,25-trihydroxy-5 [3cholest-7en-6-one activity in 29:27 313,5(x, 14 c~-trihydroxy-cholest-7en-6- 6, 20:586 Camphor 7:95; 9:530, 536; 16:123, 124; 20:16; 25:125, 128, 154, 156, 547 721, 725; 26:299, 560; 7:20, 98, 318, 319, [334] [335] [336] [337] [338] [339] [340] [341] [342] 344; 17:611, 612, 708; 20:720, 721, 725, 732, 735, [746] [747] [748] 760; 21:304 ; 25:236; 26:299, 300, 305; 30:516, 5 20, 524, 537, [539] [540] [541] [542] [543] [544] 546 2:370373,381,383,385, 390,392,398,39,400,401,402 ;4: 31, 32; 13:663;14:809,810,820,821, 854-859,869-873 ;26:139;27:747,782 15',20'- -2,7,11-triene-4,6-diol 29:100 activity in EBV assay system 29:100 activity in PKC assay system 29:100 activity in skin-1 assay system 29:100 activity in ODC assay system 29:100 7, activity in EBV assay system 29:100 activity in skin-1 assay system 29:100 activity in ODC assay system 29:100 Cembradiene hydroxy ether 15 7:190-192,194,195;21:80; 25:300,305,311 ;26.'467, 817, 868 Cholest-5-ene-24-0ne-313,7oc-diol 4[3, 21disulphate 15:98 from Ophiura sarsi 7ot, from Salvia glutinosa 20:707 Cholest-7-enyl linolenate 9:470 5 oc-Cholesta-9(11),24(25)-dien-3 ~, 6or 20,22-tetraol aglycone 15:49 5cx-Cholestan-3-one 2:168 octant rule in 2:168 5 cc-Cholestan-3 [~,6cc, 8,15o~, 16[3,25hexaol 15:77 from Protoreaster nodosus 15:77 5ot-Cholestane 20:248 Cholestane glycoside 21:636 5ot-Cholestane-3 [3,5,6[3,9-tetrol 23:159 5 [3-Cholestane-3 cc,4a, 11 [3,12[3,21pentaol 3,21-disulphate 15:96 5 [3-Cholestane-3 oc,4c~, 1113,21-tetraol 3,21-di-sulphate 15:96 (25R) 5 6[3, 15ct, 16[3, 26pentaol 15 :75 (25R) 5c~-Cholestane-3 [3,5,6[3,15c~, 1613 26-hexaol 15:75 (24S) 5c~-Cholestane-3 f3,6ct, 8,15 [3,24- pentaol-aglycone 15:61,68 Cholestanepentols 17:214 5a/513Cholestanols 9:454 steryl palmitates of 9:454 Cholestanyl palmitate 37, 447, 449, 454, 461, 462, 464 2:153,159-61,165, 166,169-173,226,227,137,140, 149,264,390,539,542;15:193,194; 423-438;22:374;26:550,551 1:43,45,78,91, 172,173,180,181,230,243,251,457, 459,471,563 ;8:180;11:471 ;13:29,30, 135,142,358,417,437,438,443,613; 16:260,340,439,471,623,627,703, 712;19:229;20:66,67 ;24:47,756,758 [3,3] incremental effects of 9:275-280 of ~-pipitzol benzoate 5:787 of (+)-1-acetoxypinoresinol 5:533,534 of (+)-1-fraxiresinol 5:535 of (+)-1-hydroxypinoresinol 5:534 of (+)-epi-pinoresinol 5 1:182,236,416, 566,567 ;3:47,98,139,190,191,249, 372;7:216 5:5,6 Coumarinolignans 5:3,5,8,9,495,496 Coumarins 4:3,5,8,9,202,204-206,220, 224,225,367,372,375,377,389,391, 399,400,495,496,505,517-521, 574-575,971-1080; 9:113-116,529; 20:283,497 8:45,185,207;11:15-20,45-47; 12:116,150-152,160,161,173,193, 416;15:266;16:127,470 Cycloasgenin C 25:185 Cycloastragenol 25:179, 184, 185, 186, 187, 190, 191, 192, 215, 217, 189, [192] [193] [194] [195] [196] [197] of (-)-deoxypodophyllotoxin 30:589 of (-)-hernone 30:590 of (-)-nymphone 30:590 of (-)-yatein 30:590 of (+)-corytuberine 30:589 of (+)-epiaschantin 30:590 of (+)-epimagnolin 30:590 of (+)-epiyangambin 30:590 of (+)-hernovine 30:589 of (+)-laurotetanine 30:589 of (+)-magnoflorine 30:589 of (+)-malekulatine 30:590 of (+)-N-formyldehydroovigerine 30:589 of (+)-N-formylnornantenine 30:589 of (+)-N-formylovigerine 30:589 of (+)-N-hydroxyhernangerine 30:589 of (+)-N-methylhernangerine 30:590 of (+)-ovigerine 30:590 of (+)-ovihernangerine 30:590 of (+)-vateamine-2' [3-N- 5:388;21:134,136,150, 174,257,259,260,262,263,265,267, 269,270,271,273,274,284,311,364, 410,634,643,656,661,690,704,744; 23:96,97,187,218,238,249,250,253, 255,272,274,277,290,292,299,308, 317,701,274 ;24:294,352,740,867; 26:212-213,1185 ;27:94,924,926; 28:118,121 ;30:27,59,226,560,588, 593,596 20:194, 242, 246 Daturalactone B 20:194, 223, 241, 246 Daturalactone C 20:180, 241 (-)-9-Demethyl-7,9-dimethoxynogarene 14:82 9-Demethyl-9-hydroxy-7-methoxynogarene 14:82 Nb-Demethylalstophylline oxindole 5:159-161;9:196,197 (+) -Demethylaspidospermidine 5:127 Demethylated gardenin A (5,6,7,8,3',4', 5'-nonahydroxyflavone) 3:20;22:196,197,200,204, 213,214 20:769,770; 21:211,434;24:8-10,27-31,195-196,762,763,766,768;26:172 3:79,80;8:403-406;10:51, 52,155,156;11:11,92,93,99-108; 12:253;13:108,117-141,144, 149;14:735;19:11,464 umshiol-type 30:116 1 ct-25-Dihydroxy-(24R)-fluorocholecalciferol 10:57,69 3,6-Dihydroxy-1,7-dimethoxyxanthone 30:622 3c~, 13-Dihydroxy-11-epi-apotrichotec-9ene 9:210 3[3,13-Dihydroxy-11-epi-apotrichotec-9ene 9:210 2ct, 13-Dihydroxy-11-epiapotrichothecene 13:520 2[3-13-Dihydroxy-11-epiapotrichothecene 13:520 10-Dihydroxy-11-methoxydracaenone 5:17,18,20,22 ,556 ent-12or, 16-Dihydroxy-13 [R] 655 5, 7, 8, 5:655 5, 7, 4, 15 5, 627, 628, 640 5, 657 213,413-Dihydroxy-6-deoxy-celorbicol 18:744 5,7-Dihydroxy-6-methoxyflavonoid 5:640 11, 11, abietatriene 29:99 activity in COX assay system 29:99 1 [3,4c~-Dihydroxy-6a-angeloyloxyeudesm-11 (13) [3, 6o~olide 27:562 7(x, 11, activity in EBV assay system 29:99 from Larix kaempferi 29: 99 15, 11, one 29:99 activity in EBV assay system 29:99 18-nor-4ct, 11, 7, 8, f] [5.5] undecane 1:692 3,7-D imethyl-1,7-octanedio 1 25:133,136 2,6-Dimethyl-l, 138 12, 1, 2:402,403,404;5:3,31-37;6:110,7:102,121,122,187-189;15:252-260;17:8,11-15,27,148; 18:756 ;21:234 ;22:379;23:488,682; 24:196-202 20:191, 194 Dunawithanine A, B 20:191 from Dunalis australis 20:191 6:39,40,86, 87,443;12:281,311,312;14:14-17, 546,741,742 ;22:235 ;24:185 ;29:244, 490 ,492 of (-)-( 1R-8aS)-1-hydroxyindolizidine 12:281 of (-)-slaframine 12:311,312 of (-)-y-rhodomycinone 14:14-17 of (+)-( 1S,8aS)-1-hydroxyindolizidine 12:281 of (+)-stoechospermol 6:39,40 of 2,5- 11:470;16:571;24:30-32, 62,63,65,66,68,72,73,87,110-112, 175,188-190 14(x, 17[3, tetrahydroxy-with-24-enolide 20:245 5 [3, dioxowitha-2,24-dienolide 20:234 (+)-7,8-Epoxy-2-basemen-6-one 16:226 Epoxy-3 [3,4a, 10a-trihydroxyguaian-6or, 12-olide 27:579 1 [3, germacra-4Z-en-12,613-olide 27:563 2~,5-Epoxy-5,10-dihydroxy-6~angeloy-loxy-913-isobutyloxygermacran-8c~, 12-olide 29:89 activity in iNOS assay system 29:89 activity in NFkB assay system 29:89 7 c~, 8 ot-Ep oxy-6 c~-hydroxyabieta-9(11), 13-dien-12-one 29:99 activity in EBV assay system 29:99 3,4-8c~-Epoxy-8-deoxycumambrin 27:577 9,10a-Epoxy-9,10-seco-abieta- 8,11,13trien-18- 4:433;5:367,429,434; 7:39,44,46,50,52,54 ;9:293,308,537,5 92,593,596,603,604,606;8:102;11:18 2,214;12:63,95-109;13:157,162,164, 261,262,283;17:378;18:709,722,727, 921 ;19:601 ;20:712;21:174,175,299, 573,600;22:623,627;23:67,137,235, 474,533;24:713;25:257,319,765,775, 925,948;26:330,331,333,402,556, 605,802,1092,1093,1135,1263,1269, 1271,1272,1274,1278;27:305; 28 propinoate 20 13;14,15- diepoxy-13-epi-labdan-3p-ol from 29:102 ent- 13-epi-8,13-epoxy-2,3- secolabd-14-ene-2,3-dioic acid 3-methyl ester from 29:102 ent- 13-epi-8,13- 4:29, 130, 197, 198, 198 5:197, 198 Guaianin A2 5:197, [198] [199] 199 Guaianin E 5:199, 200 Guaianins A-L 9:51,52,54-58 5:190;21:68,89,96,97,102, 108,109;22:24,36;25:533,537; 26:828,829 as immunosuppressive drug 25:537 tautomerism of 5:190 Harman 5:353; 18:726; 26:828, 829 from 16:367,391,400,412,416, 418,427,429,430,432,435,438,439, 447;18:96;19:22,78,279 7:427, 20:6; 21:642, 662, 674 ; 24:132, 133 ; 26:813 ; 29:586 Hederagenin 7:134, 135, 429, [431] [432] [433] 9:61, 62; 21:656, 665 Helicobacter pylori 13:183;22:432; 25:611,617,618,778;26:693;30:338 Helicobacter pylori 469, 541, 618; 26:757, 762 Hesperidin 22:325, 423, 429, 436; 23:747; 26:744, 745, 752, 759, 766, 768 Hesperidin (3', 5, 15:33 4,4',5,5',6,6'-Hexahydroxydiphenic acid dilactone 27:755 3,5,7,8,3',4'-Hexahydroxyflavone 8-0glucoside) 29:572 313,1613 ,2113 8:316, [318] [319] [320] [321] 324, 326, 330, 331, [333] [334] [335] [336] [341] [342] [343] 346 Hexanortriterpenoid 9:102, 297, 135 CD correlation 3:7,12;22:195,201 synthesis of 3:7,12,13,17,18, 20,22,40,65;4:588;13:34-37 (+) Histamine 15:328; 21:10, 14, 19, 50, 660; 22:111, 136, 437; 25:516, 520, 532, 536, 538, 612, 613, 701, 719; 30:192 of 5, 7, 2 ', 13, 15, 21, 25, 29 5:146,149;9:25,26,28, 402;12:313;15:76,270,475;20: ,590 activity of (-)-deoxypodophyllotoxin in 30:589 activity of (-)-hernone in 30:590 activity of (-)-nymphone in 30:590 activity of (-)-yatein in 30:590 activity of (+)-corytuberine in 30:589 actwity of (+)-epiaschantin in 30:590 actwlty of (+)-epimagnolin in 30:590 actwlty of (+)-epiyangambin in 30:590 actwlty of (+)-hernovine in 30:589 actwlty of (+)-laurotetanine in 30:589 actwlty of (+)-magnoflorine in 30:589 activity of (+)-malekulatine in 30:590 activity of (+)-N-activity of hydroxyhernangerine in 30:589 activity of (+)-N-formylnornantenine in 30:589 activity of (+)-N-formyldehydroovigerine in 30:589 activity of (+)-N-formylovigerine in 30:589 activity of (+)-ovigerine in 30:590 activity of (+)-ovihernangerine in 30:590 activity of (+)-vateamine-2'~-Noxide in 30:590 activity of 7-formyldehydrohemangerine in 30:589 activity of 7-formyldehydronornantenine in 30:589 activity of 7-formyldehydroovigerine in 30:589 activity of 7-hydroxy-6-methoxy- 15:472 Humantenine-type oxindole alkaloids 197; 15:472 6:276,426,435,451,168, 169; 19:6,36,38,42,104,332,362, 367-368,371 ;21:200 [2,3-b] furan -4,9- 1083 ,1084 ,1087 ,1092 ,1093 ,1095 , 1096 ,1099 ,1100 ,1102 ,1103 20S-Hydroxy-1,2-dehydropseudoaspidospermidine 5:126; 7ctH, 8, 11 ~H-eudesm-4(15)-en-8,12-olide 27:552 1-Hydroxy-11 -methoxycanthin-6-one 7:389,390 12-Hydroxy-11-methoxydiaboline 9:189 10-Hydroxy-11-methoxydracaenone 5:17-20 12-Hydroxy-11-methoxyhenningsamine 9:27 12-Hydroxy-11-methoxy-N-acetyl-nor-C-fluorocurarimine 26:1052,1053 12-Hydroxy-11-methoxy-nor-Cflourocurarine 26:1052 19-Hydroxy-11-methoxytabersonine 2:375 10-Hydroxy-11-methoxytabersonine 5:128 6-Hydroxy-12-tridecene 9:241,243 3 14, 15, 613) , ( 12, 17 )-diolide 28:508 synthesis of 28:508 Ent-16-Hydroxy-13 [R] 19R-Hydroxy-20-epi-ibophyllidine 5:127 19S-Hydroxy-20-epi-ibophyllidine 5:127;9:190,192 18-Hydroxy-20-epi-ibophyllidine (+)-19-Hydroxy-20-epi-pandoline 5:124 19-Hydroxy-20-epipandoline 539, 194, 5, 9, 7, 3', 4', 7, 7, 8, 7, 11, activity in EBV assay system 29: activity in TPA assay system 29:89 activity in PKC assay system 29:89 activity in CRG assay system 29:89 1-Hydroxyacridin-9-one (N-methylnoracridin)-9-one 13:348, 362, 358, 366, 509, 511, 513, ( Hypericum perforatum 5:656,758; 21:541 ;22:643,653,661,664,666,672, 673,675,676,679-690;25:557;29:580; 30:407,603,604,605,609,610,616, 618,619,622,624,626- 1:196,197,205,206 trans-to-cis- 1:31-34;2:172,173;5:3, 69-134,389,390,443,444 ;9:85, 163-199;13:70,92,93;10:407,411; 14:703-730 aspidosperma 13:70,92,93 Aspidosperma 12:332;21:98,193, 263,270,312,398,430,585,589,591, 594,643,659,670, 673,675,690 ;23:59, 216,808;26:217;28:481 [3,3 [3-dihydroxy-5 [3-cholest-7- en-6-one activity in 29:32 3 [3,14cx-dihydroxy-5 [~-cholest-7- en-6-one activity in 29:32 ecdysone activity in 29:32 3 [3-hydroxy-5 [3-cholest-6-one activity in 29:32 20-hydroxyecdysone activity in 29:32 inokosterone activity in 29:32 Kc cell bioassay as 29:30 makisterone A activity in 29:32 muristerone A activity in 29:32 podecdysone A activity in 29:32 ponasterones activity in 29:32 213,3 [3,5 [3,14cx-tetrahydro xy- cholest-7-en-6-one activity in 29:32 2 [3,3 [3,25-tridihydroxy-5 [3cholest-6- 493, 494; 704; 21:252, 254, 262, 266, 267, 269, 270, 271, 278, 285, 379, 595, 611 ; 23:666; 667, 670, 677, 678; 24:25, 799, 845, 866; 26:231, 232, 426, 471, 479, 485 Iridomyrmex humilis 5:223,225,240, 241,245,253 Iridomyrmex nitidus 5:222-224,233,253 Iridomyrmex purpureus 5:222,224,233, 253 Iridomyrmex rufoniger sp.gr. 5 20 Isocomene 3:6, 9, 15, 21, 24, 60; synthesis of 3:6,9,15,21,24 ,60 ISOCOMS (Immunostimulating complexes) 24:163 (+)-Isoconcinndiol 6:26 from Laurencia snyderae 6:26 (+)-14-epi-Isocopal- 12-ene-15,16-dial 6:108,110 (+)-ent-Isocopal- 12-ene-15,16-dial 6:108,110 (+)-14-epi-ent-Isocopal- 12-ene-15,16- 20:283 Isophytolaccagenin 7:144, 145 Isophytolaccinic acid A 7:144, 145 Isopicropodophyllone 5:481, 483; 7 c~, [2,3-b] furan 1:168;5:3,42, 494,265,266;13:642;21:107,733; 27:819,863;30:560,562,588,590,594, 597 (-) 13:410; 25:3, 13, 29 conformation 25:23 Isoretronecanol 1:231, 233, [235] [236] [237] 241, 244, [247] [248] [249] [250] [251] 253, 256, 257, 259, 260, 325, 326, 339 (+) 5:515, 516; 26:315, 332, 333, 334, 516 Isoscutellarein 5:624, 627, 215, 216, 222, 225, 227, 228; 5:754 12:379-381 K-252d 12:366,368,369,386 Nocardiopsis sp. K-290 12:366, 368 protein kinase inhibitor of 12:386 K-25a 12:366,368,369,384,390,395, 396,398 acid 29:101 activity in EBV bioassay system 29:101 (+)- , 57, 111, 117, 120, ,12(E)-) 25:266 8(17), 12 266 Labdadienoic acid 25:248 5R, 8R, 9R, 25:251 ent-Labdane 15:252; 244, 256, 259, 261, 266, 275, 276 17:198 Lactarius picinus 196, 201 Lactarius piperatus 17:197, 198 Lactarius quietus 17:196 Lactarius rufus 17:199 Lactarius scrobiculatus 17:153, 196, 197 Lactarius subvellereus 17:198 Lactarius thejogalus 17:200 Lactarius torminosus 17:196, 197 Lactarius vellereus 17:153, 196, 197 Lactarius, metabolites 7 S, 8 R, 8' R-(-) -Laric ires ino [1] [2] [3] [4] Larikaempferic acid methyl ester 29:100 activity in EBV assay system 29:100 Larix decidua 17:332 Larix kaempferi 29:99 Larix leptolepis 20:613; 26:185 Larmor frequency 9:127, 131 Larrea divaricata 17:315 Larrea tridentata 5:9; 26:187, 205, Larus asrgentatus 5 Lefevreiosides A~, A2, C and D 15:96 NO-Leghemoglobin complex 26:937 Legionella pneumophila 91, 139, 611; 25:92, 180, 186, 188, 246, 248, 465; 26:637, 871, 931 ; 27:443, 766 saponins from 21:642 Leguminous isoflavone reductase (IFRs) 25:319 Leishma braziliensis 18:791, 793, 794; 26:779, 780, 783, 786, 789, 790, 793, 801, 803, 805, 807, 808, 810, 821, 822, 824, 828 5:287,288,316;23:111, 115,131;25:450 1:528;5:513,9:368,559, 560;17:642;22:126,434,437;25:274, 275,939-940;30:192,225 and macrophages 30:192 [3,20[3-epoxydihydro- 13:654 Lignans 5:9, 459, 503, 753, 754, 311; 17:313, 441 ; 273, 613; 24:215, [228] [229] [230] [231] [232] [503] [504] [505] [506] [507] [508] [509] 26:229, 790, 813, 887 ; 30:560, 562, 567, 570, 590, 594 ; 24:215, [228] [229] [230] [231] [232] 26:206, 207 9:300,302,303 Limocin B 9:300,302,303 Limocinin 9:300,304,305 Limocinol (tirucalla-7,24-dien 1613-ol) 9:300,301 Limocinone 9:300-303 Limocitrin rhamnoside 25:594 Limocrocine 21:374, 405, 407 Limonen 20:6, 13, activity in lung-1, RAS bioassay system 29:83 (+)-Limonene 5:702;10:412;15:257; 21:585;27:372 Nazarov cyclization of 10:412 (-)-Limonene 16:211,216; 21:585 Limonene 16:211,221,260; 20:6,13,16; 21:574,599,600,607,614 ; 25:44,125, 133,140,145-147,149,150,15130:723 structure of 30:723 (d)-Limonene 21:585,618,621 8-Limonene 23:818 d-Limonene 27:386; 29:83 activity in AM assay system 29:83 activity in GPx assay system 29:83 activity in GST assay system 29:83 activity in NFkB assay system 29:83 activity in RAS assay system 29:83 activity in mam-1 assay system 29:83 activity in mam-2 assay system 29:83 activity in stoma assay system 29:83 477 activity in AM assay system 29:83 activity in TPA assay system 29:83 activity in liver-1 assay system 29:83 activity in lung-1 assay system 29:83 activity in AM assay system 29:83 R-(+)-Limonene 5:732, 733; 8:48; 75; 16:208, 225 ( 9:307,20:492;22:146 from Trichilia emetica 20:492 Linalool 13:332; 20:587; 21:589, 600, 602, 607, 612, 615; 22:509, 511, 537; 25:125, 136, 140, 142, 162; 26:396, 397; 28:406, 413 13:304,305,311,313,659; 21:187,189;22:317;26:361,433,434, 461;27:68 15:521 ; 27:267; 29:587, lupinine from 5:299 Lutein 7:20, 98, 320, 336, 350, 351, 352, 363, 584, 727, 733 7:318,319,321,322,327-354, 358;20:561,587,588,725;26:299,300; 30:525 in prostate cancer prevention 30:525 structure of 30:525 (7Z, 9Z, 7'Z, 335 from (9Z,7Z,9Z)-neurosporene 7:332 Lycopersene 7:325, 326 Lycopersicon esculentum 18:523,529, 532,533;25:294,298,657;29:591,604, 608,610 1:333, 334 Lycorine 20:234, 347, 351, 356, 367, 368, 384; 21:97; 22:29; 26:581, [609] [610] [611] [612] [613] [614] 617, 618 from Narcissus pseudonarcissus 20:233 Lycoris incarnata 20 26:434,435,437, 439,447-450,460,462,463,466,467, 469,471,473,476,483-493,1289 Meloidogynejavanica 26:429,430,456, 464,466,473,478,482 Meloidogyne spp. 26:428,430,432,437, 481 29:83 activity in GST assay system 29:83 cis and trans 25: 7, 8, 9, in Artemisia austriaca 7:207 193 4:11,18,29,31-36,39, 42,45,62,69,72,143,203-208, 216-218,235,270,278,287-289,291, 315-338;6:397,398,406 1:190,191 (-)-epi-Ophiocarpine 1:190,191 Ophiocoma dentata 7 Ophiosparte gigas 15:99 Ophioxanthin 28: 721 5,6,5 '-6'-tetrahydro-[3,[3carotene-3,4,3 ',4'-tetraol 4,4 Phylum chordata 28:621 Physagulin C 20:180, 242 Physagulins E 20:194 from Physalis angulaten 20:194 Physagulins G 20:194 from Physalis angulaten 20:194 Physalis angulata 20:180,182,194,247 Physalis berghei 20:522,524 Physalis cordeana 20:470 Physalis cubeba 20:619 Physalis lancifolia 20:182 Physalis minima 20:234,238,247 A4,6-hydroxyphysalin from 20:189 Physalis mirabilis 20:859 Physalis peruviana 20:247 Physalis pubescens 20:180,189,191,247 physapubescin from 20:189 physapubenolide from 20:189 pubescenin from 20:191 Physalis vulgaris 20:845,849,851,853, 854,857 Physalis yoelii from Physalis peruviana 20:191 Physangulide 20:246 Physapubenolide 20:180, 191, 242 from Physalis pubescens 20:189 Physapubescin 20:180, 189, 191, 224, 224, 242 from Physalis pubeseens 20:189 Physarium sp. 5:275 Physarum polycephalum 5:275,276; 28:133;29:23 ;223,239;29:239 all-trans-N-[ 11-(2-acetylamino-3-hydroxyphenyl)2,4,6,8,10undecapentaenoyl with Cu (I)-tributylphosphine 4:556,557 Tandem Michael-aldol reaction 3:138-143 Tandem process (two-stage coupling process) 12:55-58 mechanistic consideration of 12:55-58 Tangeretin (5,6,7,8,4'-pentahydroxy- flavone) 23:747;29:573 effects on HIV-1 protease 29:573 Tangeretin (5,6,7,8,4'- 3:12:179,180;21:96;22:217, 218 ;23:490;24:269,271,276,405,933-972;25:244,245;26:753,811,812,828, 830;27:857; 7:18,19,21 ;21:79,80;25:294, 295,296,297,298,299,300,301,302, 306,311,312,315-322;26 Chaetoglobosin D 13:108 Chaetoglobosins 13:108 Chaetomella acutiseta 21:194 chaetomellic acid A from 21:194 chaetomellic acid B from Chaetomium globosum 21:211,220, 221,229;28:125 2-(buta-1,3-dienyl)-3-hydroxy-4(penta-1,3-dienyl) tetrahydrofurane from Chagas disease 2:293,302;24:818,819; 26:673,787 ;30:740 by Trypanosoma cruzi 30:740 treatment of 26:787 Chain elongation 4:199 of D-mannopyranose system biosynthesis of 17:465 from moraceous plants 745,928 antiparasitic activity with 26:800 molluscicidal activity of 7:427 E-Chalcone 26:471 Chalcone derivatives 7:207 in Artemisia palustris Chalcone isomerase 25:668 Chalcone reductase 25:653 Chalcone synthase 25:655 malonyl Chalcone synthesis Khan's method for Chamaecaparis nootkatensis 23:341 Chamaecyparis obtusa 25:246 702 Chamigrenal 26:244 as PAF-induced inhibitor 26:244 Chamigrene precursor 6:30 Chaminic Chamomila recutita 22:427 fl-D-glycosyl-7-apigenine from 22:427 luteolin from 22:427 quercetin from 22:427 Chamydosporol Brownbridge procedure in (-)-pseudopterosin-A synthesis Charamin 18:677 from Chara Charatoxins 18:697 Charged carotenoid species 30:515 Charonia sauliae 7:306 Cheimonophyllon A&D 26:457 of isoquinoline alkaloids 30:597 of lignans Chemopreventive agent 26:219 genkwanin as 26:219 (+)-lariciresinol as 26:219 sitoindoside II Chemopreventive efficacy 27:386 of limonene carcinogenesis 27:386 Chemoprophylaxis Chemoselective epoxidation 14:366 Chemoselective hydroxylation 6:79 ofbicyclic triene 6:79 Chemoselective reduction 10:85;30:25 of unsaturated ester 30:25 with lithium tri -tertbutoxyaluminohydride 10:85 Chemosensitizers 30:595 antimalarial drugs as Chemosystematic markers 6:155 acetylenic carotenoids Chemotactic tripeptide 25:275 Chemotaxonomic markers 26:1128 Chemotaxonomy 27:369 Chemotherapeutic agent 30:5,330,742 atovaquone 30:330 for colon cancer 30:5 for multi-drug resistant cancers 30:5 for taxol-resistant breast cancer 30:5 Chemotherapeutic intervention 30:397 targets for Chemotherapy drug 27:436 antitumor activity Chenopodium ambrosioides 20:12 Chenopodium anthelminticum 20:12 Chenopodium botrys 21:584 Chenopodium quinoe 9:402 Chenopodium spp Cherimolin 26:441,442 Chest pain 30:203 use of ginseng root in 30:203 Chewed garlic 23:465 Chichipegenin 27:44 Chida's synthesis 30:38-40 of (-)-pironetin Chilo suppressalis 24:715 Chiloscyphone 18:609 Chiloscyphus polyanthos 2:278,279 Chiloscyphus rivularis Chimeramycins A&B 5:614 Chinensinaphthol methyl ether 26:194 Chinese crude drug 28:202 sanggenon A from 28:202 sanggenon C from 28:202 sang-Bai-Pi as Chinese medicinal plants 21:729 bioactive natural products from Chinese mulberry tree 28:202 isoprenylated flavonoids from Chloroorcinols 25:757 m-Chloroperbenzoic Chlorophenyl) sulfinyl acetate 21:380 bis-2-Chlorophenylhydrazones 12:379 Chlorophora tinctoria 22:360 Chlorophyllin 30:765 with dioxins Chlorophylls a,b,c 20:728 Chlorophyta Chloroplumbagin 2:212 386 with methyl 2-acetamido-4,6-Obenzylid-ene-2-deoxy-~x-Dglucopyranoside Chloropseudomonas ethylica 7:363 Chloropuupehenone 15:299 Chloropyridine Chloropyridine-3-carboxylate 20:864 to 3-hydroxymethyl-6-chloro Chondroitin sulfate D-glucuronic acid 30:101 D-N-acetylgalactosamine Chloroquine diphosphate Chloroquine potentiating antiplasmodial activity 30:597 in vivo 30:597 of laudanosine Chloroquine sensitivity 30:595 in resistant Plasmodium species Chloroquine-enhancing effectiveness 30:596 of alkaloids DMSO reaction with 6:310 monochlorinated sulfoxide from 6:310 N-chloroamines from 6:437 Chlorosulfolipid 28:655 stereochemistry Chloro-tris-( triphen yphosphine ) rhodium decarbonylation with 5:802 Chlorowithanolides 20:223 Chlorphenamine Chlorproguanit-dapsone 26:783 4-Chlorugenic acid 23:757 Chocolate spot disease as putative satiety factor 24:910 effect on contraction 24:910-913 effect on relaxation 24:910-913 related peptides 378 Cholelithiasis therapy Choleretic 22:346 Achyrocline satureioides as 22:346 biological activity 24:799 Choleretic activity 23:356 Cholesteryl 3,4,6,-tri-O-acetyl Cholesteryl acetate 9 Cholesteryl palmitoelaidate 9:457 Cholesteryl palmitoleate 9:456 Cholesteryl stearate 9 Choline sulfate 24:1007,1008 occurrence of 24 Cholinergic activity 21:736 Cholinergic antagonists 21 Cholinergic decumbenines 21:733 Cholinergic receptor 21:51 Cholinestrase inhibitor huperzine A Cholistane-3fl,5 t~ Chondria baileyana 26:479 Chondria californica 25:842 Chondria oppositiclada 6:40 cycloeudesmol from Chondria sp. 26:488 Chondria tenuissima Choriaster granulatus 7:299 Choriocarcinoma 14:805 vinblastine for 14:805 vincristine for Chorismate mutase 11:188,189 prephenic acid from 11 Chorismic acid 11:187 anthranilic acid from 11:187 from 5-enolpyruvylshikimate 3-phosphate 11:187,188 phenylalanine from 11:188 tyrosine from 11:188 Choristoneura fumiferana 22:388 6-Choro-9 Chromanes 4:391 from isoprene 4:391 from phenols 4:394 in prenylation methods by adsorption chromatrography 9:450-453 by gas chromatography Chromatographic analysis 21:535 Chromatographic methods 21 Chromatographic techniques 30:591 fractionation Chromenes 2:126 342 Chromis chromis 21:364 Chromium (II) reagents 3:81 Chromobacteria Chromodoris elisabethina 28:650 icthyotoxic latrunculin A from Chromodoris macfarlandi 17:11 Chromodoris maridadilus 6:69 Chromodoris norrisi 17:12 Chromodoris sp Chromogenic assay 30:834 of chromogenic substrate 30:834 specificity of Chromogenic substrates 7:53 Chromomycins 4:245 Chromophoric oligopeptides 30:835 role in assay 30:835 Chromophoric procedure 30:834,835 role in assay 30:835 Chromosome Chromozym TH 30:840 Chronic diabetes complication 30:697 cataracts in 30:697 peripheral neuropathy in 30:697 retinopathy in 30:697 Chronic experiment 27:313 Chronic inflammation alleviation 24:887-895 by medicinal plants Chronic leukemia 26:925 Chronic pain model 30:203 activity of ginseng in 30:203 Chronic painful inflammatory diseases 30:206 pro-inflammatory substances in 30:206 Chronic rheumatoid arthritis 30:204 monodesmodides in 30:204 treatment of 30:204 use ofhederaginin 30:204 Chronic toxicity studies 27:308 Chronic viral Chryosplenoside A 5:682 Chrysamin Chrysanthemum cinerarifolium 28:384 pesticide properties of 28:383 secondary metabolites from Chrysanthemum frutescens 9:317 Chrysanthemum golden 20:246 Chrysanthemum mortifolium 22:122 Chrysanthemum parthenium 27:376 Chrysanthemum sp. 7:427 trans-Chrysanthemyl alcohol Chrysanthenum coronarium 25:944 cis-Chrysanthenyl acetate 9 29:572, 577 effects on aminopeptidase N 29:577 effects on HIV-1 protease Chrysocephalum ambiguum 25:251 Chrysochromulina species Chrysomma sinensis 5:837 hemoglobin components of 5:837 Chrysomycin 10:347 Chrysophanic acid 22:609 Chrysoplenium pseudofauriei 5:678 Chrysospermins Chrysosplenium americanum 5:682 Chrysosplenium flagelliferum 5:682 Chrysosplenium grayanum Chrysosplenoside E 5:682 Chrysosplin 5:682 Chugaev reaction 4:45 Chukrasia tabularis 9:105 Chymacyparis taiwanesis 29:698 et-Chymotrypsin 2:35 Leu-X cleavage site of 30:837 Phe-X cleavage site of 837 Culmoriuns 13:519,536,537 from Fusarium culmorum 13:536 synergistic effects 13:536 toxicity of 13:536 Chytridiomycetes Cicer arietinum 18:719 145 inhibitor of dehydropeptidase 643 Cidofovir 24:486,487 as anti-viral agent Cieplak's theory 29:127 in sesquiterpenoids drimane-type synthesis Cimicifuga dahurica 22:516 Cimicifuga racemosa 27:277 Cimicifugic acid A 27:395 Cinachyra sp Cinchona ledgeriana 26 Cinchona officinalis 25:476 Cinchona robusta 30:344 suspension culture of Cinchona succiruba 26:779,780,820 antimalarial activity of 26:779 Cinchonamine 22:147 Cinchonidine 21:96,97 Cinnamaldehyde 21:621,622 trans-Cinnamaldehyde 27:16,33 structure Cinnamate 4-hydroxylase 5:467,468 Cinnamic acids 5:459 as anticonvulsant 22:516 for hysteria 22:516 for epilepsy Citpressine II 13:350 from Citrus grandis 83 activity in skin-1 assay system 29:83 activity in TPA assay system Citramalic acid 8:305 Citranaxanthin 20:606 192 in mangrove plants Citric acid cycle 9:554 Citronellene 17:605 R-(+)-Citronellic acid 16:344 Citronellic Citrullus vulgaris 29:614 Citrus auranhtium ssp Civetone 8:223,224 acyloin condensation of 8:224 from Viverra civetta 8:219 Wittig reaction of 8:223 L-Cladinose nucleosides 4:256 Cladobotrin 26:449 Cladobotryum rubrobrunnescens (Hyphomycetes Cladobotryum varium 26:449 Cladonia alpestris Cladonia crispata 5:310 Cladonia mitis 5:310 Cladonia rangiferina 5:310 Cladonia sp. 5:310 Cladonia squamosa 5:310 Cladophora fascicularis 5:367 Cladosporin Cladosporium sphaerospermum 26:228 Cladosporium suaveolens Cladosporium wemeckii 5:301 Cladosporum herbanum 7:119 Cladrastis lutea Coccinelline 6:447 from tetrahydropyridinium salts Cocculus sermentosus 22:517 for epilepsy 22:517 for nocturnal epilepsy Cocculus trilobus 3:488 Cochineal 20:729 Cochliobolus lunatus 25:318 Cochliobolus miyabeanus 23:133 Cochlioquinone A 26:460 Cochlodinium polykrikoides 30:400,408 anti-influenza activity of 292 Coclaurine 24:887 effect as neuromuscular blocker Codium arabium 25:704 Codium dwarkense 25:725 Codium latum 26:1138 Codonocarpine 9:73 Codonopsis Coenzyme A thioester 11:197 coenzyme B ~2-dependent rearrangement Coffea arabica 29:578 Coffea sp. 21:502 Coffee bean 2:116 Coffein Cognitive functions 30:368 role of raphe nuclei Coix lachryma 27:193,212 S)-colchicine as 29:357 (+)-(aR,7,S)-colchicine as 29:357 allocolchicinoid synthesis from 29:364 as antimitotic agents 29:357 as tubulin assembly inhibitor 29:357 discovery of 29:357 in gout treatment 29:357 NMR of 29:358 SAR of 29:357 X-ray structures cf Colchicum autumnale 5:46 Colchicum kesselringii 29:356 Colchicum luteum 22:517 for epilepsy Colchicum ritchii 29:358 Colchinol analogue 29:378 allocolchicinoids total synthesis of 29:378 Cold press extraction 21:574 Colebrookea oppositifolia 22:517 for epilepsy Coleus amboinicus 22:517 Coleus aromaticus 22:517 for convulsive affections 22:517 for epileptic affections Collisional activated decomposition spectrum (CAD) 5:634 Collisional activation (CA) spectra 5:633 Collision-induced decomposition (CID) Collision-induced dissociation (CID Colocynthis vulgaris 5:743 Colon 26 carcinoma 19:609 Colon cancer 23:293;30:5 clinical development for 30:5 chemotherapeutic agent for Colorectal carcinomas 30:762 in rat model 30:762 induction by 1,2-dimethylhydrazine (DMH) 30:762 use of Chlorella vulgaris for 30:762 Colorenone 21:285 Colorimetric assays 21:508 Colubrina asiatica 21:673 jujubogenin-3-O-glycosides from 21:673 Colubrinol Comantheria briareus 7:266 Comantheria perplexa 7:266;28:719 polyketide sulfates Comanthula pectinata 7:266 polyketide sulfates Comanthus parvicirrus 7:266 Comatula pectinata 28:719 anthraquinones from 28:719 Combined effects 27:438 506 Galacturonorhamnans 26:1156 Galangin Galanin receptor antagonists 27:799 Galanolactone 23:801 Galanthamine 4:3,4 521 Galinum sinaicum 26:220 bis-glucoside derivatives from 26:220 Galiosin 631 Galium sylvaticum 22:521 Galium verum L. 22:521 for epilepsy and hysteria Galleria mellonella 22:384 Gallic acid 23:537,551,740,746; 26:359,798;28:280;30:208 analgesic effect of 30:208 derivatives of 30:208 design of 30:208 structure Gallic Wars 19:140 Gallicin Gallocatechin 3-gallate (flavan-3-ol) 29:585 effects on proteasome CHYlike activity 656 Galphimia glauca 22:521 for epilepsy 22:521 Galpinone Galsky potato disc Gambusia affinis Germination inhibitor 1:684 synthesis of Gernayl geranyl pyrophosphate 25:248 Gerrardine 7:192 Geseneriaceae 25:251 Gestogens 17:623 semi-synthesis 644 Giardia intestinalis 26:1063 C20Gibberelins Gibberella pluicaris 25:293, 305 as gibberellin A3 6:171,172 from gibberellic acid 6:199 gibberellenic acid from 6:199 growth effect on root culture 17:425 total synthesis of 6:181-183 synthesis of 8:116 Gibberellic acid (GA3) Gibberellin oxo esters 8:128 Gibberellin thioanalogs Gibberellins GA60 8:121,122 from GA3 8:122 synthesis of 8:115 Gibberellins GA7 8:119 from GA3 8:119 synthesis of 8:115,119,120 allo-Gibberic acid 8:117 synthesis of 8:117 Gibberic acid 8:117 synthesis of Giffordia mitct~ "ae 21:306 Gigantecin Gigartina skottsbergii 30:402 carrageenans from Gilben's reagent 26:1245 Gilman reagent Glabridin 27:846;28:228,241 anti-Helicobacter pylori activity of 28:241 anti-microbial activity of 28:224 biological activity Glabrocoumarone A 28:229 biological activity 228 biological activity from Marthasterias glacialis Glaucarubin 7:394,398,660 Glaucium genera 27:163 Glaucocalactone 15:141,149 Glaucocalyxin D 15:114 Gleditsia macracantha 26:1140 Gleditsia saponins 15:191 Gleditsia triacanthos 26:1115,1116 Gleosporium fructigenum 18:715 y-Gliadin 25:320 Glial cell Gliocadium virens 21:238 Gliocadium virens deliquescens 21:238 Gliocadium virens fimbriatum 21:238 Gliocladic acid 21:230 Gliocladium deliquescens 21:225 Gliocladium fimbriatum 21:182,218 viridol from Gliocladium flavofuscum 21:238 Gliocladium fujikuroi 21:227 Gliocladium sp Gliocladium vermoesenii 21:207 nectriapyron from 21:207 vermopyrone from Glisoflavanone 28:228 biological activity Globodera rostochiensis 26:229 Gloeoplyllum sepiarium 23:354 Gloeosporium lacticolor 15:351 Gloeosporone 9:220 109 D-Glucuronopyranosyl 15:7 Glucuronoxylans Gluta renghas Glutamate N-methyl-D-aspartate receptor (NMDA) Glutamate /NMDA receptor 21:70 Glutamate receptors 30:208 Glutamate transporters 25:536 (S)-Glutamic acid 12:322 Glutamic pyruvic transaminase (S-GDT) 21:651 Glutamine synthetase 7:6 y-Glutamyl cysteines Glutaric acid derivative Glutarimide intermediate 6:410 Glutathione 5-transferase (GST) activity Glutathione peroxidase (GPx) 9:109 Glutin-5-ene 25:59 Glutinane 25:53,59 Glyasperin A 28:226,228 anti-human immunodeficiency virus (HIV) activity of 28:226 biological activity Glyasperin D 28:224,228,243 anti-Helicobacter pylori activity of 28:243 anti-microbial activity of 28:62 Glyasperin K 28:228 biological activity homologation of 30:455 synthesis from Glyceraldehyde-3-phosphate dehydrogenase 21:229 Glyceraldehyde-3-phosphate (GAP) Glycerol tri-myristate 2:48 Glycerol-3-phosphate dehydrogenase inhibitory activity Glycine max Glycine receptor 21:72;25:530 Glycine soya Glyco analogues activity 30:817 in vivo from potato 25:305 molluscicidal activity Glycocyamidine 5:549 Glycocyamine 5:549 Glycoenkephalins Grignard reagent 4:160 Grindalia haverrdii 25:252 Grindelic 757 effect of general analogues on PGF2 NA-induced contraction Gromphadorhina portentosa 9 Grosshemin 1:556 Group transfer polymerization 8:409 Growth 30:61 of tumor cells 30:61 Growth inhibition 17:142 Growth inhibitor activity 7:407 Grubbs ruthenium catalyst 30:463 Grundmann ketone 10:54 Gryllus domesticus 22:387 GST activity 21:585 GTP-binding protein 25:385 GTP-bound stimulatory G protein (+)-Haedoxan A 26:231,232 (+)-Haedoxan B 26:231 HA) 16:93,102 Haematococcus pluvialis 21:305 Haematoxylin 15:34 Haemolytic activity 23:512 of saikosaponins 23:512 Haemonchus Haemopoietic stem cells 30:766 Haemorrhagic fever virus (CCHFV) 30:410 Hairy root cultures 17:426 Hakamori method 2:336;15:192 Hakamori permethylation Hakea amplexicaulis 9:320 tlakea gibbosa 29:576 Hakea persihana 9:320 Hakea trifurcata Hakomori's procedure 27:512 Halcyon smyrnensis 5:837 Halenaquinol 6:4 Halenaquinol sulfate 28:677 absolute stereochemistry of 28:677 as pentacyclic hydroquinone 28:677 as yellow pigment 28:677 Halenaquinone Halichondria melanodocia 5:387 Halichondria okadai 5:378 Halichondria panicea 17:719 diterpenoid from 28:659 from Marshall islands 28:660 guai-6-ene skeleton of 28:660 sesqui-and diterpenoids from 28:659 Halichondria sponge 21:252 Haliclona exigua 21:267 Haliclona nigra 28:684 from Papua New Guinea 28:684 haligramides A Halicona kormella 25:722 Halicona oxigua as antifungal substance 28:680 as cytotoxic substance 680 as antifungal substance 28:680 as cytotoxic substance 680 as antifungal substance 28:680 as cytotoxic substance Halipanicine 25:852 Halipanicine 28:661 total synthesis Halistanol sulfate 28:698 antimicrobial activity of 28:698 hemolytic activity of 28:698 ichthyotoxic activity of 28:698 pp60v-src protein tyrosine kinase inhibition Halymenia porphyroides 9 Hamamelis virginiana 21:543 Hamigera tarangaensis Haminaea templadoi 26:90 Hamioea cymbalum Hamster assay 21:671 Hamster fetus 23:570 encephalocele Hanalpinone 814 Hanessian reaction 1:511 Hanessian's deconj ugation-epimerization 12:13 of avermectin Bla Hanessian's epimerization 12:28 macrocyclization with Hanessian's procedure 12:347 from debenzylidenation Hanfillin 27:564 Hanging drop vapor-diffusion technique 30:831 of EFEa Hannoa klaineana 18:726 Hanseniaspora osmophila 5:283 Hansenula beijerinkii 5:287 Hansenula bimundalis var Hansenula ciferii 5:287 Hansenula fabianii 5:287 Hansenula minuta 5:315 Hansenula mrakii 5:287 Hansenula polymorpha 22:601 Hansenula saturnus 5:287 Hansenula sp. 5:281 Hansenula subpelliculosa 5:282 Hansenula wingei Hansfordia pulvinata 6:413-415 IH, laC-NMR of analogs 6:413-415 of MurNAc 6:413-415 Hantzsch synthesis 4:86 racemization during Hapalindole Q 16:131 Hapalindoles 11:278 from Hapalosiphon fontinalis Hapalochlaena maculosa 18:724 Hapalopilus nidulans 29:265 Hapalopilus rutilans Hapalosiphon fontinalis 11:278 Hapatocyte necrosis 25:462 Hapatotoxins Haplophyllum dauricum 17:335 Haplophyllum dubium 22:522 Haplophyllum glabruinum 22:522 Haplophyllum hispanicum 26:263 diphyllin acetyl apioside from 26:263 tuberculatin from Haplophyllum perforatum 703 as HIV-1 integrase inhibitor Happlopappus arbutoides 25:251 Happlopappus pulchellus Harappamine 2:176 Hormone-like substances 6:538 Hormones Homer Bestmann oxidation 8:207 Homer reaction 6:285 carbon elongations 29:127 in sesquiterpenoids drimane-type synthesis Horner-Emmons olefination procedure 30:458 for ketene dithioacetals Emmons reaction 12:30 Horsfieldia iryaghedhi 5:753 Horsfieldin Hortia arborea 4:400 furanocoumarin from Hortia regia 22:400 diabetes inflammation 30:224 intestinal diseases 30:224 neurodegeneration 30:224 reperfusion injuries 30:224 respiratory disorders 30:224 role of free radicals in 30:224 Human growth hormone Human HEK 293 cell line 30:781 biological response of Human HL-60 leukemia cells 30:496 differentiation of 30:496 inhibition of 30:496 proliferation of Human immunodeficiency virus type-1 25:948 Human interleukin Human leukemia cells 18:269 Human leukocyte elastase 16:727 inhibitor Human leukocyte elastase (HLE) 30:830,831,843 homologous sequences of 30:831 plasminogen activator (u-PA) 30:830 Human lung carcinoma 23:290;30:5 discodermolide against 30:5 A-549(Human lung carcinoma) 30:691 phenolic triterpenes against 30:691 Human medulloblastoma 23:290 Human melanoma 23:255 Human mesangial cell proliferation 30:308 in vitro Human monoblastic leukemia cells 30:498 effect of hydroxyurea (HU) Iryanthera sagotiana 22:355 Isatis tinctoria Ischaemia reperfusion 22:438 Iso-6-cassine synthesis 29:419 by stereodivergent process Isoagatholactone 6:57 synthesis of 6:57 Isoagatmic 568 Isoamyl acetate 25:129 Isoamylases 10:498 Isoanacardic acid 9 Isoarcapillin 227 737 structure of 30:737 Isobaccharinol 30:736 structure of Isobrafouedine 6:172 biosynthesis of 6:521 spectral data of 829 F-I as 30:826 F-I-0 as 30:826 F-I-2 as 30:826 F-II as 30:826 F-I-I as 30:826 F-II as 30:843 F-Ill as 30:826 F-III-1 as -2 as 30:826,843 from Phaseolus vulgaris 9:563 immunological analyses of 3-peltatin B methyl ether 18 Istanbuline D 20:660 from Salvia yosgadensis 20:660 ltersonilia tilletiopsis 5:291 Itocyclization Jaborosalactone M 20:181 Jacaranda acutifolia 5:682 Jacaranone 16:616 Jaceidin 7:227 Jaceosidin Jaceosidine-7,4'-disulphate 5:655 Jadiffine JAK/STAT-linked receptors 25:520 JAK/STAT pathway 25:519 Janolus cristatus 28:146 Janolusimide 28:146 from Janolus cristatus 28:146 neurotoxic lipophilic activity of 28:146 Janua bioticus Jasminum officinale 7:218 anthelmintic activity of 5:429 antifungal activity of 5:428 derivative 25:768 Jaspis coriaceae 25:725 Jaspis splendans 25:768 Jaspis sponges 21:252 jaspamide from 21:252 Jaspisamides 25:727 Jaspisin 28:697 sea urchin hatching inhibition by 28:697 Jasplakinolide Jatropha curcas L. 22:524 for convulsions and fits 524 as anticonvulsant 524 as anticonvulsant Jauch 29:127 sesquiterpenoids drimane-type synthesis by 29:127 Jaundice 22:643 JB6 cell line 30:593 tumor-promotion in 30:593 JB6 cell line transformation 30:592 inhibition of 3-dihydroxy-2-methyl)-butanoate 449 Jerumanis method 21:511 metal complexing assays 21:511 (+)-Jerusalemine 29:377 allocolchicinoids total synthesis Jiuhuanin A 15:130 13C-NMR of 15:155 from Rabdosia macrocalyx var. jiuhua 15:173 lH-NMR of D-glyceraldehyde derived allylic alcohols 10:436,437 of 4-(3-hydroxy-1-propenyl) derivatives 328 Jones map 17:539 of amino acid residues 17:539 Jones model 17:507 Jones oxidation 4:50 654 Joullie Ju-Fang synthesis 6:14 of (+)-polygodial 6:14 of (-)-polygodial 6:14 of Juglans mandshurica 26:899 Juglans regia 21:503 Juglone derivative 4:396 Julandine 1:363 synthesis of 1:365 Julia coupling 1:457 Julia sulfone 1:463 Julia synthesis 9:356 of 16 Juniperus foetidissma 8:163 8,14-cedranoxide from Juniperus macropoda Juniperus occidenatalis 28:408 Juniperus procera Leishmania mexicana amazonensis 2:314 carbohydrates Leishmania panamensis 21:674 Leishmania tarentolae 2:298 Leishmania tropica 21:674 Leishmania tropica major 2:314 polysaccharides molluscicidal activity Lemna bioassay 9 Lemnalia africana 25:695 Lemon 23:747 Lemon juice phenolics 23:748 HPLC chromatogram 594 activity in human cancer cell line 30:589 activity in murine cancer cell line 30:589 as platelet aggregation inhibitor 30:594 cytotoxic effect of 30:589 N~-Maleoyl 562 R-(+)-Malic acid 16:691 L-Malic acid 4:125 chiral ylide from 4:125 in mangrove plants 6:263 in mangrove plants Malic acid 8:140; 365 Malic acid dehydrogenase Malic acid ester 6:287,290 (S)-butan-1,2,4-triol from Malic conjugates 28:262 in grapes 28:262 in lettuce 28:262 in spinach 28:262 in wines 28:262 Malignant tumors 21:158 Mallotus philippinensis MMuLV) inhibition by 29:127 Malonic acid 13:53,67 in mangrove plants Medicago scutellata 29:598 Medicago trunuclata 877,878; 30:55 chronic inflammation alleviation by 24:887-895 effect on neuromuscular synapse 24:877,878 for allergic inflammation 30:55 for arteriosclerosis 30:55 for cancer 30:55 for coronary artery constriction 30:55 for coronary heart diseases 30:55 for diabetes 30:55 for hypertension 30:55 for thrombosis 30:55 for tumor metastasis 30:55 for tumors Mediterranean fever 30:194 use of A6-tetrahydrocannabinol (THC) Medium ring ethers 10:201 biological activity of 10:201 synthesis of Oppenauer 14:481 reaction intramolecular Meerwein's reagent 8:205 Megaphone 16:705 synthesis of 16:705 Megaphone acetate 26:212 cytotoxicity of 26:212 a-Megaspermin Meglumine antimonate (glucantime Meisenheimer rearrangement 6:468 ofallocryptopine N-oxide 6:468 of cis-(+)-laudanosine N-oxide MEL-28 (human melanoma) 30:691 phenolic triterpenes against Melaconis thelebola 26:596 Melaleuca acacoides 28:419 Melaleuca alternifolia 21:615 Melaleuca argentea 28:418 Melaleuca dealbata 28:418 Melaleuca leucadendron 15:387 phyllodulcin from Melaleuca quinquenervia 21:616 Melaleuca saligna Melaleuca sp. 28:418 Melaleuca symphycarpa Melampolides 7:210 from Artemisia gypsacea Melanin formation assay 21:589 Melanine pigment 16:615 physiological role of 16:615 Melanins 26:1018-1020 biosynthesis 573 3-Methyl-2-norbomanone 8:146,147 3-Methyl-2-oxo-indolizidine 12:284 from ethyl 2-[ 1-ethoxycarbonyl methyl) piperidinyl) propanoate -Methyl-2-oxopenlyl) dihydrochelerythrine Methyl-2-phenyl-6-heptene 8:10 cyclization of 8:10 6-Methyl-2-phenyl-6-1ithio-2-heptane 8:13 2-Methyl-2-vinyl tetrahydrofuran-5-one -methylbutyl)-2-(E-3-methylpent-1-enyl)-pyrazines 5:226 -methylbutyl)-2-(Z-3-methylbut-1-enyl)-pyrazines 5:226 Methyl-3,4-dimethoxybenzalmalonate 9:225,226 4-Methyl-3,5-bis(3-trifluoromethylphenyl)pent-2-en-3-one Methyl-3,6-dio xo-4-doc o s eono ate 23:211 1-Methyl-3-acyl-5-hydroxymethyl-2,4-dione 2-Methyl-3-buten-2-yl acetate 11:130 decarboxylation of 11:130 2-Methyl-3-buten-2-yl-ester 11:129 (3S,4S)-4-Methyl-3-heptanol 1:681,682; 11:415 from (R, R)-diisopropylethanediol propylboronate 11:415 from (S)-pinane diol propyl boronate 11:412,413 from Scolytus multistriatus 11:142 synthesis of 11:412 Methylvinyl ketone 6:427,428 in solenpsin A synthesis Methylxanthine theophyline 25:532 Methylxanthines Methyoxy-2-phenylquinoline 26:820 2,3-B is(M ethyo xycarbonyl )-1-( 3,4-dimethoxy phenyl)-4-hydroxy-6 Metridium illicifolia 18:665 Metridium loesner 18:757 Metridium senile 18:813 Metronidazole Narin-II8-4'-Ome-eridictyol 30:207 activity in formalin test 30:207 activity in writhing test Nash-Davies media 7:97 Nasipuri and Mitra 29:212 miltirone synthesis by Nasutitermes ephratae 27:385 Nasutitermes exitiosus 5:702;21:277 Nasutitermes nigriceps 27:385 Natriuretic effect 26:269 Natriuretic peptides 370 from Citrus natsudaidai 13:370 Natsudain Negishi coupling reaction 30:13 Neighboring group participation 1:204, 205 acetamide assisted displacement 1:204,205 for hydroxyl inversion 1:427 Neisosperma glomerata 1:124 Neisseria 12:63 Neisseria gonorrhoeae 26:673 Neisseria perflava 7:69 Nejkpetin 5:654 Nemalion vermiculare 26:1137 Nematocidal activity Nenrasapora crassa 25:304 ergosterol mutants O-glucoside) 29:587 effects on proprotein convertase from dinoflagellates 25:543 Okadaic acid-induced TNF-a-gene expression Olacaceae 22:720 for hysteria 22:720 Old world cutaneous leishmaniansis 2:314 cause of 589 Olea capensis 5:514 Olea europa Olean-12-ene-3fl Olean-12-ene-3fl, 23,28-triol tri-Ohemiphathalate sodium 25 Oleanene acylated bidesmosides 21:675 Oleanane glucuronoide Oleanane-type saponin 21:662,665, 666,655,674 Oleanen-28,30-dioic acids 7:145 Oleanene glucuronosides Oleanene-28-oic-acid-3-Omonodesmosides 21:675 cyclopentenes 19:355 syn-stereoselective 19:355 Osteoarthritic cartilage 30:318 Osteoarthritis 30:192 use of inflammatory drugs (NSAIDs) 30:192 use of prostaglandin inhibitors Osteoarthritis pathophysiology 30:318 interleukin-113 role in 30:318 Osteomalacia 9:509 Osteoporotic drug 25:711 Ostertagia circumcinta Ostreopsis lentcularis 26:69 Ostrina furnacolis 23:66 Ostrinia nubilalis 26:186 Ostryajaponica 17:369 Ostrya sp Otoba parvifolia 26:186 Otonecine 1:242;8:211 synthesis of 1:242 Ottonia vahlii 21:378 Ouabagenin 3-O-L-rhamnoside 25:535 Ouabain receptor 26:216 Ouchterlony plate technique 7:115 Oudemansiella mucida 3:257 Ourouparine 1:125 Ovaliflavanone B 4:378 allylation of 4:21 and 6,8-diprenylflavanone in 4:378 Ovarian cancer 24:933 Ovarian cancer treatment 24:933 taxol for 24:933 Ovarian tumor 30:5,27 clinical development for 30:5 chemotherapeutic agent for 30:5 effect of pironetin derivatives in 30:27 inhibitors of tubulin 30:27 OVCAR-3 cells 21:175 Overhauser effect 11:293 515 (+)-Ovigerine 30:565,590,594 activity in human cancer cell line 30:589 activity in murine cancer cell line 30:589 as platelet aggregation inhibitor 30:594 cytotoxic effect of 30:589 Ovihernangerine 30:566,584 by HREIMS of 30:584 ElMS of 30:584 IR spectrum of 30:584 molecular formula of 30:584 UV spectrum of Oxaisotwist-8-en-2-one Oxalacetic acid 30:433,435 as pyruvate equivalent 30:433 reaction of Oxaloacetic transminase 25:935 Oxalyl chloride 9:526 Oxamicetin Oxaquinolizidine 24:578,604,605 13C spectra of 24 Bis-1-Oxaquinolizidines macrocyclic alkaloids 3-Oxathiazolidin-2-ones 14 Oxatropane 6:433,434 solenopsin A from 6:433 417,418 of (+)-catechin 27:774 of cytochrome P450 enzymes 27:348 of terminal acetylene 27:348 of xenobiotics 27:749 of vincristine 27:778 of of 1-isopropylazulene 14:336 of 2-ethyl-5-pentylpyrrolidine 6:444 of 2-furycarbinol 19:473 of 3,3'-methylene bis (guaiazulene) Oxidative cleavage 30:8 ofp-methoxybenzyl (PMB) ether 30:8 Oxidative conversion 19:484 Oxidative coupling reaction 8:160 olefin 8:160 of phenol Oxidative cyclization 9:533 of davanones Oxidative decarboxylation 1:536 of cx Oxidative DNA damage 25:66 Oxidative elimination 3:260 of arylselenide Oxidative halogenation 27:750 and electron transfer Oxidative hydroboration 12:318,322, 344 Oxidative hydrolysis 30:438 formation of 30:438 ofdithioacetal moiety 30:438 of KDO derivative Oxidative Nefconditions 19:73 Oxidative olefination Oxidative rearrangement 16:650 Oxidative transformations Oxidising action 2:3 of NO in CI (NO) mass spectra 2:3 Oxidizing agents 19:120 Oxidizing enzymes 6:520 in Strychnos dinklagei 6:520 Oxido ketones 2:169 CD of 2:169 octant rule Oxidopyridinium ions 1:340 1,3-dipolar cycloadditions of Oxime sulfonate 6:433,43 solenopsin B from 6:433 Oxindole-type alkaloids 5:107 conopharyngine oxindole 5:107 7S-isovoacristine 5:107 Oxinellamides 25:757 Oxirane opening 1:560,561 influence of (x-OH 1:560,561 reaction with lithiated nucleophile 1:157 regiospecifity of 1:560,561 with dilithioacetate 1:558 Oxirane ring opening 30:463 Oxirans 12:411,413 2-amino alcohol by 12:411,413 ring opening of 12:411 E)-2-decenoic acid 19:123 synthesis of 19:123 queen substance 19:123 12-Oxo-11-nor-drim-8-en-14-oic Oxo-16-epi-silicine 5:126 cis-3-Oxo-1-hydroxyindolizidine s 12:279 trans-3-Oxo-1-hydroxyindolizidines Ent-4-Oxo-2,3 3-dihydrosolamin 18:197-199 synthesis Oxo-2'-deoxyguanosine (8-oxo-dG) 8:376 Oxyallyl zwitterion 14:587 Oxyaminations 12:411,413 2-amino alcohol by 12:411 Oxyayanin A 5:679 Oxyberberine 6:470 magallanesine from Oxycyclopropanes 8:34 230 biological activity N-b-oxy-17-oxoellipticine from 6:516 spectral data Oxy-functionalization 27:749 of aromatic amines 27:749 of phenols 27:749 Oxygen compounds 29:317 lysolipins I as 29:317 naphtocyclinone as 29:319 naphtomevalin as 29:319 of simocyclinon D8 Oxygenated cembranes 8:15 Oxygenated homophthalates 11:120 polysubsituted anthracenes from Oxygenated monoterpenoids 27:373 Oxygenated pyrazines 5:246 Oxyhemoglobin 26:986 Oxymercuration 10:67 Oxymercuration cyclization 1:423 Oxynitidine 14:775 Oxystigma buecholtzii 25:165 Oxystiols Oxytocin 2:30 reduction during FAB MS 2:30 Oxytrogenin Oxytropis genera 27:523 Oxytropis sericea 27:516 Oxytropis sp Ozone-triphenylphosphine adduct 4:554 oxidation ofylides with Ozonization reaction 14:416 81,86;30:486,489 in steroid moiety synthesis 30:486 of ergosterol 30:489 cardanol methylether by 9:338 ofalkene 16:462 of diacetate 5:599 ofdiacet Ozonolytic degradation 6:137 of 19'-hexanoylfucoxanthin 6:137 of peridinin 6:137 Ozoroa mucronata 5:824,830;9:316, 327;21:591 P substance 30:193 as pro-nociceptive phosphatidyl linositol)-kinaseindependent pathway 25:264 p l.Moraprenyl, p2_(ot_D_galacto_ pyranosyl) diphosphate 8:108 P-388 model 25:823 P-388 (mouse lymphoma) 30:691 phenolic triterpenes against P-388 (murine lymphocytic leukemia) 30:588 activity of (-)-deoxypodophyllotoxin against 30:588 activity of (-)-yatein against P-388 lymphocytic leukemia cell 25:764 P388 mouse leukemia 12:390 staurosperine activity against 699 Pachiclavularia violacea 17:610 Pachodynerus erynnis 5:223 (+)-Pachydictyol-A 6:11 by reductive transposition 6:11 from Pachydictyon aociaceum 6:11 from c~-santonin 6:13 synthesis of Pachygone dasycarpa 29:578 Pachyman 5:288,317 antitumor activity of 5:317 Pachymatismin Pachymeinopsis lanceolata 25:722 Pachymic acid 22:117 Pachysiphine 5:127,9:190 Pachystazone 20:670 from Salvia napifolia 20:670 Pachystima 18:741 Pacifagorgiol 9:254 from Pacifigorgia adamsii 9:254 X-ray crystal analysis in gas chromatography Paecilomyces lilacinus 26:432 Paecilomyces sp. 25:725 Paecilomyces variotti Paeonia emodi 22:528 for epilepsy, convulsions,hysteria and hysteroepilepsy 22:528 Paeonia lactiflora Paeonia officinalis L. 22:528 for epilepsy, hysteria and convulsions Paeonia suffruticosa 22:528 for convulsions 22:528 Paeoniflorin 22:528,540 Paeonol 21:584,585 PAF 30:594 antiplatelet activity of 30:594 PAF antagonist activity 24:740 of 2,6-diaryl-3,7-dioxa bicyclo Palmitate esters 9:469 of spinasterol 9:470 Palmitic Palustroside III 25:104,106 hepatoprotective activity Panagrellus redivivus 26:429 488 Panal 15:247 from Eupatorium trapezoideum 15:247 Panarine 13:387 holomycin from 21:419 pandamarine from Pandanus odoratissimus 26:255 Pandaros acanthifolium 5:384 Pandine-type alkaloids 5:127 pandine 5:105 Papsorbic 1057 Panic disorder 30:368,369 effect of circadian activity on 369 role of serotonin (5-HT) 296 Paniculatine 18:4 Paniculides 7:118 (R)-Panolactone 13:326 Panotima angularis 26:698 PAN-oxides from Marshallia tenuifolia Pantoneura plocamioides from Pseudothesis species 9:37 from Sarcophyton glaucum 193 as analgesic 30:193 codeine from 30:193 morphine from 30:193 papaverine from 30:193 thebaine from Papaver somniferum 30:193 as analgesic 161 Papaya 29:592 effects on caricain chymopapain 29:592 papaya proteinase papain 13C-NMR shifts 2:182 structure of Papilamine 2:205 (+)-Papilicine 2:205 13C-NMR shifts 2:205 structure of 2:178 Papillary carcinoma 26:712 Papillomas 26:693 Papillomavirus 30:405,394 cause of cancer 30:394 cause of papillomas Papulacandin 10:387 from gluconolactone 10:387 Papulin Paracaudina ransonetii 7:278 caudinoside A from Paracentrotus lividus 15:104 Paracoccidioides brasiliensis 5:307 Paraconic acid 1:687 Paracresol 16:580 oxygenation 122 X-ray structure 367 antiparasitic activity of 28:332 asymmetric synthesis of 28:367 conversion of PHB to 28:335 hydroxylation of MFA 28:335 total synthesis of 28:367 (+)-Paraherquamide B 28:359 conversion of MFA to 28:333 stereocontrolled synthesis of 28:358 Paraherquamides 28:331 Parancistrocerus perennis 5:224 Parancistrocerus rufovestis 5:224 Parancistrocerus sp. A $:224 Parancistrocerus sp Parasitemia 25:329;30:596,694 induction by Plasmodium yoelii N67 cell line Parasitemia inhibitor 30:597 in vivo Parasiticidal activity 26:229 of lignans 26:229 Parasitmia 25:329 Parasorbic acid 13:539 Parastichopus californicus 15:87 holotoxins A, A~, B and B~ Parathyonoside R 7:277 from Parathyona sp Paratocarpus venenosa 29:773 Paratrichodorus Paratylenchus hamatus 26:429 Paravespula vulgaris 14:526 2-methyl-1,6-Dioxaspiro 60 Parinari genus 486 valienamines synthesis by 29:486 Parkeol 531 Parmelia sulcata 5:313 Paromeria laevigata TPA assay system 29:91 activity in EPP assay system TPA assay system 29:88 activity in iNOS assay system 29:88 activity in NFkB assay system 29:88 activity in TNFc~, CRG assay system 29:88 activity in CRG assay system 29:88 antibiotic activity of 24:856 antinociceptive effects of 30:206 as anti-inflammatory 30:206 effect on NF-KB activation Partial synthesis 6:157-160 of acetylenic carotenoids 6:157-160 of anguidine 6:225,226 of carotenoid sulfates 6:150 of gibberellins Parus gambeli 5:836 hemoglobin components of 5:836 Parvaquone Parvifoline A 15:118 13C-NMR of 15:132 from Rabdosia parvifolia Parvifoline B 15:116 13C-NMR of 15:130 from Rabdosia parvifolia 123 Parvifolinoic acid 15:174 from Rabdosia parvifolia 140 13C-NMR of 15:157 from Rabdosia parvifolia Paspalum utwillei 22:401 Passeer domesticus 5:836 hemoglobin components of 5:836 Passerini reaction 180 Passive immunization 30:406 with hyperimmune globulin Patchornik mehtod 12:120 cx-Patchoulene Patchouli alcohol 16:245 synthesis of 16:245 Patchouli alcohol Pateamine 28:709 dilactone functionality of 28:709 total synthesis cytotoxic activity of 5:419 revised structure 4:93-99 synthesis of 624 as macrophage scavenger receptor inhibitor of discodermolide 30:22-26 of swinholide A 26:1229 of iso-swinholide A Pathogenesis-related gene expression 25:394 Pathogenic bacteria 30:421 Legionella pneumophila 30:421 Pseudomonas aeruginosa 30:421 Shigella boydi 30:421 Pathogenic fungi 5:598 Alternaria kikuchiana 5:598 Botrytis cinerea 5:598 Piricularia oryzae 5:598 Pathogenic toxins 6:538 Pathogen-induced necrosis 25:660 Pathogen-induced oxygenase 26:947 Pathological anxiety 30:376 role of serotonin (5-HT) in 30:376 Pathophysiological inflammatory reactions Patiria miniata 15:55 miniatoside A and B from 15:61 patirioside A from Patiria pectinifera 7:297,302 Patirioside A 15:48 Patrinia intermedia 22:528 Patrinoside Pauly's reagent 17:396 Pauridiantha lyalii Pavine-benzyltetrahydroisoquinoline dimer 30:583 Paw oederma 30:207 inhibition of Dimer 3:331 synthesis of 3:331 PDE-II 1:163 Pectolinarigenin 7:227;30:725,748 antispasmodic activity of 30:748 from Salvia limbata 20:712 structure of Pedamide 1:623 enantioselective synthesis 1:623 (+)-Pedamine 14:499 synthesis Peddiea fischeri 22:471 Pederin 5:336 Peduncularine 11:284;13:491,492 absolute configuration of 11:284 from (S)-malic acid 11:284,285 synthesis of 11:284,285 178 Pedunculariside 29:84 activity in COX assay system 29:84 activity in EPP assay system Pelargonidin (anthocyanidin) 29:585 effects on LELA 29:585 effects on Pelargonidin-3-rutinoside-5-glucoside Pelargonium fragrans 7:112 Pelargonium graveloens 7:100,101 Pelargonium hortorum 21:591 Pelargonium roseum 27:377 Pelargonium sp. 7:95,96 Pelargonium xhortorum 30:146 for pest resistance Pelenolide 7:230 Pellegata oxidation Pellitorine 10:152 from Anacyckus pyrethrum 10:162 718 Penaeus vannamei Penam derivatives 12:127 Penam product 11:212,213 by isopenicillin-N-synthase 11:212,213 formation of 11:213 from cx-aminobutyrate 11:212, 213 stereochemical course Penares sollasi 23:194 Penares sp. 28:460;713 as ct-glucosidase inhibitor 28:713 penarolide sulfate A from Pentanediol diacetate 188 Pentathiepins 23:236 19-O-n-Pentyldamavaricin Fc 23:97 n-Pentyldamavaricin Fc 97 Peritassine B 23:676 Peroxyplakoric acid A1 23:341 Penaresidines 18:460 from Penares sp 462 Penduletin 7:227;30:726 structure of 30:726 Penems 4:448,476 absolute stereochemistry of 4:435 by azetidinone synthesis 4:437 synthesis 8:262 Penicillic 738 biosynthesis of 11:211-213 cephalosporin C from 11:211-213 chemical shifts of 4:442 from 5-(L-c~-aminoadipoly)-Lcycteinyl-D-valine (LLD-ACV) 11:211-213 semi synthesis of Penicillinates 4:437 stereoselective reduction Penicilliopsis clavariaeformis 22:649 Penicillium Penicillium alladadense 5:300 Penicillium allii 21:622 Penicillium atrovenetum 19:117;23:268 Penicillium brefeldianum 11:192 Penicillium brevicompactum 5:299 Penicillium calaviforme 5:300 Penicillium carneum 26:490 Penicillium caseiculum 13:305 Penicillium charlesii 5:296,299 Penicillium chrysogenum 5:299 Penicillium cyclopium 28:119 Penicillium digitatum 12:103 Penicillium hirsutum 21:622 PenicilIium islandicum 5:299,300 Penicillium italicum 25:150 Penicillium javanicum 5:299 Penicillium luteum 5:299 Penicillium madriti 11:198 Penicillium nigricans 780 glucose oxidase from 7:71 isocyanide xanthocillin from 21:329 xanthocillin from 21:221 Penicillium ochrochloron 5:300 Penicillium oxalicum 27:849 Penicillium palitans 331 Penicillium patulum 5:300 332 microbial hydroxylation of 28:346 reaction of 28:336 spiroalkyl analogs of 28:355 Penicillium rugulosum 10:646 Penicillium scleriotorum 5:299 Penicillium sp Penicillium thomii 22:627 Penicillium turbatum 11:194 antibiotic A 26771B by Penicillium varians 5:300 Penicillium wortmannii 21:238 wortmannin from Penicillium zacinthae 5:300 Penicillus dumetosus 18:688 Peniophora Peniophora filamentosa 29:265 Peniophora gigantea 29:265 Peniophora sanguinea 29:293 Penstemide 7:441 activity against P-388 lymphocytic leukemia 16:295 from Penstemon deutus Dongl. ex. Lindl. 16:295 synthesis of 16:295 Penstemon barbatus 24:799,836-837 iridoid glycosides of Penstemon gentianoides 24:839 Penstemon linarioi 27:837 phenylethanoid glycoside from 27:837 Penstemon rosseus 24:838 anti-fungal activity of 24:839 iridoid Pentacta australis 15:91 DS-penaustrosides A and B from Pentacyclic triterpenes 30:207 protein kinases inhibition by Pentacyclic triterpenoid esters 9:460 Pentacyclic triterpenoids 25:55 fridelane 25:55 glutinane 25:55 hopane 25:55 lupane 25:55 moretenane CI (NO) mass spectrum 2:8 6-Pentadecatrienylsalicyclic acid 21:593 5-Pentadecenal 26:75 wittig reaction Z-Pentadecenyl) salicyclic acid 5:825 ~3C-NMR spectrum of 5:825 ~H-NMR spectrum of 5:825 3-Pentadecyl phenol 2:280,281 2E,4E)-2,4-Pentadienamide 10:155 Pentadienols 9:572 asymmetric hydroxylation of Pentadiplandra brazzeana 27:18,19,38 brazzein from 27:18 pentadin from 27 Pentaene 6:292 fl, 6a, 16fl,24a,25-Pentahydroxy-9fl Pentalenic acid 3:6 Pentamera calcigera 28:598 calcigeroside B from 28:598 Pentamethyl ether Pentane 9:564 as marker 9:564 in lipid autoxidation 521 stereoselective synthesis of 10:521 synthesis of -Pentanone 30:10 aldol condensation of 232 1,2,3,4,6-P enta-O-galloyl-D-D-gluc o s e (galloyl ester) 29:589 effects on 150 Pentasaccharides 10:475,476 by glycosylation 10:475 Pentaspadon motleyic 9:316 Pentaspadon officinalis Pentosan polysulphate 30:412 Pentoses 30:430 as substrates Pentyl-2H-pyran-2-one 21:196 n-Pentylmagnesium bromide 21:386 2-n-Pentylquinoline 26:820 6-Pentyl-~ trans-Peptidation semi-synthesis of 17:646 siderophores 9:537-557 tandem mass spectrometry of Peptide derivatives 12:155 Peptide elicitors 25:393 Peptide enod 25:40 25:379 Peptide hormones Peptide prohormones 25:387 Peptide signals 25 biological activity of 27:804 from animal tissues 27:802 from plant tissues 27:802 Peptidoglycan 6:385-420 biosynthesis of 6:404 relation of sugar-peptide structures Peptidoglycan-related compounds 6:404-420 structural confirmation of 6:406 Peptidoleukotrienes 30:225 type of leukotrienes Peptostreptococcus sp Diels-Alder reactions of 5:768 intramolecular cycloaddition 5:782 structural modifications of 5:798 synthesis of 5:769,770 transformation to pipitzol Perforene 6:30;10:182 from chamigrene precursor 6:30 from Laurencia perforata 6:30 structure confirmation of 6:30 Perforenone 6:29,30,32,33 epiguadalupol from 6:30 from cyclophptenone enolate 6:29,30 6:29,30 Perhydroazulene 1:547 Perhydroazulene synthesis Perhydroindane esters 6:179 Perhydroisoindol-1-one 15:355 Perhydronaphthalene derivative 6:179 Perhydrophenanthrene group 6:54-58 Perhydrophenanthrene skeleton 1:661 synthesis of 859 Peri interaction 1:386 Periandra dulcis Mart 15:26;27:15, 16,30 periandrin from 7:142 periandrin I from 27:16,30 periandrin II from 27:16,30 periandrin III from 27:16,30 periandrin IV from 27:16,30 periandrin V from Periandra mediterranea (Vell.) 15:26;27:16,30 periandrin I from 27:15,30 periandrin II from 27:16,30 periandrin III from 27:16,30 periandrin IV from 191 Periandric acids I-IV Periandrin I 15:22;27:15,30,31 structure Periandrin III 27:16,30,31 structure Pericentral hepatocyte necrosis 25:466 Periconia byssoides 25:790 Pericyclic reaction 16:628 Pericyclic reactions 3:418 of arynes Pericyclivine 5:124;9:171 Peridiain 30:522 structure of Perilla alcohol 11:324 oxymercuration of 11:324 29:83 as bioactive monoterpenoid Periodate 2:346 oxidation of glucoamylase 2:346 perrottetianal 2:278 Periodate-nitromethane procedure 4:240 for purine synthesis 4:240 Peripheral analgesic properties Peripheral nervous system 30:194 cannabinoid receptors in 30:194 Peripheral neuropathy 26:1130 as syndrome type-lA Peripheric antinociceptive effect 26:416 trans-anti-Periplanar fashion 11 Periplaneta americana 6:538;8:182, 221 Periplaneta bunnea 8:182 Periplanetajaponica 8:182 (+)-Periplanone 8:182 synthesis of Periplanone-B 6:541,542;16:218 from (+)-dihydrolimonene 6:541 Still's synthesis of Periwinkle 4:29 Perkin condensation 12:381 intramolecular 12:381 Permeation 30:800 ofopioid analogues Peroxidase-catalyzed dimerization 27:765 ofp-coumaryl-hydroxy oxyagmatine 27:765 ofp-coumaryl-hydroxyagmatine Peroxidase-mediated oxidation 27:777 of (+)-catechin 27:777 Peroxidases 27:735,755 for synthesis of natural bioactive alkaloids 27:778 from grapevine 27:756 in synthesis bioactive alkaloids 27:788 in synthesis ofbioactive plant phenols c~-Peroxycholesterol 5:406 cytotoxic activity of 5:406 Peroxyparthenolide 27:566 Peroxyplakoric acid A1 methyl ester 23:344 Petrosolic 342 Phenazine analog 23:166 Phenolic metabolism 23:741 Phenylalanine ammonia lyase (PAL) 23:741 Phenylalanine 23:234 Phillyraeoidin D 23:403 Phloretic Persea indica 26:850,851,852 cinnzeylanol from 26:850 cinnzeylanone from 26:850 epi-cinnzeylanol from 26:850 idicol from 26:850 innzeylanine from 26:850 perseanol from 26:850 ryanodanes from 26:850 ryanodol from 26:850 ryanodol-14-monoacetate from 26:850 vignaticol from 26:850 Persea major 9:402 Persea obovatifolia 26:219 obavatifol from 26:219 obovaten from 26:219 obovatinal from 26:219 perseal A&D from 850 Persia thunbergii 28:419 Persoona elliptica 9:320,355 Persoonal 9:320 Persoonal dimethylether 9:355 synthesis Pervasive development disorder (PDDs) 30:372 Asperger's syndrome (AS) 30:372 autistic disorder (AD) 30:372 childhood disintegrative disorder (CDD) 30:372 effect on social skills in 30:372 group of Rett's disorder (RTT) 30:372 Pervasive development disorder-not otherwise specified (PDD-NOS) Pestalotis cryptomeriaecola 21:198 Pesticidal activity 18:196 of staurosperine 12:397 Pesticides 87 activity in 5LOX assay system 29:87 activity in PLA assay system 29:87 activity in PAF assay system 29:87 Petasinecine 1:237 enantioselective synthesis of 1:637 Petasites hybridus 29:87 Petchia ceylanica 5:135 Petersaponin I 21:673 Petersianthus macrocarpus 21:673 Peterson olefination 3:202 Petitgrain oil 27:373 from leaves 27:373 from twigs 666 Petroselinum sativum 22:457 apigenin-7-O-apiosyl-glucoside from Petrosia contignata 25:713 Petrosia ficiformis 9:42 26-dehydro-25-epiap lys tero 1 from 9:40 dihydrocalysterol from Petrosia seriata 21:267 Petrosia weinbergi 25:703;28:705,706 antiviral activity of 28:705 antiviral metabolites from 28:706 orthoesterol disulfate A from 28:705 orthoesterol disulfate B from 28:705 orthoesterol disulfate C from 28:705 weinbersterol disulfate A from from Cribrocalina vasulum 9:37 from Helicondria species 9:37 from Petrosiaficiformis 9:37 from Petrosia hebes 9:37 synthesis Peturin chloride 20:738 Peucedanum ostruthium (L.) 29:699 Peumus boledus Pichia vanro'i 5:283 Picicularia oryzae Piclavine A 16:453 antibacterial activiy of 16:453 antifungal activity of 16:453 from Clavela picta Picraline 5:125 Picrasidine F 1:126 (+)-Picrasin B 11:76,77 synthesis of 11 A2'3picrasin B 11:76,77 synthesis of 11 Picrasma ailanthoides 7:369,385 Pictet-Spengler reaction 1:139,140 Pictet-Spengler type reaction 19:91 of tryptamines 435 as inhibitor Piericidin A 28:436 as complex I inhibitor 28 Pieris brassicae 26:702 Pieris rapae 18:771 Pilocarpine-M-receptor complex 21:754 Pilocarpusjaborandi 21:488 Pilosine 25:530 Pimagnolin 30:592 as EBV inhibitor Pimarane diterpenes 23:842 Pimarane skeleton 721 Pimaricin 6:261 relative configuration of 6:261 Pimenta dioica 28:398,403 acaricidal activity of 28:403 Pimenta racemosa Pinnatol-D 6:26 from Laurencia pinnata 6:26 synthesis of 6:26 Pinnatoxin 19:616 Pinner reaction 5:557 Pinns strobus O-glucosylation of 5:525 O-methylation of -Pinoresinol dimethyl ether 26:241 as PAF-induced inhibitor 26:241 (+)-epi-Pinoresinol dimethyl ether 5:526 (+)-Pinoresinol dimethyl ether 5:526, 536 (+)-l-Pinoresinol dimethylether Pinus 26:905 Pinus canarienis 26:859 Pinus caribaca 25:151 Pinus densiflora 26:471 Pinus flexilis 26:887 Pinus maritima 29:583 Pinus massoniana 26:472 Pinus nigra 25:249;28:420 Pinus palustris 25:151 Pinus parviflora 30:407 acidic polysaccharide from 30:407 Pinus peuce Pinus pinaster 28:420 Pinus pinea 28:420 Pinus radiata 7:99 CRO bioassay system 29:102 Piocarvone Piperidinol alkaloids synthesis 29:419 by stereodivergent process AM assay system 29:83 (+)-Piperitone 16:264;29:83 activity in AM assay system Piperol A 26:243,244 as PAF-induced inhibitor as PAF-induced inhibitor 26:243 Piperonal synthesis of 1:568 transformation from perezone from O-methyl-b-pipitzol 5:783 Piqueria trinervia 24:779 Piquerol B 28:404 acaricidal activity of 28:404 toxicity to gravid female ticks 28:404 Pirano flavonoids 26:744 Piricularia oryzae 2:434 R, 6R)-5-ethyl-5,6-dihydro-6[(E)-(2R,3S,4R,5S)-2-hydroxy-4-methoxy-3,5-dimethyl-7-nonenyl]-2H-pyran-2-one 30:29 13C NMR Pistacigesrimone A 22:118 Pisum sativum Pithecellobium dulce 21:657 Pithecolobium saman 22:530 Pithomyces sp Pituranthus tortuosus 27:687 Pityol 1:692 formation from sulcatol 1:692 synthesis of 1:691 Pityrophthorus pityographus 1:692 309 Piulella xylostella Pivaloyl chloride 12:322 in aldolate trapping 550 acridine based 25:542 ellagic acid as 25:550 isoquinoline based 25:542 phenanthrene based 25:542 PKA-catalyzed phosphorylation 25:529 PKA-gated Na + channels 25:521 PKC 25:271,526,536,543,721,726 diacylglycerol activated 25:66 PKC activation 30:71 inhibition of 30:71 PKC inhibitor 25:544 561 role of Hernandia moerenhoutiana in 30:561 role of Hernandia nymphaeifolia in 30:561 role of Hernandia voyronii Placentoside A 7:302 from Sphaerdiscus placenta Plagiochila acanthophylla 2:81 Plagiochila hattoriana 2:280 Plagiochila yokogurensis Plagiochiline A 2:279 Plagiochiline I 2:279 291 Plagiolactone 16:216 Plain peptide signals 25:402 Plakellia sp. 25:715 Plakinastrella sp Plasminogen activator inhibitor (PAI) Plasminogen inhibitors 30:841 from Eiseniafetida 30:841 role in tissue protection 30:841 Plasmodia 25:348 Plasmodium 25:327,544 Plasmodium chabaudi 26:789 Plasmodium falciparum 7:391 Plasmodium genus 19:587 Plasmodium lophurae 26:803 Plasmodium malariae 20:516,517 Plasmodium ovale 20:516 Plasmodium strains 30:694 against human adenocarcinoma cell line HT-29 Plasmodium vivax 20:516 Plasmodium yoelii 21:744 Plasmopara viticola 27:768 Plastoquinone Platelet antiaggregant 25:595 Platelet arachidonate metabolism 27:422 of polyacetylene compounds Platelet serotonin (5-HT) 30:380 in autistic patients Platelet-derived growth factor (PDGF) 15:441 899 Platycodi radix 30:89,91 effects on liver triacylglycerol 30:89 effects on liver weight 30:89 effects on plasma triacylglycerol level 30:90 effects on total cholesterol 30:89 104 (PLE) (Pig liver esterase) 13:56 Pleckstrin homology 25:525 Plectranthus Plectrinone A 23:530 Pleiocarpa mutica 1:124 Pleiocarpa talbotii Pleiotropic effect of TNF-a 25:460 Pleisopermium alarum Pleuromutilin 8:418 by double Michael additon 8:418 synthesis Pleuronectes platessa 25:131 Pleurotellol Plocamium cartilagineum 18:714 3' -trihydro xy-3,6,4 ' -trime thoxy 112 Pluchea lanceolata 22:117 Pluchea sp Plumbagic acid 2:228 biosynthesis of Plumbago scandens 2:225 Plumbago zeylanica 2:215,226 inhibitor of 25:938 PMA-thrombin 30:70 inhibition of 30:70 PM-located voltage-gated Ca 2+ channels Pocine pancreatic elastase (PPE) 30:830,831,843 homologous sequences of 30:831 Podachaenin 29:90 activity in NFkB assay system Podachaenium eminens in (+)-confertifolin synthesis 4:405-408 in (+)-isodrimenin synthesis 4:405 synthesis of Podocarpus elatus 29:10 Podocarpus ferrugineus 25:246 Podocarpus gracilor 28:462 Podocarpus hallii 28:462 Podocarpus macrophylus 28:462 Podocarpus milanjianus 28:464 Podocarpus nagi Podocarpus urbanii 28:459 Podochaenium eminens 495 antifeedant activity of 28:454 anti-inflammatory activity of 28:453,454 anti-tumor activity of 28:453,454 biogenetic pathway for 28:455 fungicidal activity of 28:453,454 growth regulatory activity of 28:454,453 insecticidal activity of 28:453, 454 synthesis of Podophyllum bankakri 26:149 Podophyllum emodi 17:341 Podophyllum extracts 26:169 of antiviral activity :578 podorhizol from 18:556,557 podophyllotoxin derivatives Polonovski reaction Husson reaction 1:49 Poly unsaturated fatty acid (PUFA) 25:932,948 (Poly) peptide hormones 25:387 (Poly) peptide ligands Poly-3-hydroxybutanoate (PHB) 1:690 Polyacetylene alcohols 27:686 structure Polyacrylamide gel electrophoresis 4:283 for oligonucleotide purification 4:283 Polyalthia excessa 28:416 Polyalthia longifolia 28:416 Polyalthia viriclis 22:400 Polyamine biosynthesis Polycanthisine alkaloid 27:251 NMR studies of Polycarbocyclic marine triterpenoids 6:3-105 total synthesis of Polycarpa aurata 23:260 640 as disulfide alkaloid 28:640 as sulfur-containing antifungal agent 28:640 polycarpine as 28:640 synthesis 835,836; 28:640 as disulfide alkaloid 28:640 as sulfur-containing antifungal agent 28:640 polycarpine as 28:640 synthesis as sulfur-containing antifungal agent 28:640 synthesis Polycarpamine D 25:836;28:640 as sulfur-containing antifungal agent Polycarpamine E 28:640 as sulfur-containing antifungal agent Polycavernoside A 19:571,572 stereochemistry of 19:571 toxicity of 19:572 Polycavernosides Polychlorinated biphenyl 27:304 Polychlorinated dibenzodioxins 25:757 Polychlorinated dibenzo-p-dioxin (PCDD) congeners 30:763 via aromatic 13 286 episarcodonins as 29:290 epoxyenedione as 29:286 phlebiarubrone as 29:286 sarcodonin ot Polycyclic-p-terphenyls 29:279 cycloleucomelone as 29:279 thelephoric acid as 29:279 Polydimethylacrylamide Polyenal macrolides 6:261 biological activity of 6:261 in tumor therapy 6:261 Polyenamides 21:388 from fungi Polyene acetal 14:471 tetracyclization of Polyene amide 21:373 natural product with 21:373 Polyene antibiotics 25:299 Polyene cyclization 8:188 acid catalyzed 8:188 biomimetic 14:740 initiators 1:656 steroids from Polyfibrospongia australis 25:694 Polyfibrospongia sp. 19:577 Polygala fruticosa 7:415;23:342 Polygala polygama 17:341 Polygala senega 21:666 senegasaponins from 21:666 Polygalacic Polygnum cuspidatum 27:405 for hyperlipidaemia EBV assay system 29:87 2:289 from thujone-derived synthons Ju-Fang synthesis of 6:14 piscicidal activity of 2:289 synthesis of Polygonati rhizoma 21:668 14a-OH-diosgenin from Polygonum bistorta 22:118 Polygonum caepitosum 22:633 Polygonum chinense 22:614 Polygonum conspicum 607,608, 609,611,633,637;27:854;30:340 anthraquinone emodin from 30:340 for hyperlipidaemia Polygonum dumetorum 22:633 Polygonum ellipticum 22:610 Polygonum falcatum 22:610 Polygonum filliforme Polyhydroxy sterols 5:410;23:177 Polyhydroxydihydro-13-agarroduran 23:663 examples of 23:663 sesquiterpene skeletons of 23:663 Polyhydroxyindolizidines 12:275 Polyhydroxylated 2-phenylnaphthalenes 30:225 effect on 5-1ipoxygenase inhibition 3fl,5a,6a, 15a-Polyhydroxylated steroids Polyketide biosynthesis 5:613 Polyketide methodology 11:130,131 (+)-semivioxanthin synthesis by 11 Polyketide sulfates 7:266 of Comantheria perplexa 7:266 of Comatualpectinata Polymastia boletiformis 25:704;28:704 Polymastia sp Polymer 17:646 semi-synthesis of 17:646 Polymer support synthesis 4:274, 277-283 protecting groups 4:276 protocol for oligonucleotide synthesis 4:288 Polymer supports 3:82 Polymerase activity 25:826 Polymerase chain reaction (PCR) Polymerization 27:760 of dihydrodiconiferyl alcohol 27:760 of guaiacylglycerol-[3-Oconiferyl alcohol 27:760 ofcinnamyl alcohols 27:760 ofconiferyl alcohol 27:760 ofp-coumaryl alcohol 27:760 ofsinapyl alcohol 27:760 of pinoresinol 477 by regioselective Polypropionates 17:25,26 Polyrhaphin A 17:12 Polysaccharide gums 29:543 in adhesives 29:543 in beverages 29:543 in personal care produts 29:543 in pharmaceuticals 29:543 processed foods 1077 antigenicity of 19:689-745 as antitumor agent 5:315 as antiviral compound 24:540, 541 as cell-surface antigens 5:322 enzymatic activity Polysialoglycoprotein 11:429 of rainbow trout eggs 11:429 Polysiloxanes 13:327 synthesis Polysubstituted anthracenes 11:120 Polysubstituted dihydropyrans 10:340 from enolate Claisen rearrangement 10:340 synthesis of 10:340 dihydroguaiaretic acid from 26:249 guayacasin from 22:352 895 Porter's reagents 21:516 Porteresia coarctata 7:189 Porthetria dispar Post translational modification 25:367 "Post-malonate" exchange process Potamogeton sp Potassium ferricyanide 22:204,211 Potassium graphite (CsK) 11:366 Pin2-L as 29:611 Pin2-R as 29:611 PSI-1.1 as 29:610 PTI as SaPIN2a & SaPIN2b as 29:611 Potato viruses 30:412 antiviral activity against 30:412 Potato-saponin 25:319 a-chaconine Pothomorphe peltata 22:356 uses of 357 Pothomorphe umbellata 22:356 Pothos scandens L. 22:530 for convulsions Potomogeton nodosus 25:260 Potyalthia macropoda 344 Powdered garlic 23:465 PP inhibitors 25:521 PP1 inhibitors 25:543 PP2A inhibitors 25:543 pp60v-src protein tyrosine kinase inhibition activity 28:698 ofhalistanol sulfate 28:698 (PPL) (pig pancreatic lipase) 13:54,55 PPO activity 25:656 PPO cytochemistry 25:654 PPO phenolic compounds 25:656 PPSE 1:15 for cyclization Pratylenchus coffeae 26:436 Pratylenchus curvitus 26:477 Pratylenchus neglectus 26:464 Pratylenchus penetrans 26:429 from Capnella imbricta 6:33 from triquinane 6:33 Diels Alder reaction 6:3,34 by intramolecular photocycloaddition by Sharpless oxidation 6:34 by Wittig olefination 6:33 Preclavulone A 8:140 Preclinical development 21:176,177 of A.D.E.P.T. 21:176,177 of benzylcarbamate prodrug HMR1826 21:176,177 of HMR1826 21:176,177 of P.M.T Precocene I 2:126,127 Precorrins 1-8 9:597 Precyclospongiaquinone-I 15:298 Predator mites 28:434 as pathogen Pregnane steroids 21:308 Pregnanes from chloesterol catabolism 5:709 Pregomisin 26:244,247 as PAF-induced inhibitor 26:244 Prehispanolone 25:273 effect on B cell proliferation Prelissoclinamide 2 Prenyl bibenzyls 2:283,285,286 distribution in Radula sp Prenyl diphosphates 7:322 from mevalonic Prenyl monoesters of 8:33 Prenyl substituents 27:929 Prenyl transferase 7:96 Prenyl transferase reactions 7:321 Prenylated benzophenones Visima decipiens Prenylated coumaric acids 30:730 structure of 376 use in osteomyelitis 29:720 use in Parkinson's disease 29:720 use in psoriasis 29:720 use in respiratory problems 29:720 use in skin ulcerations 29:720 Prenylnaphto-1,2-quinone 27:851 6-Prenylnaringenin 28:229 biological activity L-alaninal 4:127 synthesis by oxidative methods 4:113,114 synthesis by reductive methods 4:114 asymmetric synthesis Prep ANP 3-unsaturated allyl glycoside 10:420 of 2-indolyl acetaldehyde 11:315,316 of a building block 11:307,308 of acyclic c~,~-dialkylated ester 10:411 of aristotelin-19-ol 11:312 ofaristotelin-19-one 11:312 of 4-acetoxy of chiral building blocks 13:73-84 of C-methylated hexopyranose 10:414,415 of diastereomeric aminonitrile 10:126,127 of hexopyranose derivatives 10:426-428 of indolo of low-valent-titanium reagent 11:364 of monofluorinated chiral building blocks 13:81 of nonulosonic acid 11:466 ofoctulosonic acid 11:466 of Oppolzer's chiral auxiliary 11:307,308 of rifamycin S 23:57,60,84 of sulfoxides Prephytoene diphosphate Prepinnaterpene 6:9,10 from Laurencia pinnata 6:9 from Laurencia subopposita 6:9 synthesis of 535 Presqualene diphosphate 7:325 squalene from Preussia isomera 21:209 thepreussomerins from 21:209 Preussomerins Previtamin D derivatives 30:486 thermal isomerization of 515 Prevost reaction 5:189 Priano melanos 25:822;28:685 Priano sp 823 Prianosinsdischabdins 25:802 Prickles 27:59 as plant protecting organs 27:59 Primaquine 22:150;25:349,350;26:836 Primary biliary cirrhosis 25:463 Primary granulosa cells 25:269 apoptosis in 25:269 Primary hormone 27:321 Primary solid-tumor growth 30:64 effect of triterpenoids on Primula denticulata 5:211 Primula obconica 7:427 Primula viscosa Prins cyclization 18:174 Prins reaction 13:41,42 Prionitin 5:31 APT spectrum of 5:31 ~3C-NMR spectrum of 5:31,32 COSY spectrum of ~H-NMR spectrum of 5:31,32 INEPT spectrum of 5:31,32 NOE spectrum of Prions 24:482 Pristimarin 30:692 cytotoxic activity of Pristimera grahamii 23:659 Pristimeria indica 30:664 celastrol from 30:664 pristimerin from PRL1 & PRL2 proproteins 29:592 effects on cysteine protease Proaporphine dienones 2:259 correlation between specific rotation and absolute configuration absolute configuration of 2:253 stereochemistry of 2:253 Probes 27:332 activity of 27:346 for 7',7'-difluoro-ABA 27:348 for 7'-hydroxylation 27:348 for 8'-hydroxylation 27:346 for ABA receptors 27:332 for abscisic acid receptors 27:330 for determining the abscisic acid reception 27:331 for isomerization to phaseic acid 27:348 for structure activity relationship 27:332 ofabscisic Procambarus bouvieri 19:665 Procambarus clarkii 19:627 Prochiral carbonyl groups 4:332,333 asymmetric addition to Prochiral ketones 1:689 chiral alchohols from 1:689 reduction with yeast Prochiral naphthalene rings 4:332 asymmetric additions to Prochiral sulfides 14:517 Prochloron 10:243 Procumbide 7:477 Procurcumenol 29:90 activity in TNFcz assay system 29:90 Procyanidin B1 21:505 Procyanidin B-5 3,3'-di-O-gallate 29:580 effects on ACE Procyanidin dimer 25:541 Procyanidin glycoside 25:594 Procyanidin polymer (flavan-3-ol polymer) 29:580 effects on ACE Procyanidins B6 21:535 Prodelphinidins Prodrug monotherapy 21:157 natural anthracyclines for 21:157 Prodrugs 21:157 of natural anthracyclines Pro-inflammatory cytokines 25:461 Pro-inflammatory substances 30:206 in chronic painful inflammatory diseases Projulinine 5:211 Prokaryotes 21:303 PRL) 25:265 Proleus mirabilis 25:259 Proliferation 30:368,378 effect of serotonergic neurotransmission on 30:368 serotonin action on 30:378 /-Proline 14:555 Proline endopeptidase 2:35 Prolines 4:327 Prolysine 25:388 prophylactic effects Pro-nociceptive prostaglandins 30:192 in inflammation Pro-nociceptive transmitter 30:194 release inhibition of 30:194 Proothramycins 21:374 Prooxidant activities 30:745 in thiobarbituric acid assays 30:745 of chemiluminescence 30:745 of tert-butyl hydroperoxide 30:745 Prooxidant property 30:524 of carotenoids Propane-1,3-diols 13:53-105 asymmetric synthesis of 13:53-105 enantioselective 13:53-55 enzymatic 13:55 transesterification of Propargyl alcohol 13:585 Propargyl alcohol 14:569 cis-olefin from 14:569 pyrrolidine derivative from Propargyl alcohol 14:569 cis-olefin from 14:569 pyrrolidine derivative from 14:569 Propellanes 14:490 asymmetric synthesis of 14:490 via asymmetric cyclopropanation 14:490 (E,Z) S-1-Propeny allyl thiosulfinate 23:467 (E,Z)-S-1-Propenyl methanethiosulfinate S-1-Propenyl cysteine 23:464 S-1-Propenylcysteine sulfoxide 23:458 S-2-Propenylcysteine thiosulfinate Prophylactic activity 13:666 Prophylactic drugs 30:407 Prophylactic effect 25:429 of prolysine 25:388 [2-2H2, 2-13C] Propionate 11:196,197 incorporation of 11:196,197 incorporation into erythromycin A 11:196,197 incorporation into erythromycin B 11:196,197 incorporation into lasalocid A 11:196,197 incorporation into monensin A Propionibacterium acnes 25:463,471 ; 28:534 mononuclear cell infiltration Propionibacterium shemanii 9 Propionyl CoA 11:195 carboxylation of 11:195 (2S)-methylmalonyl CoA from 11:195 Propiophenone derivative 30:731 structure of Prorhinotermes simplex 19:118 Prorocentrolide 19:617 stereochemistry of 19:617 Prorocentrum Prorocentrum lima 5:384 Prosafrinine 13:482 Prosafrinine synthesis 29:419 by stereodivergent process Prosafrinine/iso-6-cassine synthesis 29:425 of c~,ct Prosophylline 13:481 Prosophylline synthesis 29:419 by stereodivergent process 29:419 Prosopidione 9:68,69 (+)-Prosopinine 18:347 Prosopinine synthesis 29:419 by stereodivergent process Prosopis chilensis 28:424 Prosopis glandulosa 29:580 Prosopis juliflora 5:211 Prosopis sp PGH2) 25:595 Prostaglandin 12 (prostacyclic) 12:399 by K-252a 12:399 by staurosperine 12:399 production Prostaglandin inhibitors 30:192 clinical use of 30:192 use in rheumatism 30:192 use in osteoarthritis 30:192 use in headache 30:192 use in dental surgery Prostaglandin lactones 19:549 Prostaglandin synthetase Prostaglandins E2 19:571 Prostanoids 30:192 formation of 30:192 from arachidonic acid 30:192 Prostanoids from Prostate cancer prevention 30:525 role oflycopene Prostoglandin F2 3:227 synthesis of Prostoglandin PGA2 3:247 synthesis of Prosystemin cDNA 25:370 Prosystemin polypeptide 25:375 Proteacea Protease 6:551;16:737;30:226,831 chymotrypsin 30:831 earthworm chymotrypsinogen 30:831 F-III-l(2) 30:831 human leukocyte elastase (HLE) Protection/deoxygenation procedures regioselective Protection-deprotection reaction 30:461 G-Protein Protein binding 27:377 Protein biosynthesis Protein kinase 5:384;23:537 Protein kinase A (PKA) 12:384;30:192 in regulation of ionotropic receptors 834 classical forms of 27:822 from Dictyostelium discoideum 12:384 from mammalian cells 12:384 used for anticancer drug design 12:384 Protein kinase C (PKC) activator 30:70 Protein kinase C inhibition 24:573 PKG) 12:384 Protein kinase inhibition 30:207 by pentacyclic triterpenes 30:207 Protein kinase inhibitor 23:168,180 secosterols as 23 Protein kinases 27:826 activity inhibitor of 25:707 Protein phosphate 27: Protein phosphorylation 27:819 by natural products 27:819 biochemical basis Protein S-nitrosylation 26:913 Protein synthesis 30:407 inhibitor of 30:407 Protein transduction domain (PTD) Proteinaceous polysaccharide 27:511 Proteinaceous receptor 25:371 Proteinase activity 21:150 Proteinases 21:224 Protein-coupled receptor 27:821 G-Proteine kinase C activity 21:638 Proteins inase activity 27:842 offlavonoid aglycones 27:842 of glycosides 27:842 ofKoelreuteria henryi Protein-tyrosine kinase inhibitory activities Proteolytic activity Protium kleinii 30:206 anti-inflammatory effect of 30:206 antinociceptive effect of 749 from spirobenzylisoquinolines 1:217,218 photochemical formation 1:217, 218 ring D inversion 217 589 Protodesilylation 12:322 Protodestannation 1:490 Protodioscin 23:824 Protohypericin 22:646,648,649; 30:607,608 structure of 30:608 Proton pump inhibitors (PPIs) 25:612 Protonated astaxanthin 30:534 delocalisation of 30:534 in crustacyanin 30:534 structure of Protonated carotenoids 30:546 bond lengths of 30:546 dipole moments of 30:546 exo-Protonation 4:654 Proton-proton NOE 2:70 Proton-translocating NADH:Q oxidoreductase 28:435 high-affinity inhibitors of 28:435 Protooncogenes 25:47,269 ?'-myc and bcl-2 Protopine alkaloids N-oxide derivatives 6:494 dibenzo oxazacycloundecine derivatives from 494 corydalisol from 6:494 hypcorine from 6:494 Protopseudohypericin 22:648;30:607, 608 structure of Protoreaster nodosus 7:290 Protostephanine 6:480;21:769 biosynthesis of 6:480 from 1-benzyltetrahydroisoquinoline system 6:480 in Streptomycesjaponica 6:480 synthesis of 6:478 Protostreptovaricin 21:430 glycocomplexes of 5:612 Protozoocidal activity 30:329,741,742 against Leishmania 30:329 against Plasmodium 30:329 against Tryponosoma 30:329 genus Baccharis 30:741 in vitro 30:329 of neo-clerodane diterpenoids 30:742 of quinone derivative 30:329 Protozoocidal compounds 30:740 use of Protozoocidal neo-clerodane diterpenoids 30:741 structure of Prunella vulgaris 29:588;30:401 antiviral activity of 30:401 Prunin 26:745 Prunus avium 23:746 Prunus cerasus 20:721 ;23:746 Prunus domestica 21:506;23:750 Prunus ovium 21:498 Prunus persica 21:503 Prunus sp Psammaplin A (bisprasin) 28:693 effects on Bacillus subtilis Psathyrotes ramosissima 7:427 Pschorr reaction 20:301 or, c0-bis-isothiocyanates of 28:665 Fijian species of 28:65 e~-is o thioc yano-o-formyl analogues Pseudoakuammigine 9:183 Pseudoarachniotus roseus 21:389 aranorosin from 20S-Pseudoaspidospermidine 539 Pseudobaptigenin 22:446 Pseudobases 27:171 disproportionation of 27:174 of sanguinarine Pseudobersana mossambicensis 20:478 bioactive steroids from Pseudodistoma arborescens 23:264 Pseudodistoma aurum 25:782 Pseudodistoma kanoka 10:249 Pseudodistomin A 23:188 relative configuration COSY spectrum of 23:187 HSQC spectrum Pseudodistomin C acetate 23:187,188 ~H-NMR of 23:187 HMBC spectrum of 23:187 HSQC spectrum of 23:187 Pseudodistomins Pseudoguaiane 11 ~, 13-dihydrohelenalin acetate 29:90 activity in CRO assay system 29:90 ent-Pseudoguaianolide intermediate 4:675 Pseudoguaianolide sesquiterpenes 1:545,546 Pseudoguainolides Pseudoheliotridane 1:242 674,687;30:608,627 against cytomegalo virus 30:627 against human immunodeficiency virus-1 Pseudoindoxyl-type alkaloids 5:102 conopharyngine pseudoindoxyl 5:102 19R-hydroxyibogaminepseudoindoxyl 5:102 ibogaine pseudoindoxyl 5:102 ibogamine pseudoindoxyl 5:102 voacangine pseudoindoxyl 5:102 voacristine pseudoindoxyl 5:102 Pseudo-isomaltose 13:213 antifertility activity of 21:758 antifungal activity of 21:758 as fertility-regulating agent 13:653 synthesis of 21:757 Pseudolaric acid B Pseudolaric acid C 21:755 Pseudolaric acid E 21:755 Pseudolarin kaempferi 21:654 Pseudomonas alginate 26:1151 Pseudomonas amygdali 26:583 Pseudomonas aureofanines 9:527 Pseudomonas bromopseudilin 21:298 Pseudomonas caryophylli 26:594 Pseudomonas cepacia 4:432;21:205 Pseudomonas cepacia lipase 30:473 in isopropenyl acetate Pseudomonas convexa 25 Pseudomonas coriacea 12:294 Pseudomonas denitrificans 9:600,603 Pseudomonas diminuta 26:1155 Pseudomonas eruciviae 25 Pseudomonas fluoescens 3:263 Pseudomonasfluorescens lipase 1:685 Pseudomonas genus 19:791 Pseudomonas incognita 25:133,140 Pseudomonas lipase PSL 13:55 Pseudomonas magnesiorubra 28:115 Pseudomonas maltophilia 4:432 Pseudomonas medicinalis 25:257 Pseudomonas morganii 5:434 Pseudomonas perolens 13:320 Pseudomonas pseudomallei 25 Pseudomonas taetrolens 13:320 Pseudomonic acid 10:339 by Claisen rearrangement 10:339 synthesis of Pseudo-nitzschia multiseries 25 Pseudoplexaura porosa (Plexaura crassa) 8:20 crassin acetate from 8:20 Pseudoplexaura wagenaari 8:20 crassin acetate from 8:20 Pseudopteranes Pseudopterogorgia americana 6:18 Pseudopterogorgia bipinnata 23:154 Pseudopterogorgia hummelinkii 23:154 Pseudopterogorgia kallos Pseudopterogorgia rigida 23:154 Broka's synthesis of 6:74,75 by Chan-Brownbridge procedure 6:74 by Friedel-Crafts alkylation 6:74,75 by glycosidation 6:74,75 by Michael addition 6:74,75 by selenation-oxidation 6:74 Pseudopterosins 23:154,158,180 synthesis of 23:154 Pseudorabies virus 30:404 in vitro replication of 30:404 role ofheparin Pseudostichoposide A 15:94 from Pseudostichopus trachus Pseudostichopus trachus 15:94 pseudostichoposide A from Pseudosuberites hyalinus 18:696 Pseudo-sugars (carba-sugars Pseudotabersonine 5:124 Pseudoterane skeleton 23:170 Pseudo-tetrasaccharides Pseudovincadifformine 19:103,19:105 P seudovincadifformine-type alkaloids (+)-19-hydro xy-20-ep i -20S-pseudovincadifformine 5:105 Pseudovincamines 1:114 Pseudovobparicine 5:125 Pseudoxanthoma elasticum Pseurata A 15:116 13C-NMR of 15:130 from Rabdosia pseudo-irrorata 15:174 IH-NMR Pseurata B 15:118 13C-NMR of 15:132 from Rabdosia pseudo-irrorata 15:174 1H-NMR Pseurata C 15:116 13C-NMR of 15:130 from Rabdosia pseudo-irrorata 15:174 ~H-NMR Pseurata D 15:118 13C-NMR of 15:132 from Rabdosia pseudo-irrorata 15:174 IH-NMR Pseurata E 15:120 t3C-NMR of 15:134 from Rabdosia pseudo-irrorata 15:174 ~H-NMR 579 Psidium guianense 21:614 Psidium guyava L. 22:530 for epilepsy and convulsions in children 22:530 PSII inhibitors Psittacula krameri 5:837 hemoglobin components of 5:837 PSK derivatives 25:378 PSK in mitosis 25:377 PSK-receptor 25:378 PSK-a activity Psolus fabricii 7:278,279 Psolusoside A 7:278,279 from Psolusfabricii Psolusoside B 7:278,279 Psophocarpus tetragonolobus 29:605 Psoralea corylifolia L. 29:705 Psoralea glandulosa Psoriasis 9:514,517;30:484 use of l(x,25(OH)2D3 415 Psoroptes mites 28:410 in bull fattening management 28:410 spread of 28:410 Psorospermin 13:368 from Psorospermum febrifugum 498 Psychiatric disorders 30:369 anorexia 30:369 bipolar disorder 30:369 bulimia 30:369 effect of circadian activity on 30:369 obsessive compulsive disorder 30:369 panic disorder 30:369 schizophrenia 30:369 seasonal effective disorder 30:369 unipolar depression 30:369 Psychloleine 21:72 Psychodelic drugs 26:820 cocaine as 26:820 morphine as 26:820 semisynthetic LSD as Psychotria campoutans 26:804 Psychotria curviflora 22:530 for convulsions 22:530 Psychotropic activity 7:7 Psychovegetative disorders Psycotria colorata 30:205 to relieve abdominal pain 30:205 use in earache Psycotria sp Pteidanoside's 26:703 722 Pteridioside 26:704 Pteridium aquilinum 6:194 Pteridium aquilinum var. caudatum 26:687 Pteridium arachnoideum 26:699 Pteridium esculentum 26:699 Pteridium laliusculum Pteridophyllum genera 27:163 Pteridophyta 27:735 Pteris aquilina 26:691 Pteris cretica 26:745 Pterocarpanes 26:745 Pterocarpus santalinus 20:774 Pterocarya paliurus Batal 21:674 Pterocaulon plystachium 22:347 rhamnetin from Ptilocaulis spiculifer 28:690 alkyl sulfate from 28:690 dakaramine from Ptilometra sp. 28:719 anthraquinones from Ptilota filicina 25:718 P-Toluene sulfonic acid 22:203 PTX 251 D alkaloid 27:250 PTX 341A Ptychodiscus brevis 6:135 Ptygonum bistorta Puberulin A 26:243,244 as PAF-induced inhibitor Puccinia antirrhini 9:220 Puccinia arachidis 9:220 Puccinia coronata 9 Puccinia coronata f sp Puccinia graminis f sp Puccinia helianthi 9:220 Puccinia podophylli 26:176 Pueraria lobata 25:93 Pueraria thomsonii 446 PUFA 25:933 PuGPu sequences 21:419 Pulchea indica Punta Toro virus 30:411 treatment of Pupukeanone 6:83,84 from Diels-Alder adduct 6:83,84 from 4,6-dimethyl-1,3-cyclohexadiene 6:83,84 synthesis of 6:83,84 (+)-9-Pupukeanone 6:83,84 by Birch reduction 6:83,84 by intramolecular Diels-Alder reaction 6:83 Purification methods 30:825 affinity chromatography as 30:825 gel filtration as 30:825 high-pressure liquid chromatography (HPLC) as 30:825 ion exchange as 30:825 sulfuric ammonia precipitation as 30:825 Purifying blood 26:50 Herniaria hirsuta Purine alkaloids 21:72 Purine receptors 25:532 Purines 220 9:73 Puromycin reaction 7:386 Purpurea glycoside A 15:362 Purpurea glycoside B Purpurosamine B derivative 4:125 synthesis of Putative satiety factor 24:910 effect of cholecystokinin 24:910 Putranjivadione 30:644 stereochemistry of 30:645 NOESu experiment of Putrescine 22:724 Putterlickia verrucosa 23:70 Puupehenone 15:299;25:698,699 from Heteronema species 6:23 from Hyrtios eubanuma 6:23 synthesis of 6 Pycnonotus cafer 5:837 hemoglobin components of 5:837 Pycnonotusjocosus 5:837 hemoglobin components of 5:837 Pycnopodia heliantoides 15:46 pycnopodiosides A,B and C from from Pycnopodia heliantoides 15:61 Pycnoporus Pycnoporus coccineus 26:1012 Pycnoporus sanguineus 26:1012 Pygmol 7:218 from Artemisia pygmaea 7:218 Pyochelin 2-b] acridin-6-one(isoacronycine) 345 Pyranoid linalool oxide 25:143 cis and trans 25:143 Pyranonaphthoquinones 4:591 Pyranose 17:638 derivative of 17:638 semi-synthesis of Pyranosic homologation 21:431 Pyranoside 10:373 enol esters from 10:373 stereoselective C-glycosylations 355 synthesis of 10:355 Pyrazofurin A 10:392 by Wittig reaction 10:392 from ribofuranose by Wittig reaction 10:392 from ribofuranose 10:392 Pyrazolopyridines 1:167 Pyrenomycetes 23:109 Pyrenophora avenae 581 Pyrethrin analogues Pyridine nucleotides 20:868 Pyridine substrates Pyridine-2,5-dicarboxylic acid 12:283 bicyclic keto Pyridine-2-carboxamide-netropsin Pyridinebetaine B 25:873 Pyridinium acetate 11:84 Pyridinium acetate 11:84 Pyridinium dichromate 11:350 Pyridinium methylides 1:334 Pyridinium salts 1:91 reduction with dithionite 1:91 Pyridinone Pyridoacridine alkaloids 28:639 cytotoxic effects on KB cells 28:639 Pyridoacridines Pyridoxal phosphate 10:148 Pyridoxine 2:424 2-(2-Pyridyl) ethyl 4:286 as protecting group 4:286 2-Pyridylcarbinol 12:283 hydrogenation of 12:283 Pyrilium oxide 1:189 isomerization of 1:189 Pyrilium salt 7:459 Pyrimethamine Pyrimidine phosphorylase 4:230 inhibition of Pyrimidine phosphorylase 4:230 inhibition of Pyrimidine-2-amino-2-deoxynucleosides 4:239 synthesis of Pyroglutamic acid 19:32 chiral pool 19:32 ofkuwanon Pyroglutamic acid 27:394 from red Ginseng root 27:394 structure of 390 levoglucosenone from 14:268 ofisoquinoline N-oxide 6:468 of N-acyllactams 6:430,431 of N-lauryl-6-methyl-2-piperidone 6:430,431 of acid-treated cellulose 14:268 ofprotopine N-oxide 6:494 of microgranular cellulose 14:268 Pyronaridine 25:344 T-Pyrone 5:591 5R,6S,3'R)-Pyrrhoxanthin 30:517 structure of Pyrroloquinoline alkaloids 7:444 Pyrroloquinoline quinone 9:581 Pyrroloquinolines 25:705,707 1-Pyrrolylacetic Pyruvate dependent aldolases 30:423 catabolic function of 30:423 equilibrium of 30:423 in vivo Pyruvate orthophosphate dikinase 11:182 from Propionibacterium shermanii Pyruvate-dependent aldolases 30:424 structure of 30:424 Pyruvic acid 23:463 Pythium 25:303 Pythium acanthicum 5:276 Pythium middletoni 21:199 Pythium sp Pythium ultimum 7:183 Pytophthora cinnamomi 5:276 Pytressin-induced coronary spasm Pyura sacciformis 23:257 QSAR analysis 30:195 of A8-tetrahydrocannabinol Quadrangularin A 26:567 Quadranguloside 25:206 Quadrature detection Quadrupole mass spectrometers 9 Quantitation 21:548 using UV absorbance Quasi-dimeric-type alkaloid 5:111 ceridimine Quassi excelsia 7:124 Quassia amara 7:392 quassin from Quassia indica 23:296 Quassia simarouba 28:400 Quassimarin 11:79,80,95-105 synthesis of 11:79 Quassinoid derivatives 23:303 preparation of Quassinoid glycoside 23:296 Quassinoids Quercetin 3-glucoside 23:342 Quercetin 3-O-a-L-rhamnopyranoside 28:64,65 anti-oxidant activity of Quercetin 3-O-[3-D-galactopyranoside 28:64 anti-oxidant activity Quercetin 3-rutinoside 4 Quercetin-3 [3-D-glucopyranoside-6 Quercetin-3-methyl ether 20:712 from Salvia limbata Quercetin-3-O-rhamnopyranoside-2 Quercetin-3-O-tx-L-rhamnopyranoside 28:64 anti-oxidant activity Quercetin-3 [3-D-glucopyranoside-2 Quercus aliena 23:417 Quercus faginea 27:663 Quercus genera Quercus ilex ssp. ballota 27:663 Quercus imbricaria 21:657 Quercus infectoria 22:530 for epilepsy Quercus pedunculata 29:589 Quercus phillyraeoides 23:403 Quercus sp Queretaroic acid 25:60 Questin 22:609 Quillaia 26:55 of adjuvant activity 26:55 Quillaic acid 7:155,156 Quillaja saponaria 21:646,648 593 Quinaldic acid 20:118 by Streptomyces azurens 11:209, 210 from L-tryptophan Quinidine 21:73,96,97 attachment of sugars 4:350 Quinoaldimine 26:1272 Quinocarcin 10:117,126;19:290 absolute configuration of 10:126 antitumor activity of 10:117 chemical modification of 19:290 inhibitor of DNA 19:290 structure of 19:289 structure-activity relationship of 19:289 synthesis of 1:341 retrosynthetic analysis of 19:304-305 structure of 19:289 Quinocarcinol 19:289,291 pharmacological activity of Quinoline alkaloids 13:662 Quinoline-5-carboxylic acid 14:763 isokomarovine from 14:763 komarovidine from Quinoline-ring antimalarial drugs 25:327 Quinolines Quinolinic acid 26:965,966 bioactivity of 27:233 biosynthesis of 14:738,739 from amphibans 27:234 from ants 27:234 structure of 27:233 synthesis of Quinolizidine alkaloid spartein (lupinidine) 25:534 bis-Quinolizidine alkaloids 21:267 Quinolizidine derivatives 27:284,285 testing against Mycobacterium tuberculosis Quinolone alkaloids 2:121 dimeric Quinone methides 30:694 antiplasmodial activity of 30:694 o-Quinone methides 4:582 Quinonemethide 5-isopropylidene-3,8-dimethyl-1-azulenone Quinone-methide triterpenes 5:745 Quinonemethide triterpenoids 23:709 examples of 23:709 Quinonemethides 30:666 biosynthetic pathway of 682 biosynthesis of 30:682 from angiosperms 30:304 from bacteria 30:304 from fungi 30:304 from gymnosperms 30:304 from lichens 30:304 molluscicidal activity of 7:427 occurrence of 30:304 plant sources of 23:551 structural characteristics of 348 Quinovic acid 7:218,60 derivatives of 17:123 glycosides of 17:124-125 antiviral activity of 17:134 from Artemisia vulgaris Quinuclidine derivative 1:112 Quisqualic acid 22:25 Rabbit muscle aldolase (RAMA) 11:467 Rabbit pancreas 12:390 by staurosporine 12:390 study of protein kinase in 12:390 Rabbit veins 12:390 study of protein kinase Rabdocoetsin D 15:138 13C-NMR of 15:155 from Rabdosia coetsa 15:171 IH-NMR of 15:146 Rabdoepigibberellolide 15:112 from Rabdosia shikokiana Rabdoforrestin A 15:120 13C-NMR of 15:134 from Rabdosia forresti 15:171 ~H-NMR of 15:127 Rabdohakusin 15:162,63 13C-NMR of from Rabdosia umbrosa var. hakusanensin 15:175 l H-NMR of Rabdoinflexin A 15:140,149,157,172 13C-NMR of 15:157 from Rabdosia inflexa 15:172 lH-NMR Rabdoinflexin B 15:118 13C-NMR of 15:132 from Rabdosia inflexa 15:172 IH-NMR of Rabdokaurin A 15:138 13C-NMR of 15:155 from Rabdosia longituba 15:173 IH-NMR of 13C-NMR of 15:161 from Rabdosia longituba 15:173 JH-NMR of Rabdokumin A 15:118 ~3C-NMR of 15:132 from Rabdosia kunmingensis 15:172 IH-NMR of 13C-NMR of 15:130 from Rabdosia kunmingensis 15:172 ~H-NMR of Rabdokunmin C 15:118 13C-NMR of 15:132 from Rabdosia kunmingensis 15:172 ~H-NMR of Rabdokunmin D 15:118 13C-NMR of 15:132 from Rabdosia kunmingensis 15:172 IH-NMR of Rabdokunmin E 15:120 13C-NMR of 15:134 from Rabdosia kunmingensis 15:172 IH-NMR of 15:127 Rabdolasional 15:143,153,162 13C-NMR of 15:161 from Rabdosia lasiocarpa 15:172 1H-NMR of Radical reduction 11:141 2-deoxy-1-hydroxysugars from 11:141 of dithiocarbonates 3:475 Radical scavenging activity 23:362 of coumarin 23:335 Radical spirocyclization 16:28 Radioligands 30:814 from brain membrane synaptosomes Raman spectrometry 26:1267 Raman spectroscopy 30:540 principles of 30:540 scope of 30:540 limitations of Ramulosin 16:3 from Pestalotia ramulosa of chemical selection 24:415,416 of combinatorial libraries 24:417 of compound libraries Raney nickel 6:150,151 desulfurization 11:357 catalytic hydrogenation with Rankinidine 9:196,472 rANP-triggered signal transduction 25:382 Ranunculaceae 25:180 Rapanea umbellate 30:657 24-(E)-3-oxo-dammara-20,24-dien-26-al from 382 steganes synthesis by 29:382 Raphanation Raphanusanins 26:1084 Raphe nuclei 30:368 role in cognitive functions 134 Raphisia pallida 25:705 Rapoport 29:374 allocolchicinoids total synthesis by Rauwolfia tetraphylla 1:126 Rauwolfia verticillata Rauwolscine 8:395,400,429 Ravidomycin 10:343 C-glycoside analogues of 10:374 Reaction mechanism 14:561,562 of asymmetric intramolecular Michael reaction 14 Reactivity 27:740 of enzyme intermediates 27:740 Read and Vining 29:295 biosynthesis by 29:295 Rearranged abietane diterpenes Rearrangement 10:236 1,2-Rearrangement 10:412 of~,y-epoxy alcohols 3-exo-methyl shifts in 4:626, 627,633,634 1,2-Rearrangement reaction 10:592, 593 from pyranosides 10:592 TPA bioassay system 29:101 structure 8-Receptor affinity 30:814 binding properties of 30:814 g-Receptor affinity 30:814 binding properties of 30:814 of glycopeptide Receptor agonists 30:797 pharmacological activity of 30:797 p-Receptor agonists 30:797 pharmacological activity of 30:797 ~c-Receptor agonists 30:797,806 pharmacological activity of 30:797 p-Receptor antagonists 30:797 pharmacological activity of 30:797 8-Receptor antagonists 30:797 pharmacological activity of 30:797 ~c-Receptor antagonists 30:797 pharmacological activity of 30:797 Receptor binding 27:377 Receptor binding assay 30:810 in vitro 30:810 mouse vas deferens (MVD) activity in 30:810 of guinea-pig ileum (GPI) 30:810 Receptor binding properties 30:815 of Tyr-D-Ala-Phe-[ ~-D-Glc(OAc)4]Tyr-Pro-Ser-NH2 30:815 of Tyr-D-Ala-Phe-Asp-Val-Val-Gly-NH2 (deltorphin C) 30:815 of OA c )4 ]-G ly-NH2 : 30:815 of Tyr-D-Ala-Phe-Gly-Tyr-Pro-Ser-NH2 (deltorphin C) 30:815 of D-Glc)-Tyr-Pro-Ser-NH2 30:815 of Tyr-D-Ala-Phe-Thr([3-D-Glc)-Val-Val-Gly-NH2 Receptor tyrosine kinase (RTK) 25:512 Receptors 27:363;30:421 and cell-cell adhesion 30:421 and cell-cell communication 30:421 antigenic determinants of 30:421 for bacteria Recombinant prourokinase (pro-UK) 30:839 as fibrinolytic enzymes 30:839 Recombinant tissue-type plasminogen activator 30:839 as fibrinolytic enzymes 30:839 Recombination energy 2:3 of NO + 2:3 Red algae 23:342 Red rhizomes 23:820 Red sea tunicate 23:240 Red wine 27:430 biological activity of 27:430 Red wine Redox inhibitors 30:225 of 5-1ipoxygenase Redox-based assays 21:511 Red-Pigment Concentration Hormone (RPCH) 334 Reduced nicotinamide adenine dinucleotide (NADH) 30:384 Reducing agents 19:120 3oc-Reductase Baker's yeast 19:129 by Ueno method 10:322,323 catalytic 19:475 chelation controlled 3:253 chemoselective 16:307 Relayed 13C-1H correlation spectrum 2:101 intramolecular 12:283 of primary mesylate 16:19 ofsubstrate 17:495 of symmetrical diketones 19:129 ofa Reductive acetylation 4:232,324 Reductive alkylation 10:409 of c~(phenylthio) methyl enone Reductive cleavage 1:439 with LAH Reductive cyclization 1:106,279,281 indolizidine from 11:241,242 of ketones 11 Reductive decyanation 6:431,432 of 2,6-dialy-2-cyanopiperidines 6:431 Reductive desulfurization 12:81 Reductive elimination 19:6 of acyloxysulfones 4:522 ofallylic radicals 4:525 with low valent titanium Reductive N-methylation 6:435,443 in ant alkaloids synthesis Reductive opening 1:519 with Et3A1C1-CH2C12/Et3SiH 1:519 Reductive oxygenation 10:532 with NaBH4-DMF-O2 cancer treatment 24:933 taxol for Regelone 30:643 structure of Regeol A 30:675 ~3C-NMR data of 30:675 IH-NMR of 30:675 MS spectrum of 30:675 UV absorption of Regeol C 30:675 ~3C-NMR data of 30:675 ~H-NMR data of 30:675 NMR spectra of Regioselective dehydration Regioselective Diels-Alder reaction 14:48 Regioselective glycosidation 6:262 Regioselective hydroboration Regioselective reduction 6:289 391 in Diels-Alder reactions 4:584-586 of C-aryl glycoside 11:142 of 2-substituted 1,2,3,4-tetrahydronaphthalene acetate 11:118 of Claisen rearrangement 4:368, 369 of Friedel-Crafts alkylations 4:391 ofhydroboration 4:116 Regiospecific Regiospecific enolization 12:84 Regiospecific lithiation 6:509,510 of 1-(phenylsulfonyl) indole 6:509 Regiospecific oxidation 6:508 of ellipticine Regiospecific sulphonation 4:633 of camphor Regiospecificity 4:391 of Friedel-Crafts allylations Reimer-Tiemann reaction 2:67,68 ~3C-Relaxation measurements 2:67 o f (+)-castanospermine 12:332 of 2-hydroxyindolizidines 12:284 of lienomycin 6:261 ofpimaricin 6:261 of pyrrolidine venom alkaloids 6:435 of (-)-slaframine 12:309,310 of(-)-swainsonine 12:313 oftetramycines A,B 6:261 of tetrols 5:705 Relative confiuration 23:188 of pseudodistomin A 23:188 ofpseudodistomin B 23:188 Relative stereochemistry ~H-Relaxation measurements 2:67 IH-Relaxation measurements 2:67 Remote oxidation 4:645,646 of (+)-bornyl acetate 4:645,646 of (+)-camphor 4:645,646 of (+)-isobornyl acetate 4:645 576 antibacterial effect of 16:576 as antinflammatory agent 16:576 synthesis reduction of 16:587 synthesis Reniera sarai 22:30 Reniera sp. 21:266 1,6-D imethyl-7-methoxy-5,8-dihydroisoquino-line-5,8-dione from 21:263 Repandusic acid (hydrolysable tannin) 29:573 effects on HIV-1 protease Repellent properties 28:395 of Amblyomma variegatum 28:395 Reperfusion injuries 30:224 role of free radicals in 30:224 Replacement of sulfur by oxygen 1:560 by [2,3]-sigmatropic rearrangement of sulfoxide Replic plating technique 7:115 Reproduction ofchirality 4:345 Reptoside 29:83 activity in EBV assay system 29:83 Resacetophenone Rescorcinolic lipids 30:165-167 effects on enzymatic activity 30:165-167 interaction with proteins Rescorcinolic lipids 30:165-167 interaction with proteins Resistance-modifiers 30:595 antimalarial drugs as Resistant Plasmodium species 30:595 in chloroquine sensitivity 30:595 Resolution 1:319,324-327 diastereomeric 1:585-588 kinetic 1:589 through chiral ketones from Loberia retigera 13:22 X-ray crystal structure 521 activity in AM bioassay system 29:111 in visual signal transduction 30:520 structure of 30:521 13-cis-Retinioic acid 4:526 Retinoid chemistry 28:69 recent progress Retinoid retinol 29:111 activity in AM, EBV bioassay systems 110 in mammary cancer 29:110 in urinary bladder cancer 520 cleavage of 30:520 13-cis-Retinol Retinol (vitamin A) 28:69 in mammalian Retinol acetate 29:111 activity in AM bioassay system Retinol palmitate 29:111 activity in AM bioassay system 29:111 Retinyl phosphate 8:78 synthesis Retroene reaction 11:46,47 Retro-Mannich reaction 1:157,158 Rhodophin glucoside 30:521,522 structure of Rhodotorula acuata 21:391 Rhodotorula glutinis Rhodotorula lactosa IFO1424 13:233 Rhodotorula minuta Rhodotorula peneaus 5:292 Rhodotorula rubra 7:340;26:673 torularhodin from Rhoeadine alkaloids 1:187,189 from indenobenzazepines 1:212-214 from spirobenzylisoquinolines 1:212-214 synthesis of 456 FPTase inhibition by 24:456 Rhomitoxin 71 vitamin A synthesis by 25:698 Rhopaoloic acid A B and C 25:698 RHPLC 9:333 Rhus cotinus 29:579 Rhus rhodantherma 29:579 Rhus sp Rhynchophylline ent-allo A-17-demethoxy Rhynchophylline-type alkaoids 5:83 Rhytidoponera aciculata 5:224 Rhytidoponera metallica 5:224 250 Ribes nigrum 20:721 Ribes rubrum 27:839 Ribes sanguineum 27:839 extracts 694 Ribitol 4:510 synthesis of Ribofuranosylethynes 10:359 D-Ribo-hexitol 6:357,358 C2-P bond analog of 6 369 2-azido-D-arabino-hexofuranoses from 6:369 from D-allofuranose 6:369 R-Ribonolactone 292 (4S)-hydroxymethyl butanolide from Ribosome-inactivating proteins (RIPs) 24:523 dimeric 24:523 single chain (homologous) 24:523 Ribostamycin Riboypyranoses 6:366,367 Dsynthesis of 6 Ricinoleate 26:361 Ricinoleic acid 9:387;21:197;30:193 analgesic action of 22:531;28:400; 30:193 ricinoleic acid from Rickettsial pathogens 28:394 Cowdria ruminantium as Rieke's zinc 13:146 Rifampicin 84 absolute configuration of 23:85 preparation of 23:57 Rifamycin-type macrolides 24:545,546 antiviral microbial-derived compound 24 Rift valley fever infection 30:411 treatment of 30:411 Rigidin 10:247 166 Rimantadine 24:489 Rimantidine 27:108 for treatment of influenza in infections Ring (C)-homoberberin analogue 6:496 spiro-isoquinoline derivative from 496 derivative from 6:496 reaction with dimsyl sodium 6:496 Ring cleavage 16:139 of (+)-9,10-dibromocamphor 16:139 in (+)-spiniferin-1 synthesis 6:73,74 of erythrinan-3-one 6:477,478 of ct-narcotine N-oxide 6:468 Ring interconversion Ring opening 12:411,413 2-amino alcohol by 12:411,413 of oxirans 12:411,413 with nitrogen nucleophiles 12:411 Ritter reaction 11:281 Ritterella sigillinoides 5:253;25:782, 816 T7RNA polymerase 4:306 enzymatic ribonucleotide synthesis 4:306 m-RNA polymerase 7:387 RNA polymerase I 13:258,259 RNA virus 30:394 arenavirus type of 30:394 of 30:394 RNA-dependent RNA polymerase activity RNA-directed DNA-polymerases 29:127 inhibition by Sf-9 cell line Robinia pseudoacacia 25:93 Robinin (kaempferol 3-O-galactosylrhamnosyl-7-O-rhamnoside) (flavonol O-glycoside) 29:573 effects on HIV-1 protease Robinioside J 25:95 Robinson annelation Rocaglamide 16:565 antileukaemic activity of 16:565 synthesis of 16:565 Rocaglaol 26:220 Rocaltrol 9:513 Roche acid 1:471 Rodobyrum giganteum 2:277 Rodophilia bifida 26:615 Roemeria sp ROESY correlation 30:586 of (7R,8S,7'R,8'R)-(+)-7'-acetyl-5'-methoxypicropodophyllin 30:586 ROESY experiment of 30:646 structure of 30:646 ROESY spectrum 17:129 of oligosaccharides 17:129 Rofecoxib 30:192 as COX-2 inhibitor Role 27:797 of cholecystokinin 27:797 of gastrin 27:797 of protein phosphorylation 27:821 Rollidecin 26:793 Rollinia emarginlu 26:793 Rollinia mucosa 18:208 rolliniastatin Rollinia ~ylvatica 9:399 Rollinia ulei Rolliniastatin-2 18:208 from Rollinia mucosa 18:208 synthesis Romneya genera 27:163 Roosters Roridin D 30:736,737 structure of Roridins 30:743 antiviral activity of Rosa rugosa 23:397,404 Rosaceae 23:396,404;30:610 acylphloroglucinols from Rose oil ketones (damascones) 14:425 Rose oxide 25:138 trans and cis 25:138 Rosefuran 19:174 Rosenolactone 19:402 synthesis of 19 Rosmanol (abietane diterpene) 29:575 effects on HIV-1 protease Rosmanol (abietane diterpene) synthesis 29:575 from camosolic Rosmarinecine 19:149 isolation of 19:149 Rosmarinic Rosmarinus officinalis 21:599;29:587 Rosmarinus sp Rosthorin A 15:123,139 13C-NMR of 15:130,156 from Rabdosia coesta 15:171 from Rabdosiajaponica 15:172 from Rabdosia rosthornii 15:174 ~H-NMR 13C-NMR of 15:133 from Rabdosia rosthornii 15:174 ~H-NMR of Rotational correlation time 2:61,62 Rotational isomers 27:340 structure of 27:340 Rotational strength 2:145 Rotational symmetry 7:4 Rotavirus gastroenteritis 30:406 treatment of 30:406 Rotaviruses 209 from Artemisia tridentata sp 101 activity in APO bioassay system 173 from Rabdosia lophanthoides var. gerardiana 15:173 RPR113228 24:437 structures 575 RTK tyrosine kinase 25:545 RT-PCR analyses 28:323 of tumor necrosis factor TNF-c~ Rubella virus replication 30:374,409 autistic features in 30:374 blocking by 30:409 inhibitory effect on 30:409 Ruberythric acid 26:629 from Rabdosia rubescens Rubescensin D 15:163,164,167 13C-NMR of 15:165 from Rabdosia rubescens anthragallol from 26:657 lucidin from 26:657 munjistin from 26:657 mutagenic activity of 26:675 nordamnacanthal from 26:657 pseudopurpurin from 26:657 purpurin from 26:657 rubiadin from 26:657 xanthopurpurin from Rubottom epoxidation 11:75 Rubottom oxidation 12:215 Rubradirin 23:54,68,88 ansa moiety Rubrosides H 25:763 Rubus ellipticus 22:531 Rubus foliolosits 25:251 Rubus fructicosus 20:721 Rubus ideans Ryanodol-type diterpenes 26:852 insecticidal effects of 26 Rylander oxidation natural abundance of 9:110 respectivity of 9:110 resonance frequency of 9:110 spin quantum number Sa mae sarn 28:574 antitumor activity of 28:574 as mild cathartic 28:574 from cassigarol A 28:574 from piceatannol 28:574 from piceatannol acetate 222 biosynthesis of 11:221,222 from geranyl diphosphate 11:221,222 stereochemistry of Saccharomyces bailii 1:689;8:238 Saccharomyces carlsbergensis 19:601 Saccharomyces dobzhanskii 5:287 Saccharomyces drosophila 5:287 Saccharomyces fibuligera 25:308 Saccharomyces kluyveri 26:1127 Saccharomyces lactis 5:287 Saccharomyces lodderi 5:283 Saccharomyces microellipsodes 5:283 Saccharomyces phaseolosporus 5:287 Saccharomyces pretoriensis 5:283 Saccharomyces rosei 5:283 Saccharomyces sake 12:401 Saccharomyces sociasi 5:287 Saccharomyces sp. 5:279 Saccharomyces vager 5:283 Saccharomyces wieckerhamii 5:287 Saccharopolyspora erythraea 22:265 Saccharopolyspora spinosa Saccharothrix mutabilis Saccharum officinale 27:191 Saccharum officinarum 15:3;29:593 Sacchromyces epidermidis 26:1095 Sacchromyces sp. 26:1087 Saccorliza polyschides Sacculaplagin 2:81-90 absolute configuration of 2:89 derivative of 2:89 ~H-NMR of 2:82 structure of 2:81-90 sacculaplagin triacetate IH-COSY spectrum of 2:86 COSY spectrum of 2:83 2D-INADEQUATE spectrum of 2:88 long range 13C, tH-COSY spectrum of 2: 87 NOESY spectrum of 2 Sacculatane diterpenoids 2:90278 Sacupira branca Saegusa oxidation reaction 16:430 Saegusa ring expansion 6:37,38 in tricarboxylic epoxide 6:37 Safety evaluation 27:299 of stevin 27:299 of stevioside 315 anti-tumor activity of 28:314,315 as coloring agent 28:313 uses in medicine antibacterial activity of 10:78 antitumor activity of 10:78 synthesis of 10:83-100 transformation Sagecoumarin 30:220 isolation of 30:220 structure of Sagittaria sagittifolia Saikosaponin 6 27:674 structure of Saikosaponin 8 27:674 structure of 27:675 Saikosaponins Salacia campestris 30:639,667 cyclase activity of Salacia krausii 30:667,693,694 against bilharziasis 30:693 against dysentery 30:693 28-hydroxyisoiguesterine from 30:667 quinone methides from 30:694 Salacia macrosperma 7:150 salaspermic Salacia madagascariensis 30:667 isoiguesterine from Salacia oblonga 30:645 uses of 30:645 Salanacea 21:622 Salaspermic acid 7:146,147,167 from Salcia macrosperma Salcolene axide elicitor of pathogen related genes 27:63 generation of 27:63Salicyclic acids S)-Salinixanthin 30:517 structure of 30:517 Salinomycin 11:152 Saliva desoleana 26:407,409,410,411 composition of 26:407 Saliva officinalis 26:391 Saliva sclarea 26:395 Salivene 16:265 Salix caprea 29:581 Salix fragilis 30:195 salicin from Salix petsusu 20:627 Salix purpurea 30:195 salicin from Salix sachalinensis Salmonella abortus 28:539 in human macrophages 28:521 in peritoneal carcinomatosis 28:533 phase I trials with 28:539 receptor for 28:520 Salmonella anatum 6:262 O-antigen from 6:262 Salmonella choleraesuis 21:607 Salmonella enteridis 12:401;26:673 Salmonella minnesota 28:537 Salmonella monteyideo 8:102 Salmonella mutagenicity assay 22:682 Salmonella newington 8:101;14:233; 26:1160 O-antigenic polysaccharide from 14:233 Salmonella paratyphi 9:308;26:673 Salmonella schottmuelleri 9 Salvia 26:172;30:242 flavonoids of Salvia acetobulosa 20:673 horrnonone from 20:673 1-oxoferruginol from 20:673 3-oxoferruginol from 20:673 18-oxoferruginol from 20:673 pisiferal from 20:673 sempervirol from Salvia blepharophylla 30:246 diosmetin from 30:246 pedalitin from antiinflammatory activity of 26:416 Salvia divaricata 20:661 6-horminone-18-oic acid from 20:661 6 erithrodiol 28-acetate from 20:707 313-hydroxy-11-oxo-oleana-12-ene from Salvia hierosolymitana 20:672 forskalinone from Salvia leucophylla 20:4 Salvia limabata 20:673 Salvia miltiorrhiza 2:402,26:235,29:212 cell suspension cultures of 2:402 danshensuan B from Salvia montbretii 20:666 Salvia pinnata 30:244 apigenin from 30:244 luteolin from Salvia plebeia 30:247 hispidulin 7-glucuronide from Salvia pomifera 20:663 Salvia sclarea 7:101,103,110,123 Salvia serotina 28:400 Salvia sp. 21:599 biological investigations of 20:659 chemical investigations of 20:659 Salvia splendens 5:646 Salvia tchihatcheffii Salvia triloba 20:711;29:588;30:243 salvigenin from 20:711 Salvia uliginosa 30:247 petals of Salvia wiedemanni 20:688 16-tetranorlabdane-12-oic acid 20:692 B from 20:696 Salvianolic acids 30:221 synthesis of Salvinolone 5:34;20:666 APT spectrum of 5:34 ~3C-NMR spectrum of CSCM 1D spectrum of 5:34 from Salvia montbretii 20:666 ~H-NMR spectrum of 5:33,34 INEPT spectrum of Salvipisone 20:680 from Salvia candidissima 20:680 from Salvia nemorosa 20:683 Salvitchitatine 20:676 from Salvia tchihatcheffii SAM biomethylation 316 SAM MM 23:38 structure elucidation of SAM MM1 23:29,41 ~3C-NMR assignments of 23:31 ~H-NMR assignments Samarium iodide mediated cyclization 8:232 Sambucinic acid 6:213 ~3C-NMR assignments of 23:31 chemical degradation of 23:30 crystallization of 23:33 ~H-NMR assignments of 23:29 HMBC spectrum of 23:28 hydrolysis of 23:32 mass spectra of 23:35 mechanism of 23:35 N-acetylation of 23:36 salt formation of 23:33 structure elucidation of 23:26 structure of 23:30 tautomeric structure of 23 Sampangine mammalian metabolite (SAM MM Sampangine-4'-O-methyl-[3-glucopyranoside (SAMM1) 23:3 13C-NMR assignments of 23:31 ~H-NMR assignments of 23:29 structure elucidation of 23:34 tautomeric structure of 23:37 tautomerism Sample preservation 21:501 Sampsoniones 30:625 structure of Sandfly fever sicilian virus (SFSV) 30:410,412 phlebovirus type of Sandrasin A 23:624,625 ~3C-NMR data of 23:625 ~H-NMR data Sandrasin B 23:624,625 ~3C-NMR data of 23:625 ~H-NMR data 678 sulfate olefaction Pi 28:209 as herbal medicine Sanggenol M 28:230 biological activity Sanggenon A 28:212,230 biological activity of 28:212,230 from moraceous plants biological activity of 28:230 from moraceous plants 230 biological activity of 28:230 from moraceous plants Sanggenon D 28:212 biological activity of 28:212 from moraceous plants Sanggenon M 28:230 biological activity Sanggenon O 28:201 from moraceous plants 28:201 Sanginarine 22:27 Sanguanella 23:656 Sanguidimerine 27:138,169 structure 13C-NMR spectrum of 5:45 CSCM 1D spectrum of 5:46 derivatives of 27:172,173 from coptisine Sanguisorba officinalis 17:421,423 136 synthesis of 8:145 c~,~-Santalol 29:91 activity in skin-1, ODC assay systems 29:91 from sandalwood oil Santonia chamaecyparissus 7:100, 101 Sapargine 25:528 as immunosuppressive drug 25:528 Sapindaceae Sapindus emarginatus L. 22:531 for epileptic fits Sapindus rarak DC 21:660 Sapindus trifoliatus L. 22:531 for epilepsy, hysteria and hysteroepilepsy Sapium 25:242 Sapium genera 27:830 Sapium indicum 7:188 4a-sapinine from 7:187 SAPO 50 26:41 hemolytic activity Sapogenin 1:305 Saponaria 26:55 of adjuvant activity antiinflammatory activity of 26:27 antiviral activity of 30:407 gypsogenic acid from 26:5,6 4-secogypsogenic acid from 26:5,6 triterpenoid saponins from Saponarioside C 26:26 HMBC correlations of 26:15,25 HOHAHA spectrum of 26:10 MALDI-TOF MS of 26:26 phase-sensitive NOESY spectrum Saponification 6:146 Saponin E 27:41,45,47 structure of 27:47 Saponin fraction 30:86 in oolong tea Saponin QS-21 21:646 Saponinase 25:312 4ot-Saponine 7:187 from Sapium indicum Saponins 1:305 Saposhnikovia divaricata 27:422 Saposhnikoviae radix 27:422 Saprolegnia parasitica 9 37 Saprorthoquinone 5:36 Saquayamycnis 24:480 FPTase inhibition by 24:480 Saquinavir 24:489 inhibitor of HIV-1 protease 24:489 SAR 26:167,168;30:205 of (+)-allomatrine 30:205 of (+)-matrine Saraine (cyclostellamine) 24:573 Sarcocapnos enneaphylla 3:428 Sarcodon leucopus Sarcomelicope agyrophylla 20:807 Sarcomelicope simplieifolia 20:807 Sarcomelicope dogniensis 100 activity in skin-2 assay system 29:100 activity in mam-3assay system 29:100 antileukemic activity Sarcophyton glaucum 8:18;21:279 Sarcophytum sp Sarcoptes scabiei 28:409,416 cause of mange mites 28:409 cause of scabies Sarcosine 1:335,336;25:537 decarboxylation of 1:335 Sarett oxidation 14:635 Sarett reagent 4:434 Sargasm horneri 30:400,405 anti-CMV activity of 30:405 polysaccharide (PS) from Sargassum lacerifolium 25:867 Sargassum muticum 26:1152 Sargassum tortile Sargasum muticum 30:400 polysaccharide (PS) from 30:400 Sargramostim Sarotherodon nilotica 7:184 Sarothra gentianoides 30:605 n-nonane from Sarpagine-type indole alkaloids Sassafras sp Satratoxins 30:743 antiviral activity of Scaevola racemigera 6:522 strychnovoline from 6:522 12-epi-Scalaradial 6:111 from Dictyoceratidae Scalarane ring system 6:58 (+)-Scalarane-type sesterterpenes 6:122-129 synthesis of stereoselective synthesis Scandenoside R11 27:15,25,26,27 structure Scandenoside R6 27:15,25,26 structure of 27:26 Scanning electron microphotographs 27:399 structure of 27:399 Scanning electron microscopy (SEM) Scapaniapyrone A 9:95 O2-Scavenging acitivity Scavenging activity 21:675 Scavenging effects 23:443 of tannic Schiff's base mechanisms 20:833 Schilrs synthesis 14:861 Schinus terebinthifolius 22:131 Schisandra 26:183 decrease of heart rate 26:183 effect on cardiovascular system 26:183 effect on heart rate 26:183 for treatment of hepatitis 26:183 platelet activating factor antagonist activity Schisandra rubriflora 26:205 Schisandrin Schisandrol A 26:245 as PAF-induced inhibitor Schistocerca gregaria 24:715,716 Schistosomiasis (Bilharzia) 7:405 Schizandrin C&D 26:250 Schizaphis graminum 23:535 Schizolobium parahybum 29:605 Schizonepeta tenuifolia Schizonticidal drug 26:837 Schizophrenia 21:101 Schizosaccharomyces pombe 5:280,286 Schlessinger 29:370,384 steganes synthesis by Schollkopf system 4:125 Schollkopfs isocyanides 10:88 c~-metalated 448 Schottenol glucoside 30:720 structure of Schreiber's synthesis 30:6-10 of (+)-discodermolide Schwann's cells 22:586 Schwanniomyces alluvius 5:283 Schwanniomyces castelli Schwartz's reagent 21:381 Schweinfurthia papilionaceae 9:75 Scitonemin A 5:429 13-epi -Sclareol 25:246 Sclareol 7:100 Sclareol glycol 25:265 Sclareol isomers 25:266 Sclareolide 25:253 absolute configuration of 6:549-551 from Sclerotiniafructicola 6:546 structure elucidation of Sclerotinia cinera 12:401 Sclerotinia fructicola 6:546 Sclerotium fermenti 5:280 Sclerotium fragilis Sclerotium glucani 5:277 Sclerotium glucanicum 5:314; 23:115,142;30:401 scleroglucan from Sclerotium rouxii 5:282 Scolytus multistriatis (elm-bark beetle) 15:348 Scopadulan-type diterpenoids 21:692, 721 biosynthesis of 21:721-723 structure activity relationship of 21:717 synthesis of 263 Scoparinol 29:101 activity in CRG bioassay system 29:101 from Scoparia dulcis Scripus maritimus 9:391 Scrophularia auriculate 29:84 Scrophularia canina Scropolioside A 29:84 activity in TPA assay system 29:84 Scrovalentinoside 29:84 activity in TPA assay system Sculponeatin A 15:141 13C-NMR of 15:158 from Rabdosia sculponeata 15:174 ~H-NMR of 13C-NMR of 15:159 from Rabdosia sculponeata 15:174 ~H-NMR of 13C-NMR of 15:158 from Rabdosia sculponeata 717 15:174 1H-NMR 144 13C-NMR of 15:161 from Rabdosia sculponeata 15:174 1H-NMR of Scutellarein 21:690;30:288 structure of Scutellaria altissima 30:250 baicalein from 289 baicalein from 30:55 flavonoids from 30:56,289 in allergric inflammatory disease 30:69 viscidulin III from Scutellaria discolor 30:251 norwogonin from 30:251 wogonin from 678 Scutellaria ocellata 30:248 wogonin from Scutellaria orthocalyx 29:679 Scutellaria przewalskii 30:249 apigenin from 581 Scutellaria tenax 5:678 Scutellariae radix 27:431 biological activity Scutionin (xB 30:685 13C-NMR spectra of 30:685 2D NMR spectroscopic data of 30:685 ~H-NMR spectra of 30:685 molecular formula of 30:685 structure of 157 Scylonema hofmanni 26:363 Scyphyphora hydrophyllaceae Sea cucumbers 28:597 calcigeroside C2 from 28:597 calcigeroside D2 from 28:597 cucumarioside A0-1 from 28:597 cucumechinoside A from 28:597 cucumechinoside B from 28:597 cucumechinoside C from 28:597 cucumechinoside D from 28:597 cucumechinoside E from 28:597 cucumechinoside F from 28:597 triterpene glucosides from 28:601 Seasonal affective disorder 30:369 effect of circadian activity on Secalonic acid 27:849 13,14-Seco-13,14-dioxoabiet-13-en-18-oic acid 29:100 activity in EBV assay system 29:100 6,7-Seco-19 53 lactonization of 12:52,53 via-2-pyridine thiol ester 178 2,3-Secoaromadendrane sesquiter Secoemetine derivatives 6:485 amoebicidal activity of 6:485 synthesis Secogypsogenic acid 26:29 Secoiridoid glycosides 330 antimicrobial activity of 26:330 gentiopicroside type 7:443 oleuropein type 7:443 secologanin type 7:443 Seco-lanostane triterpenes 22:105 Secologanin 1:31,32 Gray 16:307 tryptamine condensation with 6:520 Secomanoalide 18:717 "Second generation 572 Secondary metabolism 7:93,98 617 acaricidal activity of 28:432 biological activity of 28:617 biosynthesis of 20:291-293 chemistry of 23:592 evolution Secondary metastatic tumor growth 30:64 effect of triterpenoids on 30:64 Secophenanthoindolizidine Secoxyloganic Secretory activity 21:98 Secretory fungal peroxidases 27:736 Securidoca longepedunculata 22:532 Securiflustra securifrons 18:691 Securinega alkaloids 5:49 Securinega Securinine alkaloids 14:657-659 via Norrish type II reaction 599;27:660 arnica as 22:559 Artocarpus heterophyllus as 22:513 Basilicum polystachyon for 22:514 Sedative activity 21:673 Sedative in convulsions 22:518 Crocus sativus L. for 22:518 Sedative in epilepsy 22:535 Withania somnifera L. as Sedum sarmentosum 21:737 Seed oil (Croton oil) 25:242 Segetalic Segoline A 23:276 Selagin Selaginella tamariscina 24:273 Selection 7:116,117 by autoxicity 7:116,117 of metabolically-active cells 125 Wittig olefination of Selective acylation 12:346;13:586; 14:163 ~t-Selective agonist 30:807 dermorphin Selective aldehyde reduction 13:579 8-Selective antagonist Tyr-Tic-Phe-NH2 Selective antitumor activity 15:355 Selective benzoylation 13:557;14:244 Selective cleavage 7:155 of bisdesmosides 7:155 of ester type glycoside linkage 7:154,155 of glucuronide linkage 7:156-158 of sugar aglycone linkage Selective cytotoxicity 13:648 Selective deoxygenation 14:160 of maltose 14:160 of primary alcohol 16:348 Selective deprotection 12:345 [3-Selective glucosylation 15:28 Selective heteronuclear J-resolved spectroscopy 2:147 Selective hydrogenation 6:83 in (+)-9-isocyanopupukeanane synthesis of 6:83 Selective hydrolysis 12:343;13:571 2D Selective J-resolved spectra 2:115 Selective ketalization 6:33 485 5-Selective opioid agonist 30:817 deltorphin B 30:817 g-Selective opioid peptide 30:802 5-Selective opioid peptide 30:817 Selective reaction 6:282 c~-Selective thermal glycosidation 8:367 of cyclooligosaccharide 8:367 of cyclo-L-rhamnohexaose 8:367 c~-Selective thermal rhamnosylation 15:28 Selective thiocarbonylation 14:162 of sucrose derivative 14:162 CNX) 30:811 of ICI 19944 30:811 ofk opioids 30:811 6,~t-Selectivity 30:819 in vivo 30:819 of glyco analogues 30:819 threo-Selectivity 4:130 179 anhydride reduction with 3:489 in stereoselective reduction Selenastrum capricornutum 26:373 Selenocyclization 11:98,99 Selenoxide-based elimination 1:248 Selenylation 1:452 Self-incompatibility (SI) 25:402 Self-incompatibility in pollen from Humulus lupulus 14:450 from Myrica gale 14:451 from Pisidium guajava 14:450 from Podocarpus dacrydiodes 14:449,450 from Riccardiajackii 14:450 synthesis of Selinum vaginatium Selligueafeei Bory 15:33;27:18,35 selligueain A from Semecarpus anacardium L. 22:532 for epilepsy and hysteroepilepsy Semecarpus heterophylla 9:319 Semecarpus vernicifera 9:319 Semi synthesis 29:363 of (-)-rhazinilams Semibullavene 5:776 13C-NMR spectrum Semi-empirical methods (AMI) 22:568, 569,576;30:542 for calculations Semisynthetic LSD 26:820 as psychodelic drug Sempervirol 20:673 fromSalvia acetobulosa 20:673 from Salvia multicaulis Sendai virus infection Senecio oxyodontus 13:13 senoxydene from Senecivernic acid 1:264 Senercinine 1:203 synthesis of 1:203 Senescent plant 27:86 lipid peroxidation products of 27:86 sapogenins from 27:466 Senieramycin 25:826 77Se-NMR 9:119 of phenylselenyl alkanes 9:119 of phenylselenyl cyclohexane 9 Senna multiglandulosa 22:580 Senna occidentalis 26:1143 Senna spp. 22:580;26:1139 Sennosides 30:305 structure of from Senecio oxyodonius 13:13 synthesis of 3:10 Sensory neurons 30:194 hyperpolarisation of Sentellaria scandens 30:253 5,7,2 ',5 '-tetrahydroxy-6-methoxyflavanone from 30:253 Separation scheme 27:507 of polysaccharide Sepedonium ampullosporum 20 21:532;30:234 use for flavonoid purification Sepositoside A 15:59,60;7:295 from Echinaster sepositus 7:294 Separation Septoria lycopersici 25:293 Sepulchre's Sequoia sempervirens 28:408 Ser264 inhibitors 130 and Danisefsky's-diene addition 4:130 in cyclocondensation 4:122 Serindea warneckei 23:342 Serine 11:420;27:850;30:836 activity of 27:850(z2-macroglobulin inhibition by 30:836 synthesis of 11:420 L-Serine 4:130 Serine protease inhibitor proteins 29:617 arrowhead PIs API-A & API-B as Cp-thionin as 29:617 effects on barley malt cysteine endoproteinases 29:617 effects on chymotrypsin 29:617 effects on subtilisin 29:618 effects on subtilisin (or-amylase inhibitors -HT) receptors 30:376,378, 382,383 in brain 30:383 in limbic brain regions 30:383 pharmacological aspects of 30:378 type of G-protein-linked receptor Serotonin (5-HT) re-uptake inhibitors 30:368 mechanism of -HT) synthesis 30:370,376, 377 from tryptophan 30:370 in autistic children Serotonin (5-HT) transporter-linked polymorphic organ Serotonin (5-HT) transporter-linked polymorphic region (5-HTTLPR) Serotonin (5-HT) 1AR receptor antagonists 30:378 in postnatal treatment -HT)sA receptor 30:375 in brain development 30:375 in phenotypic behavioral irregularities 30:375 in purkinje cells 30:375 mRNA expression of 30:375 Serotonin action 30:378 on apoptosis 30:378 on maturation 30:378 on neuronal functioning 30:378 on proliferation Serotonin agonists 25:531 anticomplementary activity of 25:46 role of cyclic AMP-dependent protein kinase 25:46 delayed-type allergy suppressant activity of 25 Serotonin synthesis inhibitor 30:378 parachlorophenylalanine as Serproidins 22:83 Serratenone 11:309 from hobartin 19-ol Serratoline 11:321,322 1,2-rearrangement of 11 Serricomin 14:275 absolute configuration of 14:275 from cigarette beetle (Lasioderma serricorne) 14:275 from levoglucosenone 14:267,275 synthesis of 1:695 Serum ALT activity 25:471,476 of sweroside 25:471,476 ofColchicum autumnale Serum TC 27:420 biological activity Serum transaminase 27:415,417,420 biological activity of 27:415 Serum transaminase activity 25:469 of Curcumia longa L. 25:469 Serum triglyceride 27:404 biological activity of 27:404 Serum tumor necrosis factors Sesamum indicum 26:249 pinoresinol from 26:249 sesaminol from 26:249 sesamol from Sesbania punicea 1:305 Sesbania sesban 7:427 Sesbania vesicaria 136 Sesquicamphors 16:136 Sesquicarene 17:609 Sesquilignans 20:613,621 from Abies sachalinensis from Chosema arbutiflia 20:644 from Eucommia utomoidis 20:644 from Salix sachalenensis 20:627 Sesquiphellandren structure 847 form Stylotrichium rotundijbluim 8:58 from Ammania baccifera 9:65 from Cadabafarinosa 9:64,65 from Curcuma longa 8:52 fromFerula communis 8:59 from Fusarium sporotrichiodes 9 from Lychnophora sellowii 8:48-5O from Pluchea arguta (Conyza odentophylla Sesquiterpene alkaloids 18:753 Sesquiterpene isocyanides 6:79,80 in Halichondride 6:79 in nudibranchs 231 molluscicidal activity of 7:427 structure of 27:479 Sesquiterpene pyridine-type alkaloids Sesquiterpene quinones 5:768-771 antimicrobial activity of 5:429 cytotoxic activity of 5:429 synthesis of Sesquiterpene synthetase (cyclase) 7:109 13C-NMR data of 23:634 ~H-NMR data of 23:634 costunolides as 29:97 parthenolides as 29:92 polygodial as 29:91 sesquiterpene lactones as 29:86 structures of 29:93 zerumbone as Sesquiterpenoids drimane-type synthesis 29:127 avian myeloblastosis virus (AMV) inhibition by 127 by Jauch Cieplak's theory in 29:127 enantiospecific total-29:127 endo selection in 29:127 7t-facial selections Homer-Emmons carbon elongations in 29:127 starting from 2,3-anhydro-Darabinitol derivative 29:127 tetracyclic intermediate in 29:127 use of Sharpless asymmetric epoxidation strategy Setaria FMTI 29:600 Setaria italica 25:781 Seubert's medium 25:153 Seven membered cyclic ethers 10:209, 224-226,234 by rhodium carbenoid mediated cyclization of hydroxy c~-diazo Seven-membered oxepane 10:202 Seven-membered rings 10:309-311 from five-membered rings Sexual potency Seychellogenin 7:270 SFORD spectrum 2:93 SFORD techniques 18:972 sGOT 30:292 activities of 30:292 sGPT 30:292 activities of 21:654 Shapiro synthesis 11:84 Sharpless asymmetric dihydroxylation 16:332 diastereofacial-selective manner 19:492 dihydroxylation of 19:246 of 2-ethyl-2-propen-1-ol 14:828 of 2-heptenol 19:61 of allylic alcohol 10:534 Sharpless hydroxylation 12:218 Sharpless kinetic resolution 10:236 of (+)-N-benzyloxycarbonyl-3-hydroxy-4-pentenylamine 12:281 Sharpless method 4:483 in thienaycin synthesis 4:483 Sharpless oxidation Shewanella putrefaciens Shigella ambigua 26:673 Shigella boidii 26:673 Shigella boytic 25:260 Shigella dysenteriae 9:308 Shigella flexneri 26:673 Shigella largei-sachsii 26:673 Shigella lycopersici Shigella shiga 25:260 Shigella sonnei Shikimate 3-phosphate 11:185 479 as unsaturated carbauronic acid 29:479 pericosine B as 29:479 van der Walle approach to 29:478 Shikimic pathway 30:420,431,609 3-deoxy-D-arabino-2-heptulosonic acid 7-phosphate (DAHP) role in 30:431 Shikoccidin 15:119 from Rabdosia shikokiana var. occidentalis 15:174 from Rabdosia umbrosa 15:175 from Rabdosia umbrosa var 13C-NMR of 15:165 from Rabdosia shikokiana var. occidentalis 15:174 from Rabdosia umbrosa 15:175 from Rabdosia umbrosa vat. hakusanensis 1 fi: 175 from Rabdosia umbrosa var Shikokianal acetate 15:173 from Rabdosia nervosa Shikonin 7:96,112,116 from Lithospermum erythrorhizon Shine-Dalgamo sequence 13:262 Shing and Wang Shodoptera littorolides 20:245 Shogaol 237 from cyano derivative 10:355 from free sugars 10:393 Shorea disticha 23:547 Shoreaphenol Shug Chher 25:275 Shuteria vestita Sialic acid analogues 27:116-129 aromatic sialic acid analogues 27:134-140 carbocyclic sialic acid analogues 27:140-141 long chain ester analogues 27:122-129 polar analogues Sialic acids 2:309 from Streptococcus sp. 16:86,87 nojirimycin analogues inhibition with Sialylaldolase catalyzed 11:466 condensation Sialyltransferase Siamenoside I 15:24 Siamine 1:163 Siastatin A 10:551 from Streptomyces verticillus var. quintur 550 antimetastatic activity of 16:81 from Streptomyces culture 16:76 methyl ester 16:97 N-acetyl Sibiricol 4:375 asymmetric synthesis of 14:539-544 from l-prolinol 14:542 from Nitraria sibirica Sida acuta 5:751 Sida carpinifolia Sida rhombifolia 5:751 Sida sp. 5:751 Side effect 30:194,799 of analgesic alkaloid 30:799 of opioids Sideritis angustifolia 29:687 Sideritis arborescens Sideritis leucantha 22:429 Sideritis lycopersici 25 Sideritis marmorea 30:260 trimethoxykaempferol from Sideritis mugronensis 25:250 Sideritis nutans 25:249 Sideritis raeseri 30:258 apigenin from Sideritis shiga 25:260 Sideritis sp. 5:658;30:259 p-coumaroylglucosides from Sideritis varoi 25:250 Siderophores Sidnyum turbinatum 28:643 1-heptadecanyl sulfate from 28:643 1-hexyl sulfate from 28:643 1-octadecanyl sulfate from 28:643 sodium (2S)-2,6,10,14-tetramethylpentadeca-1,18-diyl sulfate Sieberoside I 25:191 Sigmatropic 1,3-H-migration 18:166 [2,3]-Sigmatropic elimination 12:11 of PhSeOH :67,68 for C-S to C-O conversion 1:560 of allylic sulfonium ylide 16:255 ofsulfoxides 1:560 ofallylic sulfoxides 11:326 Sigmatropic Sigmatropic shift 24:763 [1,5]-Sigmatropic shift of hydrogen Sigmoidin A 28:229 biological activity Signal pathway-associated proteins 25:370 acyl-CoA binding protein 25:370 calmodulin 25:370 lipooxygenase 25:370 prosystemin 25:370 nucleotide diphosphate kinase 25:370 Signal reception 30:377 in autistic children 30:377 Signal transduction 21:20 Signal transduction mechanisms 25:518 Signal transductors/activators of transcription (STATS Sih's compactin synthesis 13:593 Silandrin 26:255 as antihepatotoxic agent 26:255 Sildenafil 30:155 used for erectile dysfunction Silenejenisseensis 24:150 Silene latifolia 26:45 Silene rubicunda 26:45 Silene sp Silene succulenta 26:45 Silene villossa 26:45 Silene vulgaris Siler trilobum 29:83 Silica gel column chromatography 30:62 in isolation of triterpenoid fractions Silicine 5:126 20-epi-Silicine 5:126 Silicon ethers 6:262 in glycosidation Siloxane bridged oligonucleotides 13:271 Siloxy methyl 8:179,180 [3-Siloxyacetals 14:483 with organometallic reagent Siloxy-Cope ring expansion 8:246 Siloxydiene 4:334 asymmetric Diels-Alder reaction with Silphinium perfoliatum 8:165;13:8,11 silphinene from 8:165 Silphiperfol-6-ene 13:11 from Silphium perfoliatum Silver (II) oxide 5:769 oxidative demethylation with 5:769 Silver cyanide 12:113 allyl isocyanide from 12:113 Silver oxide 11:86 oxidation with 11:86 Silver oxide method 4:386 in prenylation methods 4:386 Silver staining 17:396 Silver sulphamate Silver trifluoroethane sulphonate method 4:323 Silybin 26:255 as antihepatotoxic agent Silybum marianum 5:496 Silydianin 8:166-168 as antihepatotoxic agent 8:166 synthesis of Silyl enol ether 3:129 reaction with 1-phenyl-2-buten-1-one 3:129 reaction with unsaturated ketones Silyl enolate Claisen rearrangement 1:563;2:685 Silyl group 1:452,453 removal with n-Bu4 NF 1:452 Silyl ketene acetals 10:422,423 Claisen rearrangement of ketene acetals 3:243 in Claisen rearrangemment Silyl Pummerer rearrangement 4:550 Silylacetylenic reagents 14:473 Silylated phosphonium ylides 4:546 reaction with acid silyl esters 4:546 synthesis of 4:563 Silylation Silylenol ethers 4:475-477 c~'-Silyloxy (E)-enone 19:59 0~-Silyloxy propargylsilanes 10:227 by exocyclic ring closure 10:227 synthesis -3-Silyloxy-2-methylpropanal derivatives Silyloxydienes 4:113 in cyclocondensation Simaba guianensis 26:815 Simaba multiflora 7:369 Simarolide 7:392,396 Simarouba glauca 13:660 glaucarubin from Simaroubaceae species 11:71 Simaroubaceous plants Simerestis welwitschii 23:660 Simiarenol 20:17 from Artemisia anomala 7:218 from Artemisia argyi 7:218 SIMM Simmons-Smith cyclopropanation 6:72;11:29,30 annulation by 6:5 diastereoselective 14:487-489 of chiral vinyl ether alcohols 14:487,488 of c~ Simmons-Smith reagent 14:490 chelation controlled delivery 1:637 cyclopropanation with 1:631 Simocyclinon 29:319 antibiotic activity of 29:319 cytostatic effects of 29:319 structure of Sinapis arvensis 29:618 1 '-O-S inapo yl-6'-O-galloyl Sinapyl alcohol 5:472 Sindbis virus Single nucleotide polymorphisms (SNP) 30:384 Single pathway modeling 23:18 Single-helix configuration 23:122 Sinomenine 25:472,476 hepatoprotective effect Sinularene 6:75 from Sinularia mayi 6:75 synthesis of Sinularia sp Sinularia flexibilis 25:690 Sinularia nanolobata 25:690 Sinularia sp Siphocampylus verticillatus 30:204 antinociception effect of 30:204 piperidine alkaloid hydrochloride from Siphonaria atra 17:25 Siphonaria baconi Siphonaria diemenesis 17:24 Siphonaria laciniosa 17:25 Siphonaria maura Siphonaria sp Siphonarin B 17:25 Siphonoborgia sp Siphonodictyon coralliphagum 28:669 bis(sulfato)cyclosiphonodictyol A from 28:669 siphonodictyal D from 28:669 siphonodictyols G from 28:669 Siraitia grosvenorii 15:5,22 Siricic acid methyl ester 7:132,133 from diacetyl dimethyl bartogenate Siringaresinol 27:503 structure 533 Sisafolin 23:353 Sitakisogenin 27:45,48 structure Site-1 proteases 25:390 Siteselective a-lithiation 24:9 Sitobion avenae Sitoindoside II 26:219 as chemopreventive agent Sitosterol 5:753,7:124 Sitosterol 3-glucoside 7:218 from Artemisia rupestris 7:218 from Artemisia Sitosterol glucoside 22:609 Sitosteryl stearate 9 Sium latifolium 5:724 Six-membered cyclic ethers 10:209 by rhodium carbenoid mediated cyclization of hydroxy ~-diazo Six-membered ring 8:175 Skaanderup and Madsen 29:496 carbaoxirose/carbaoxetoses synthesis by 29:496 Skeletal rearrangements Skimiate pathway Skimmianine 3:385,386 Skimmin 3:224 Skin cancer 5:747 Skin diseases 30:732 Skin inflammation 30:323 anthrones used for 30:323 SKK Moth Skullcapflavone II 30:288 structure of Slaframine 18:386 activity of 12:306 biosynthesis of 12:307 enantioselective synthesis of 12:309,310 relative configuration of 12:309 Slaframine alkaloids 27:250,255 as muscarinic agonist Slaframine type alkaloids 27:250 HPLC determination Slave-keeping ants 6:454 Sleeping sickness 2:293 Smenoquinone 5:434,425 antimicrobial activity of Smenospongia aurea 5:437 8-epichromazonaral from Smilagenin 7:138 from Echinophora lamellose 17 glycyphyllin from 27:17 Smiles rearrangement 23:415 Smirnovia turkestana Bunge 27:517 Smith 29:371,402 rhazinilam synthesis by 29:371 Smith degradation 1:436,43912:25,26 Opitz syndrome 23:582 Smodingium argutum 9:318 Smoke-bush 23:657 Smooth muscle contraction Smooth muscle relaxation 24:875-925 as biological action 24:875 of Kampo medicines SN 2 reaction 11:207 Snake 8 kDa polypeptide toxin ~x-bungarotoxin 25:528 Snake bite 30:691 treatment of 30:691 use of Crossopetalum gaumeri 30:691 SNAr reaction 20:410 Snechocystis sp Snularene 6:78,79 by Claisen rearrangement 6:78,79 by intramolecular [4+2] cycloaddition 6:85 by intramolecular type-I Mg-ene reaction 6:76,77 by mesylation 6:76,77 by O-methylation 6:76 29:214 miltirone synthesis by 29:214 Sobrerol 29:83 activity in mam-2 assay system 29:83 activity in GST assay system 29:83 activity in RAS assay system 29:83 Social phobia 30:368 role of serotonin (5-HT Soda Fabrik 28:71 synthesis of 29:439 vitamin A synthesis by Sodium (or potassium) 2,6-dimethylheptyl configuration of 28:642 Sodium amalgam 11:349 desulfonylation with 11:349 Sodium artesunate 13:657 Sodium cyanoborohydride 11:87 reduction with 11:87 Sodium dodecyclosulfate-polyacrylamide Sodium metaperiodate 25:134 Sodium methanethiolate 6:340 Sodium naphthalene 11:371 Sodium naphthalenide Sodium phenylselenide 6:489,490 reaction with (+)-canadine 6:489 Sodium salt of caffeic acid tetramer 24:742,743 anti-HIV activity of 24:742 Sodium triacetoxyborohydride Sodoponin 5:171 from Rabdosia eriocalyx 15:171 from Rabdosia setschwanensis 15:174 from Rabdosia ternifolia 15:175 Sodoptera littorais 18:772 Sofalcone Soft acids/bases 3:409 Soft agar transformation assay 30:592, 593 for isolation of (7R,8S,7'R,8'R)-30:(+)-7'-acetylpicropodophyllin 30:593 for isolation of lignan 30:593 Soilborne fungi 21:181 bioactive metabolites Soilborne phytopathogens 21:182 biological control Solanaceae alkaloids 11:229 steroidal type 11:229 Solanaceous plants 17:395 Solanaceous sp Solanidane alkaloids 23:574 structure Solanidane-induced teratogenicity 23:573 22S,25R-Solanidanes Solanum acaule 23:343 Solanum alkaloids 7:17 Solanum americanum 22:532 Solanum dasyphyllum 22:532 as anticonvulsant agent 22:532 Solanum dimidiatum Solanum nigrescens 21:662 Solanum nigrum 22:532 as anticonvulsant agent 532 as antiepileptic agent Solanum umbelliferum 20:489 steroidal alkaloids from 20:489,490 Solasodine glycoside 7:19 from Solanum elegnifolium Solaster borealis 15:55 solasteroside from Solenopis aurea 6:423 piperidine venom alkaloids 453 antibiotic activity of 16:453 from methylvinyl ketone 6:426,427 from oxatropane 6:433,434 hemolytic activity of 16:453 insecticidal activity of 16:453 synthesis of 6:426 Solenopsin B 6:430 absolute configuration of 6:430 enantioselective synthesis of 6:429 Solenopsin-A 6:431,432 asymmetric synthesis of 6:431 Solenopsis carolinensis 6:423 piperidine venom alkaloids Solenopsis fugax 6:436 piperidine venom alkaloids in 6:436 Solenopsis geminata 6:423 piperidine venom alkaloids Solenopsis texanas 6:436 pyrrolidine venom alkaloids Solenopsis xyloni 6:422,423 2-methyl-6-alkyl-1-piperideine in 6:422 piperidine venom alkaloids in 6 Solidago altissima 19:247 Solidago saponins 15:191 Solidago sp. 6:28 kolavenic acid from Solidago virgaurea 21:634 Solid-phase method 6:405 in MDP analogs synthesis Solon 22:427,440 Solunum xanthocarpum Somatostatin receptor 21:72;22:26; 25:530 type of G-protein-linked receptor Sonic hedgehog proteins 23:581 intramolecular autoprocessing reactions Sonneratia alba 7:176 Sonodione 30:566 from Hernandia sonora Sophora chrysophylla 15:522 Sophora flavescens Sophora griffithii 9:149 Sophorajaponica 26:1142;29:573 Sophora significantly 22:431 Sophora sp. 30:205 sophoranol from Sophora subprostrata 22:425 Sophoradin 22:425,432 Sophoradiol glucoronides 25:111 Sophoradiol glycoside 25:115 Sophoradiol monoglucuronide (SoMG) 25:111 Sorbitol dehydrogenase 25:472 Sorbus aucuparia 10:152 311 formation of 11:310,311 from hobartin-19-ol 11:305 from (+)-20-hydroxyhobartine 11:323 indole-protected 11:310,311, 328-330 synthesis of 11:326-328 Sores 30:616 tricyclic acylphloroglucinols in 30 Sorghum bicolor 9:322,344 Sorivudine 24:474,486 as anti-viral agent 24 Sorocea bonplandii 17:458 Soroceal 28:201 from moraceous plants Sorocein F 28:230 biological activity of 28:230 SOS chromotest 22:623 Sotmatal opening 27:345 for abscisic Soulamea soulameoides 7:396 Soulamea tomentosa 180 Sour orange 23:747 Sowdanones 25:705 Sowden method 4:197,203 in L-glycero-D-mannoheptose synthesis Soyabean saponins 25:222,223 hypocholesterdemic effects Soyasapogenol A glycoside 103 Soyasaponin A3 15:196 from Glycine max anti-obesity action of 27:398 biological activity of 27:399 from soybeans 27:398 structure Soybean isoflavones 28:286 in humans 28:286 Soybean lipoxygenase-1 30:225 studies on Sp6 RNA polymerase 4:306 enzymatic ribonucleotide synthesis of Hernandia moerenhoutiana of Hernandia voyronii 30:561 of imperatorin 23:350,358 of plant polyphenols of Thymus satureioides 30:264 on guinea pig ileum 30:748 on smooth muscles 30:264 Spasmolytics Spectalinine 20:486 Spectinomycin 11:216 biosynthesis of 11:216 by TDP-glucose oxidoreductase 11:216 from glucose 11:216 from Streptomyces sp Spectral data 6:148,150,155,156; 26:1078 for HMTP 26:1078 of acetylenic carotenoids 6:148 519 of N-b-oxy-17-oxoellipticine 6:515,519 of strellidimine 6:516 Spergularia ramosa Spermatophyta 18:740 Spermicidal activity 26:53 of Gypsophila paniculata Spermidine alkaloid 9:73 synthesis Sphaeranthus indicus 9:145 Sphaerechinus granularis 15:104 Sphaereophorus globosus 5:310 Sphaerodiscus placenta Sphaerophorin cetraria 9:317 Sphaerotheca pannosa 27:178 Sphaerotrichia 26:1121 Spheciospongia vagabunda Sphingolipid biosynthesis 22:248 Sphingolipid receptor Ca 2+ channels 25:535 Sphingolipid receptors 25:534 Sphingolipids Sphingosine derivative Sphingosine-related marine alkaloids 23:185 Sphinxolide 10:153 Spin quantum number 9:110 of 170 9:110 of 33S 9:110 of 77Se 9:110 of ~25Te 9:110 Spin trapping experiments 9:573 Spinaceamin 15:328 Spinacetin Spingosine kinase 25:269 Spiniferin-1 6:72 from Pleraplysilla spinifera Spiniferin-1 6:73,74 by intramolecular cyclopropanation 6:73,74 by ring expansion rearrangement 6:73 Spiniferin-1 and 2 21:361 Spinning band distillation 11:359 Spinning-band column distillation Spirastrella abata from Nitraria schoberi 14:742 from Nitraria sibirica Spiroalkyl analogs 28:357 biological activity of 28:357 of MFA Spirobenzoquinone furan unit 6:55 in stypolidione 6:55 synthesis of 6:55 Spirobenzylisoquinoline alkaloids 1:187-189 formation from Spirobncarbocyclic chamigranes 6:60 from Laurencia species 6:60 synthesis 6:59 Spiro-isoquinoline derivative 6:496 of ring C-homoberberine analogue Spiroketals 9:530;13:60 diaxial configuration 1:476 stereoselective synthesis of Spiro-oxirane ring derivatives 23:605 13C-NMR data of 23:608 tH-NMR data of 23:608 of neo-clerodanes Spirostane 21:643 Spirostane glycosides 17:136 Spirostane saponin Spirostane-type saponin 21:675 Spirostanol Spirovetivane 6:59 as sesquiterpene Spirovetivane-type sesquiterpenes 14:546 enantioselective synthesis Spirulina platensis 25:725; 30:399,404,408 anti-influenza activity of 30:408 biological activity of 30:404 calcium spirulan from 30:399 polysaccharide (PS) from Spizella arborea 5:837 hemoglobin components of Spizella passerina 5:837 hemoglobin components of Spleen/adipose tissue weight 30:56,57, 66 effect of fucoidan on 30:56,57 effect of oleic acid on 30:65 Splicing reaction Spodoptera Spodoptera litura 24:715,716 Spongia mycofijiensis 19:568 Spongia nitens Spongian diterpenes 9:4 Spongian diterpenoids 1:662 synthesis of stereoselective synthesis of Spongiaquinone potassium salt 15:298 Spongiatriol Spongistatins 4 and 5 Spongouridin 5:403 Spontaneous apoptosis 26:926 Spontaneous metastasis Sporangium cellulosum 26:450 Sporobolomyces odorus 13:309,312 Sporobolomyces roseus 5:291 Sporobolomyces sp Sporogenic substances Sporomia fungi 15:384 6-methoxymellein from Sporomiella australis 22:70 Sporomiella intermedia 22:70,253 74 Sporothrix inflata 5:304 Sporothrix rugulosa 22:74 Sporothrix schenckii Sporotrichum dimorphosporum 8:349 xylanase A from 8:349 xylanase B from Sporotrichum pulverulentum 26:1013 Sporotrichum thermophile Sporulation 6:552 classification of fungi by Sprekelia formosissima 458 Sputtering of ions (SIMS) 5:632 by bombardment with fast ions 5:632 Squalene 7:131 Squalene biosynthesis 7:322 Squalene cyclization 1:655 Squalene oxide cyclase 14:740 Squalestatins from Vaccaria segetalis Squash family serine protease inhibitors 29:614 BD-TI-II as 29:614 CMTI-I as 29:614 CMTI-III as 29:614 CMTI-IV as 29:615 CPGTI-I as 29:615 CPTI-II as Stachenone 29:101 activity in EBV bioassay system Stachys chrysantha 30:270 xanthomicrol from Standinger reaction 1:352,353 Standishinal 29:100 activity in EBV assay system 29:100 Standishinal diacetate 29:100 activity in EBV assay system 29:100 bis-Stannane 21:400 Stannoxane 1:274 Stanols Stapfinine 5:125,172,173 Staphylococcus albus 22:398 Staphylococcus aureofaciens 28:135 as antibacterial agent :269,324, 339;30:628,739 antibacterial activity against 30:739 antibacterial properties of 30:628 antifungal activity against Staphylococcus botryosum 25:305 Staphylococcus citerus 9:308 Staphylococcus coli 23:533 Staphylococcus epidermidis Staphylococcus ganera 29:311 Staphylococcus haemolyticus 25:776 Staphylococcus hominis 25:258 Staphylococcus spp. 26:556 Staphyllococcus saprophyticus 30:693 minimal inhibitory concentration (MIC) of Staphyllococcus warnieri 30:693 minimal inhibitory concentration (MIC) of Starfish fertilisation inhibitor 28:712 callyspongin B as from methyl (R)-a-hydroxyphenyl propionate 12:480 synthesis of 12:477,480 (+)-Statine 12:430,431 mutual transformation of 12:430,431 with epistatine 12:430,431 (3S,4S)-Statine 12:476 synthesis of 39,40 strogin 1 from 27:39,40 strogin 2 from 27:39,40 strogin 4 from AM-2282") 12:365 from Streptomyces staurosporeus antibacterial activity of 12:384 biosynthesis of 12:373,374 dynamic NMR study of 12:367 from Streptomyces diastatochromogenes M-193 Staurosporine aglycone 5:55 ~H-NMR spectrum of 488 as anti-viral agent 24:474,486, 488 Steam distillation 21:575 Stearic acid 11:192 Steganacin 5:461,462 216 Steganes 29:360 absolute configuration of 29:360 antitubulin activity of 29:399, 400 29:401 microtubules assembly inhibition by 29:399 (-)-steganacin as 29:360 (-)-steganangin as 29:360 (-)-steganol as 29:360 (-)-steganone as 29:360 SAR of 29:399 structural variety of 29:360 tubulin assembly inhibition by 29:360 Steganes synthesis 29:369,380 by Brown and Robin 29:392 by Enders 29:389 by Kende 29:380,384 by Kende/Schlessinger 29:391 by Koga 29:386 by Krow 29:384 by Magnus 29:389,390 by Meyer 29:394 by Motherwell 29:399 by Raphael 29:382 by Schlessinger 29:384 by Suzuki-Miyaura 384 isomerization studies of 29:380 matairesinol-type intermediate in 29:371 of (-)-isostegane 29:389 of (-)-steganone 29:393 of (-)-steganone by Molander 29:398 of (-)-steganone by Uemura 29:397 of (+)-yatein 29:388 of (+)-steganacin 29:382,384, 387,392 of (i)-steganone 29:382,390 of natural (-)-steganone 29:392 oxidative dimerization of coniferyl alcohol in 29:370 phenanthrene ring enlargement in 29:382 role of stegane diastereoisomers Suzuki biaryl coupling in 29:396 Ullmann biaryl coupling in 29:391 use of vanadium in 29:391 weaknesses of Steganone 24:780,781 of arylnaphthalene derivatives Steganone 29:382,390 steganes synthesis episteganangin from 26:216 steganangin from 26:216 stegancin from 26:216 steganolide A from 26:216 steganoate B from from Korean Stelleta sp. 21:269,273 273 Stellettamine 28:687 N-deacetylkuanoniamine C from 28:687 total synthesis Stemona parviflora Stemona sessilifolia 21:759 Stemona tuberosa 21:752 Stemphylium botryosum 25:307 Stemphylium epidermidis Stemphylium radicinum 19:154 Stemphylium solani 25:302 Stenodynerus fulvipes 5:223 Stenogramme interrupta 30:402 carrageenans from Stenotrophomonas maltophilia 28:140 Stentor coerulus Stephania cepharantha 22:533 for epilepsy Stephania pierrei 20:522 Stephania tetrandra Stephanotis lutchuensis Koidz. var. japonica 21:674,27:41 sitakisoside I-IV, XI-XIII from 27:41 sitakisoside XVI from 27:41 sitakisoside XVIII from 27:41 Steracaulon ramulosum Sterculia urens Roxb. 30:405 antiviral activity of Stereocaulon japonicum 5:310 Stereochemical control 29:422 of c~,c~ Stereochemical inversion 6:178 Stereochemical revision 9:19 of methyl nuapapuanoate Diels-Alder reaction 4:122, 123 of (7R,SS,7'R,8'R)-(+)-7'-acetyl-5 '-methoxypicropodophyllin 30:586 4:122, 123 in Diels-Alder reaction Stereocontrol methods 1:578 Stereocontrolled approach 29:379 to allocolchicinoids total synthesis Stereocontrolled 3yn aldol reaction 13:546 Stereocontrolled synthesis 28:358 of (+)-paraherquamide B 28:358 Stereodifferentiating reactions 16:399 using chiral auxiliaries Stereodivergent process 29:419 decahydroquinoline-type dartpoison frog synthesis by 29:419 iso-6-cassine synthesis by Stereoisomeric alkaloids 21:759 Stereoisomeric mixtures 6:152 Stereoisomers 17:483;30:145 of fucoxanthin 6:139 of neoxanthin 6:139 of peridinin 6:139 of triene Stereomutation studies 6:154 of acetylenic carotenoids 6:154 of diacetylenic alloxanthin 6:153 of monoacetylenic-7,8-didehydroastaxanthin 6:153 of tetradehydroastaxanthin Mukaiyama reaction 24:773,774 offl-keto ester 24:759,760 ortho-ester Claisen rearrangement 24:3 radical carbocyclization 24:3 reduction 24:745 Stereoselective addition 19:33 in D-glycero-D-galactoheptose synthesis 4:198 Stereoselective arylation 10:345 C-glycosidation 373 Stereoselective construction 19:470 of withanolide D-type side chain Stereoselective glycosidation 8:359 Stereoselective hydrogenation Stereoselective Michael addiction 13:619 Stereoselective pinacol-type rearrangement 15:509 Stereoselective reduction 10:537 of (+)-dolasta-1 (15),8-dien-14 [3-ol 6:54 of (+)-eremophilone 15:243 of (-)-swainsonine 12:330 o f (+)-castanospermine 12:353, 354 of cis cyclopentane 8:9 of 3,7-octadien-l-ol-12:467,468 of acetogenins 18:193-227 of bicarbocyclic fused systems 6:5-38 of carbonolides 11:163-172 of cis-2,6-dialkylpiperidines 6:431 of E-retinal 28:74 of diterpenes bioactive 29:169 oftrans cyclopentane 312 Stereoselective a-hydroxylation 9:518 ~-Stereoselectivity of (Z)-conjugate esters 4:177,178 of C(3)-monosubstitution reactions 4:653 of (E)-nonenopyranuronate 4:180 of Wittig reaction 4:175 endo-Stereoselectivity Stereospecific-11:98 Stereospecific deuteration 20:839 Stereospecific hydroxylation 1:404 Stereospecific intramolecular-Diels-Alder cycloaddition 6:86 Stereospecific oxidation/reduction 17:484 Stereospecific preparation 12:466,467 of (3E)-3 Stereospecific reduction 4:234 ofketonucleosides Stereospecific synthesis Stereospecific c~-glycosylation 30:459 Stereospecificity 14:201-259 of glycosylation reactions Stereum purpureum 26:133 Steric effect 27:355 of benzene ring Steroid moiety 30:486 acetylation of 30:486 deoxygenation of 30:486 iodonization of 30:486 LiA1H4 reduction of 30:486 ozonolysis of 30:486 synthesis of Steroid saponins 7:426 from Veratrum califorincum 7:16 from Solanum umbelliferum 20:489 teratogenic potencies of 23:575 Steroidal amines 7:16-24 teratogenic metabolites of 7:21-24 toxic Steroidal estrogens 5:448 Steroidal glycoalkaloid 25:293 Steroidal glycosides 7:286 Steroidal lactones 14:439 Steroid-alkaloid glycoside 5:110 Steroid-pyrazine 18:875-905 via c~-amino ketones 46 synthesis of 8:188-195 semi-synthesis of Sterol biosynthesis 25:303 inhibitor of Sterol sulfate antitumor activity of 25:43 antiinflammatory activity of 25:43 from olive oil 27:702 Sterulic catalytic deuteration of 9:476 chromatographic analysis mass spectrometric analysis of Stevens condensation 3:463 Stevens rearrangement 6:497 chronic toxicity studies of 27:306-308 effect on fertility 27:309,310 for diabetics 27:314 for stevioside 27:307,310 immunological activity of 27:315 nutritional significance of 27:314,315 safety evaluation Stevia extract 27:307,310,314 for diabetics 27:314 Stevia leaves 27:315 immunological activity of 27:315 Stevia phlebophylla 15:16 Stevia plant 27:315 allergenic activity Stevia purpurea ent-kaurene from 27:22 labdane glycosides from 27:22 of asteraceae 27:299 rebaudioside A from 27:8,9,13 rebaudioside B from 27:13 rebaudioside C from 27:13 rebaudioside D from 27:13 rebaudioside E from 27:13 stevia extract from 27:8 steviolbioside from 27:13 stevioside from 27:8 sugar-transferred Stevia extract of 27:8 Stevia selriana TPA bioassaysystem 29:101 of 27:306,307,308 effect on fertility 27:309,310 for phenylketonuria 27:315 mutagenicity tests for 27:303,304 nutritional significance of 27:314,315 purity of 27:316,317 structure of 27:300 subacute toxicity studies Stichloroside A~ 7:272,274 Stichloroside A2 7:272,274 Stichloroside B~ 7:272,274 Stichloroside B2 7:272,274 Stichococcus bacillaris Stichoposide D 7:273 from Stichopus variegatus Stichopus chloronotus 7:272 Stichopus japonicus 7:277 holotoxins A, A~, B and B~ Stichopus sp. 7:282 Stichopus variegatus 7:272,282 stichoposide D from 7:273 Stictanin 208, 505,570,719 analgesic effect of 30:208 from Salvia glutinosa 20:707 from Salvia limbata 24S)-24-ethyl-cholest-5,22-dien-3 ~-ol Stilbene derivatives 27:405,409;28:579 biological activity of 27:405,409 2,3,5,4'-tetrahydroxystilbene-2-O-D-glucoside as 28:579 in LLC-bearing mice 28:579 piceid as 28:579 resveratrol as 28:579 tumor growth inhibition by Stilbene phytoalexin 25:662 Stilbene synthase 25:502,655 Still olefination 10:157 Stille reaction Stimulant agent 23:642 of teucrium sp Stimulus-response mechanisms 25:515 Stipitatic acid 1:340,341 synthesis of 1:340 Stizolobic Stoichactis helianthus 26:11 Stomoxys calcitrans 26:691 Stomphia coccinea 15:66 Stongylocentrotus purpuratus 9:575 Stork modification 10:185 of Michael addition Stowell's iodide 8:146 Strecker reaction 6:312 intramolecular Strecker-type reaction 10:463 Strellidimine 6:516 from Strychnos dinklagei 6:516 spectral data of 6:516,518 synthesis of 6:516 Streotpmyces lysosuperficus 1:417 Strepromyces albolongus Streptococci 29:535 classification of 29:535 identification of 29:535 pathogenicity of 29:535 serological groups Streptococci 29:535 pathogenicity of 29:535 serological groups Streptococcus fecium 25:925 Streptococcus ganera 29:311 Streptococcus haemolyticus 26:673 Streptococcus mutans 7:69 Streptococcus pneumoniae 14:233 Streptococcus pyogenes 5:601 Streptokinase (SK) 30:839,844 fibrinolytic enzymes Streptokinase/streptodornase 25:271 Streptolic acetate 14:104 Streptolic Streptolydigin phosphonate tetramic acid 14:117 Streptolygidin 28:130 antibiotic activity of 28:130 as bacterial RNA polymerase inhibitor 28:130 as terminal DNA transferase inhibitor Streptomyce lividans 26:1010 Streptomyces achromogenes Streptomyces aizunensis 12:63 aizumycin from Streptomyces albus 21:420 porothramycin A from Streptomyces aldus 25:781 Streptomyces althioticus 28:143 Streptomyces amakusaensis 19:178 Streptomyces ambofaciens Streptomyces antibioticus 11:214,215 Streptomyces arenae 29:319 Streptomyces aureofaciens 21:414 Streptomyces avermitilis 1:435 Streptomyces azureus 11:209 thiostrepton from Streptomyces bikiniensis 18:700 Streptomyces cacaoi 23:343 Streptomyces cacaoi var 434 albomitomycin A from 13:433 isomitomycin A from 13:433 mitomycins A-C from Streptomyces cellulosae 12:103,54 Streptomyces chrysomallus 8:102 Streptomyces cinnamonensis 11:197 Streptomyces clavuligerus 22:263 Streptomyces coelicolor 5:617,618 325 Streptomyces diastatochromogenes 12:366 staurosporine from Streptomyces flavogriseus 10:103 Streptomycesfradiae 5:591 Streptomyces fungicidus 29:332 Streptomyces genus 29:321 Streptomyces globisporus 29:326 Streptomyces gougerotti 4:242 Streptomyces graminofaciens 29:326 Streptomyces griseochromogenes Streptomyces griseolus 1:408 actinophage B 1 from 21:408 aplasmomycin from Streptomyces hydroscopicus 21:388 830 Streptomyces kasugaensis 23:343 Streptomyces lavendulae Streptomyces lusitanus 10:103 Streptomyces lydicus 14:105 Streptomyces malachitofuscus 29:317 Streptomyces matensis 11:113;28:143 vineomycin A l from Streptomyces mediocidicum 11:278 telocidines from 11:278 Streptomyces melanovinaceus Streptomyces Streptomyces Streptomyces Streptomyces Streptomyces Streptomyces :289 Streptomyces nodosus 4:513 Streptomyces nogalater 14:47 nogalamycin from Streptomyces novoguineensis 1:404 Streptomyces OM-4842 5:597 Streptomyces orientalis 21:406 reductomycin from Streptomyces phaeochromogenes 5:553 Streptomyces primprina 883 Streptomyces purpeofuscus 26:373 Streptomyces pyogenes 29:536 Streptomyces ramulosus Streptomyces refuineus 21:420 anthramycin from Streptomyces rhishiriensis 11:189 ansatrienin (mycotrienin) from Streptomyces riseochromogenes 23:343 Streptomyces rishiriensis 127 Streptomyces roseopalvus 22:263 Streptomyces rugosporus 29:339 Streptomyces sandaenis 13:434 Streptomyces sapporonensis 12:63 bicyclomycin from Streptomyces showdoensis 29:265 Streptomyces sp. M-193 12:365 Streptomyces sp. N-126 Streptomyces spectabilicus 20:796 Streptomyces spectabilis 21:430 Streptomyces spiroverticillatus 18:269 Streptomyces strain 21:414,437 Streptomyces thiolutens 21:420 mazethramycin A from Streptomyces tolypophorus 23:56 Streptomyces toyocaensis 26:493 Streptomyces venezuelae 5:552;29:309 Streptomyces verticillatus Streptomyces virginiae 29:332 Streptomyces viridochromogenes Streptomyces viridosporus 15:441 Streptomyces xanthochromogenus 21:405 reductomycin from Streptomycin sp. 21:410 Streptopelia chinensis suratensis 5:837 hemoglobin components of Streptopelia orientalis 5:837 hemoglobin components of 5:837 Streptopyrone Streptosporagium sibiricum 26:1211 Streptovaricin Streptovaricin A 21:430,431 79 ansa moieties 23:86 ~3C-NMR spectrum of 23:64 conversion Streptovaricin D 21:432,435;23:64 biosynthesis of 23:64 ~3C-NMR spectroscopy Streptoverticilium rimofaciens B98891 Streptoverticillium ardum 13:433 porfiromycin from Streptoverticillium mobaraense 12:366,370 BE-13793 C from Streptoverticillium olivoreticuli 22:533 Streptoverticillium olivoreticuli ssp Streptoverticillium verticillus Strictanine 5:167 Stricticine 5:176 Strictine 5:153 Strictosamide Strictosidine lactam 2:375 Strictosidine synthase 13:662 Striga asiatica 5:823;9:364;30:162 infection with Strobilurus tenacellus Stronglyocentrotus purpuratus 25:813 Stronglyophora hartmani Strongylocentrotus droebachiensis 7:285 Strongylocentrotus intermedius 7:285 sulfated sterols from Stro n gylocentro tus purpuratus 15:104 Strongyloides ratti 26:486 Strongyloides stercolaris 26:486 Strongylophora Strongylophora durissima 21:275 strongylophorimis from Strongylophorine dimer 21:285 Strongylophorine meroditerpenes 275 Strongylostatin 7:1 Strphanthus gratus 25:537 Structural elucidation 28:601 of sea cucumber triterpene glycosides Structural studies 571-580 of 1 ot,25-dihydroxyvitamin D 30:485 of 1 (x-hydroxyvitamin D analogues 30:485 of 2-phenyl-4H-1-benzopyran-4-one 27:841 of 5-hydroxytryptamine 30:370 of 5-hydroxytryptophan 30:369 Structure dereplication 29:658 bioactive natural product database 658 molecular ion profile of 29:659 natural products information system (NAPIS) in 29:671 6:135,138 667 by MS, IR, NMR spectroscopy 27:659 of abscisic acid 6:559 of pironetin 30:26 of ptaquiloside 26:708 of reseveratrol oligomers 26:535-551 of saponins Structure modification 6:405 in MurNAc Structure-based inhibitor modeling 30:832 of (EFEa) Structure-odour relationship 27:378 Structure-terata correlations Strurnus vulgaris 5:836 hemoglobin components of Strychnane alkaloids as immunosuppressive drug Strychnos 6:503 Strychnos atlantica 26:1050 Strychnos bifurcata 26:1034 Strychnos bisindole 26:1062 anticancer activity Strychnos camptoneura 26:1060 Strychnos cinnamomifolia 22:533 for epilepsy Strychnos colubrina 26:1029 Strychnos decussata 26:1032 dinklageine from 6:522 ellipticine from 6:506 gentianine from 6:529 10-hydroxyellipticine from 6:509 18-hydroxyellipticine from 6:513 isobrafouedine from oxidizing enzymes in 6:520 N-b-oxy-17-oxoellipticine from 6:513,515 strellidimine from 6:516 venoterpine from Strychnos divaricans 26:1055 Strychnos floribunda 26:1032 Strychnos grossweilleri 1:125 ;26:1060 Strychnos guianensis 26:1055 Strychnos henningsii 26:1032 Strychnos longicaudata 1:124 Strychnos madagascariensis 26:1033 Strychnos melinoniana 1:124 Strychnos mitis 26:1033 Strychnos monoindole 26:1061 anticancer/antiprotozoal Strychnos mostueoides 26:1034 Strychnos ngouniensis 1:124 Strychnos nux vomica L. 26:143 Strychnos panganensis 26:1033 Strychnos pentantha 26:1034 Strychnos potatorum 26:1031 Strychnos spinosa 26:1033 Strychnos toxifera 26:143 Strychnos trichoneura 26:1034 Strychnos usambarensis 1:124,126 Strychnos vacacoua 6:503 bakankoside from Strychnos vomica Strychnovoline 6:523 from Scaevola racemigera 6:522 from Strychnos dinklagei 6:522 spectral data of 6:524 Strychnoxanthine 1:125 Strychnozairine 1:38,39 Sturmus pagodarun 5:837 hemoglobin components of 5:836 Styelid ascidians Stylocheilus longicauda 17:4,104 Stylophora pistillata 28:646 palythrine-threonine-sulfate from Stylophorum diphyllum 27:159 Stylophorum genera 27:163 Stylophorum lasiocarpum Stylopus australis 28:704 Stylosanthes hamata 28:399 against Boophilus microplus Stylosanthes humilis 28:399 against Boophilus microplus Stylosanthes scabra 28:400 Stylosanthes sp Stylotella agminata 25:770 Stylotella aurantium 21:351 Stypodiol 6:54 from Stypopodium zonale Stypodiol methyl ether 6:55 14-deoxy-stypodiol from 6:55 reaction with Stypopodium flabelliforme 25:690 Styracaster caroli 15:75,76 carolisterol A-C from cycloaddition reactions of 16:561 epoxidation of 27:753 polymerization Subacute toxicity 27:307 from animals 27:307 of stevioside Subclone 5:448 of BALB/c 3T3 embryo derived mouse fibroblasts Subcosine I 1:367,370 (+)-Subcosine I 16:477 synthesis Suberea creba 25:719 Suberenol 20:497 from Pleisopermium alatum Subergorgia suberosa 13:26 Subergorgic acid 3:6,60 Suberin 25:655,658,666 Suberosenone 25:695 Suberosin 20:497 from Pleisopermium alatum 20:497 Suberosol Subproside Vll 25:95 Substantial kinetic isotope effect 11:212 2-Substituted 2,4,5-trimethyl-1,3-dioxolanes 14:480 "with mixed hydride reagent 4-tetrahydro-pyrimidin-5-yl) mercuric acetate 10:343 2-Substituted glycals 10:348 ct-anomers from 10:348 5-Substituted indolizidines 11:245 N-Substituted oxazolidin-2,4-diones 12:464 2-Substituted oxepanes 10:215,216 Substituted phenols 16:571-638 biogenesis-like transformation of 16:571-638 2-Substituted quinolines 396 N-Substituted valiolamine derivatives 7:47 (R)-4-Substituted-2-oxazolidinones 12:435,436 from (R)-N-Boc-2-aminoalcohol Substituted-2-oxazolidinones 12:416,417 from ketopinic acid 12:416,417 from 4-methoxy-2-oxazolidinones 12:435-438 optical resolution of 12:437 Substrate binding domain 17:487,494 for HLADH 17:500,502-503 surrogates Substrate specificity 27:745 of peroxidases Subtilase (SBT) 25:388 Subtilisin-like serine protease 25:388 Subulitermes bailey 14:451 Subulitermes oculatissimus 14:451 neointermedeol from Succinic acid 21:398 Succinic acid dehydrogenase 7:387 Succinimidochloroformate 21:165 Succinoxidase 504,505 castanospermine inhibition with 7:12 Sucrase isomaltase 10:498 Sucrononic :3,4,5 as sweetener 27:3 1-thio analog of 8:322 FD spectrum of 2:52 synthesis of Sucrose substitutes 27:4,5 acesulfame-kas 27:4 sweetness of 27:4,5 aspartame as 27:4 cyclamate as 27:4 glycyrrhizin as 27:5 mogroside V as 27:5 neotame as 27:5 saccharin as 27:4 sucralose as 27:4 sucronic acid as 27:4 super aspartame as Sucupira branca 472 carbaaldopyranoses synthesis by 29:472 SUDHL-4-1ymphoma 21:138 Sufentanil 30:200 as morphine analogue Sugar derivatives 20:116 Sugar derived heptosyl bromide 30:440 as substrate 30:440 Sugar derived heptosyl bromide 30:440 in KDN synthesis 30:440 in Neu5Ac synthesis Sugar sweetner mechanism 27:4,12 non-sugar sweetner system Sugar-epoxide 14:168 reductive cleavage Sugar-peptide structures 6:385-420 reactions of 6:385-420 relation to peptidoglycan 6:385-420 synthesis of 348 for abscisic acid 8'-hydroxylase 27:347 of 8'-hydroxylase 27:348 Suicide substrates (irreversible inhibitors Sulfate olefaction 27:678 of sandrosaponin I-X 27:678 of saponin Sulfated sterols 7:285 from Strongylocentrotus intermedius Sulfated trisaccharide moiety 27:673 34-Sulfatobastadin 13 28:695 as endothelin A receptor inhibitor 28:695 c~-Sulfenylacetamide 3:461 cyclization to erythrinans Sulfhydryl compounds (SH) 22:442 Sulfide contraction reaction 6:438 Sulfide isoquinolines 25:824 Sulfide pyridoacridines 25:819 Sulfide pyrroloquinolines Sulfide-containing pyrroloiminoquinones 28:685 as antileukaemic agents 28:685 prianosin A as 28:685 structure Sulfidopeptide lipoxins 9:576 Sulfinates 4:490 Sulfinemycin Sulfircin 28:672 as N, N-dimethylguanidinium salt 28:672 hipposulfates A from 28:672 Sulfite reductase Sulfoethyl glucan (SEG) 23:139 Sulfonation 16:127 of endo-3-bromocamphor Sulfone 28:715 as constituent of Mediterranean sponge Sulfone anion addition 1:471 to epoxide 91 Sulfonic acid 25:900 Sulfonium ion-induced cyclocarbamation Sulfoxidation 27:752 of methyl p-tolyl Sulfur accumulation 2:275 in liverworts 2:275 Sulfur analogue 12:160,161 by Pummerer rearrangement 12:160,161 from (R)-2-methyl-1 Sulfur-containing compounds 17:81 Sulfur-containing cyclic peptides 28:678 biological activities of 28:678 cytotoxicity of 28:678 discodermin A as 28:678 discodermin B as 28:678 discodermin C as 28:678 discodermin D as Sulfuric ammonia precipitation 30:825 enzyme isolation by Sulphated glycoprotein 23:163 Sulphated polysaccharide (PS) 30:398, 400,405 anti-CMV activity of 30:405 anti-HIV activity of 30:398 antiviral activity against HIV Sulphated polysaccharide (PS) extracts 30:399 from brown algae 30:399 from red seaweed 30:399 inhibitory activity of Sulphonium ylids 13:144 sigmatropic rearrangement of 13:144 Sulphonylurea drugs 25:534 Sulphur trioxide/pyridine complex 30:527 chlorosulphinic acid from 30:527 pyridine from Sunflower cystatin phytocystatin 29:593 effects on cathepsin H ficin 29:593 effects on papain 29:593 Sunflower multicystatin 29:593 effects on papain 29:593 Sunillin Supercritical fluid (SF) 23:467 Supercritical fluid extraction (SFE) 21:576 Superoxide dismutase 22:309 Superstolide A 19:597 absolute configuration of 19:597 NOESY data of 19:597 relative stereochemistry Supinine 1:339;26:874 Suppressing activity 30:308 on cells proliferation Suppurative dermatitis 22:607 use of Platycodon grandiflorum Susceptible Burkitts lymphoma (BL) 25:272 apoptosis Suspensaside 5:513 antihypertensive activity of 5:513 Suspension cultures 7:92 Suvanine 28:670 as acetyl cholinesterase inhibitor 28:670 total synthesis of 28:672 Suzuki coupling 21:148 Suzuki coupling reaction Suzuki methodology 21:382 Suzuki reaction 396 steganes synthesis by Swainsona galegifolia alloaromadendrane-4b, lOa-diol 14:379-384 of (+)-alloaromadendrane-4c~ 134-138 of (+)-tirandamycin B Ireland alcohol 14:119 274 of (+)-africanol 14:487,488 of (+)-arborescin 14:365,366 of(+)-carissone 14:406-413 of (+)-dihydropinidine 14:572,573 of (+)-eburnamine 14:636 of (+)-isoambrox 14:420-425 of (+)-multistriatin 14:267 o f (+)-pedamine 14: 499 of (+)-PS-5 14:497,498 of(+)-streptolic acid 14 of (+)-13-eudesmol 14:490 of(E)-olefinic alcohol 19:452 of (1)-ct-santonin 14:406-413 of (R)-(-)/(S)-(+)-3'-methoxy-4'-O-methyl joubertiamine 14:501,502 of (S)-2-(6-methoxy-2-naphthyl) of 2'-phosphorylated ribonucleotides 14:304-312 of 2-pyrrolidones 14:560,561 of 3,4-anhydro-c~-Daltropyranoside 14:170 of 3-arylisoquinoline alkaloids 14:796-799 of 3-deoxy-1,2: 5,6-di-Oisopropylidene-D-xylohexofuranose 14:172 of 3-deoxy-1,2:5,6-di-Oisopropylidene-(x-D-ribohexofuranose 22:533 Swertia purpurescens 22:533 Swertia randaiensis 22:533 Swertia sp Swertianoline 22:521 Swinfolide 5:356,357 1229 paterson's synthesis of 26:1229 synthesis of 18:186-190 stereostructure of 19:589 X-ray analysis Sylibum marianum 22:428 Symbiodinium sp Symbiotic algae 23:234 Symbiotic marine microorganisms 23:185 bioactive metabolites Symbiotic zooxanthellae 23:177 Sympathetic ganglia 30:782 blockade of 30:782 Sympathetic nerve activity Symphomyrtus subgenus 24:233 euglobals of Symphonia globulifera Symploca hydnoides 25:887 Symplocos helminthosporium carbonum Symplocos lancifolia 27:17 Syn elimination 16:335,357 of selenoxide 16:335 of trifluroacetate Synapic potential mediation 28:318 by non-NMDA receptors 28:318 Synaptic actions 30:381 of serotonin Synaptic dopamine transporters 25:539 Synaptic glycine transporters 25:539 Synaptic serotonin transporters 25:539 Synaptogenesis 30:368,377 effect of serotonergic neurotransmission on Synaptolepis kirkii 22:533 for epilepsy 22:533 Syndrome type-1A 26:1130 adipose tissue distribution as 26:1130 cerebellar dysfunction as 26:1130 liver insufficiency as 26:1130 peripheral neuropathy as 26:1130 psychomotor retardation as Synechococcus sp Synechocystis PCC 26:366 Synechocystis trididemni Synergies interaction 21:601 Synergistic activity 21:673 Synergistic effect 21:608,611; 30:498,596 ofhervelines B 30:596 ofhervelines C 30:596 of retinoids 30:498 of vitamin D derivatives Synergistic interaction 21:698 of acyclovir(ACV) 21:698 of ganciclovir (GCV) 21:698 with ganciclovir (GCV Synergistic purgative actions 30:306 of rheinanthrone 30:306 of aloe-emodin-anthrone Syn-isomerization 11:220,221 metal ion-assisted 11:220,221 tertiary allylic isomer from 11 Synoicum prunum 28O of (+)-2-oxoindolizine 12:283, 284 of (+)-5-epipumiliotoxin 18:340 of (+)-6-demethylstatine 13:514 of (+)-6-epi-slaframine 12:311 of (+)-dihydroanatoxin-A 13:494 of(+)-elacokanine C 12:289-293 of(+)-elaeokanine A 12:289 493 of (+)-Na-benzyl-20-desethylaspidospermidine 18:323 of (+)-nanaomycin-A 11:127-130 of (+)-nupharolutine 13:488,489 of (+)-O-methylpallidinine 12:470,471 of (+)-pleuromutilin 8:418 of (+)-semivioxanthin 11:130, 131 of (+)-seychellene 8:412 E-[3-santalene 8:145,146 of (-)-E-[3-santalol 8:145 of (+)-monomorine I 11:231-244 of (+)-picrasin B 11:76,77 of (+)-pseudoephedrme 12:479, 480 of (+)-quassin 11:76,77 of (+)-steganacm 24:779 of (+)-streptazoline 13:514,515 of (+)-thienamycin 13:498-504 of (+)-tuberiferm 24:56,57 of(+)-A 2"3 picrasin B 11:76,77 of (+)-c~-homonoj irimycin 11:431,432 of (+)-c~-santalol 8:145,146 of (+)-fl-cyperone 24:116,117 of (+)-3[3-hidroxinagilactone F 28:503 of (1 ~ 1)-aldosyl aldoside 415 of a-amyrin linoleate (c~-amyrin cis-9, cis-12-octadecadienoic acid ester) 29:583 of c~-amyrin linoleate (c~-amyrin cis-9,cis-12-octadecadienoic acid acid ester) 29:585,586 of ot-amyrin palmitate (c~-amyrin hexadecanoic acid ester) 29:583 of (d, /)-bulnesol 10:310 683 of (R)/(S)-homoproline 13:513, 514 of (S)-pinanediol 11:410 of (Z)-trans-1-hydroxy-10-vinyl-2-cyclodecene 8:196 of (ot-chloroalkyl) boronic ester 11:410 of (c~-haloalkyl) boronic ester 11:425 of 1,2-disaccharide 8:362 of 1 ~,25-dihydroxyvitamin D3 11:384,385 of 1 ~,25S,26-trihydroxycholecalciferol 10:69 of 1 c~ 84 of 2-(c~-hydroxyalkyl) pyrrolidines 12:473 of 2-(e~-hydroxyalkyl) piperidines 12:453-456 of 2,3,4,5-substituted tetrahydrofurans 11:433 of 2,3-dibenzylbutrolactones 24:744-754 of 2,3-unsaturated-1-thioglycosides 8:346 of 2,6,7-trideox-2,6-imino-Dglycero-D-manno-heptitol 11:467 of 2,6,7-trideoxy-2,6-imino-Dglycero-D-gluco-heptitol 11:467 of 22,23-dihydro-1 cx,25-dihydroxyvitamin D2 11:395-398 of 24,24-dihomo-1 cc,25-dihydroxy vitamin D3 of 2-deoxy-3,24-diepibrassinolide 18:515 of 2-flurorostradiol 5:447,449 of 2-hydroxy-6-methylbenzoic acid 9:347,350 of 2-hydroxyindolizidines 12:283,284 of 2-isocephems 12:126,127 of 2-iso-oxacephems 12:128,129 of 2-1ithio-2-phenyl-6-heptene 8:7,8 of 2-methylseleno-2-phenyl 6-heptene 8:7 of 3,13-diacetyl-GA3 8:122,123 of 3,13-diacetyl-GA3 phenacyl ester 8:133 of 3,4-dihydroisoquinoline 8:230 of 3,5-disubstituted indolizidine alkaloids 11:245-259 of 30-methyloscillatoxin D 18:294-309 of 3-amino-5-hydroxybenzoic acid 9:434 of 3-cyanocephem derivative 12:135 of 3-dehydro-24-epiteasterone 18:512,513 of 3-dehydroteasterone 18:512 8-disubstituted indolizidine alkaloids 11:260-267 of 5-acetyl-DIBOA 27:263,204 of 5-amino-7-methoxy-2,2-dimethyl chroman 13:358 of 6(E)-alkylidene-8-hydroxy-8-methylindolizidines 459 of 6-hydroxyindolizidines 12:285,286 of 6-S-[3-D-galactopyranosyl 6-thio-D-glucose 8:339 of 6-S 423 of aluminum borohydride 8:467 ofambrucitin 10:386 of amino acids of boromycin 10:414 ofbranched amino sugar 10:421 of branched pentasaccharide 10:476,477 of branched tetraacetate 10:476, 477 of branched trisaccharide of cytochalasins 8:213 ofd, l-chaparrinone 11:105,106 of D-allo-c~-amino acid 11:460, 461 ofdecumbenine B 21:735 of dehydroisoerivanin 24:61,62 of dendrobatid alkaloids ofdracaenones 5:20,21 of D-(x-aminouronic acid 11:459,460 of ebumamonine 8:264 of elaeocanine 12:454 of eldanolide 11:414 of elemanolides of higher carbon sugars 11:429-480 ofhobartine derivatives 11:309, 310 of hobartine-19-ol 11:309 of homothienamycin 8:262 of humulene 8:156 ofhuperzine A 21:746-748 ofhuperzine A from 21:746-748 of hydroazulene 24:80 of hydroxy-amino-acid 12:431-438 of hydroxylated indolizidines 12:263-275 of I-active oligosaccharide containing lactose 10:477-479 of I-active oligosaccharide containing lactose 10:477-479 of Ii-active oligosaccharide containing mannose 645 of isodeoxybouvardin methyl ether 10:644,645 of isodihydrofutoquinol 8:169, 170 ofisodityrosine 10:630 of isoerivanin 24:61 oflasalocid A 10:424 of leucomelone 29:299 ofleukotriene B3 10:159 of leukotriene L-ribose 11:390,391 of ludovicin C 24:61,62 of lupeol palmitate (lupeol hexadecanoic acid ester of macrocycle A 10:280,281 of macrocyclic cytochalasans 13:108-120 of macrocyclic semiochemicals 8:219-256 of macrolide 8:176;10:423 of macrolide antibiotics 12:35-62 of macroline 13:383,411,423, 424 of macroline-related alkaloids 13:383-432 of maesanin 5:821-824 of mannans and oligomers 26:1158 of melicopicine 13:353,354 of methoxybipyrrole aldehyde 8:273 of methyl (2E,4E)-2,4-nonadienoate 10:166 of methyl epijasmonate 8:152-157 of methyl jasmonate 8:152-157 of methyl-c~-peracetylhikosaminide of sarcophytol B 8:18,19 of sarmentosin 21:739,740 of sarmentosin 21:739,740 of scopadulane-type diterpenoids 21:706 of secasterone 18:512 of seco-taxane 12:179,180,201 o f serine 11: 420 of serotonin 30:370 of sesquiterpenes 24:53-125, 175-513 of shikimic acid 13:188 of sildydianin 8:166,167 of silphinene 8:165,166 of silybin 5:486 of sinefungin 11:437,438 of siozonarol 24:188-190 of sodium trimethoxyborohydride 8:467 of sopadulan-type diterpenoids 21:706-717 of sorelline 11:326,327 ofspirocyclic core 21:391 ofspirocyclic core 21:391 of spiroethers 18:269-309 ofspiromentins B 29:300 of steganone 24:779,780 of sterepolide 8:280 of steroid 8:167-174 of steroid moiety 30:486 of suaveoline 13:383 vinylsilanes 8:242,243 vitamin D 11:379-408 vitamin D aldehyde 10:52 of vitamin D analogues 3,4-tetrahydroisoquinolone alkaloids 10:683-685 of o~(1--+4)-linked 4,4'-dithiotrisaccharides 8:344,345 of o~-l,4-disaccharide 8:369 of a-amino acid 12:435-438 of o~-copaene 8:33-36 of c~-cyclodextrins 8:367,368 of ct-D-fructofuranosyl-1-thio of ct-enamino derivative 8:262 of ct-halomethylcycloheptane 8:35-37 of (x-hydroxy of D-turmerone 8:51,52 of ),-allenyl-GABA 13:514 of?-aminobutyric acid (GABA) 13:514 of ?-dehydro-cz-amino acid 11:471,472 of c~,(x-disubstituted 3-piperidinol alkaloids 29:421 reaction with lead tetraacetate 5:21 reaction with tristrifluoroacetate (TTFA) 5:21 via 6-epi-purpurosaine B 4:120 purpurosamine B 4:120 vinblastine of diarylethers 20:307 Synthetic peptide 18:920-926 Synthetic pharmacological agents 30:224 antioxidant activity of 30:224 Synthetic podolactones 28:484 allelopathic activity of 28:484 Synthetic psychotropic agents 24:1093 Synthetic reagents Synthetic routes 29:227 to arcyriaoxocin A 29:227 Synthetic strategies 29:128,129,130,452 for carbaaldofuranoses 29:452 of kuehneromycin A 29:128 Synthetic studies 15:493-500 of humantenine-type oxindole alkaloids 15:493-500 of koumine-type alkaloids 15:500-503 of sarpagine-type alkaloids enzyme-carbohydrate interactions 218 Syringa Syringaresinol 26:243 as PAF-induced inhibitor O-glucosylation of 5:525 O-methylation of 3-sinapyl alcohol ether di-p-hydroxy Systemic wound response protein 25:402 Systemin 25:85 Systemin maturation 25:376 Systemin oligopeptide 25:371 Systemin polypeptide 25:371 Systemin signal 374 Syzygium carynocarpum 29:708 Syzygium malaccense 29:708 from Claisen ester enolate rearrangement 3-epi-18-nor-18,19-dihydroantirhine from 14:708 Tetrahydropyridinium salts 6:447 in coccinelline synthesis 484 Tetrahydrosecodine 19:90 from Rhazya stricta 19:90 16 227 role in HIV-1 in inhibitor activity 30:227 3fl,6a, 16fl 25-epoxy-9fl, 19-cyclolanostane 25:184 (22R,23R,24S)-2c~,3ot,22,23-Tetrah y dro x y-24-methyl-B-homo-6 a -oxa Tetrahydroxy-3-geranyl fl avone 28:17 aromatase inhibition by 28:17 3 [3,6cx, 12o~ 7fl,24a,25-Tetrahydroxy-9fl Tetr ahydroxyflavanone 28:17 aromatase inhibition by 48 structure of 27:48 Tetrahydroxypavinan 30:225 effect on 5-1ipoxygenase inhibition Tetraisopropyl disiloxane-1,3-diyl (TIPS) 14:287 desilylation of Tetrakis (triphenyl phosphine) palladium (0) 10:342 Tetrameles nudiflora 22:533 for convulsions 10-tetraoxododec anedioate from 11:115 Tetramic acid 28:109,110 biological activity of 28:110 13C-NMR of 28:113 derivatives of 28:109 1,5-dihydro-4-hydro xy-2 Hpyrrol-2-one as 28:109 IR values of 28:113 2,4-pyrrolidinedione as 28:109 spectral properties of 28:111 structure of 28:110,111 synthesis of 28:110 UV spectra of 28:113 Tetramic acid glucosides 25:763 Tetramic acid-4-hydroxy-2-pyridone 21:216 Tetramic acid-containing compounds 28:109 biological activity Tetramorium caespitum 5:235,254 2,5-dimethyl-3-ethyl-p yrazines from 5:223 2,5-dimethyl pyrazines of 5:222 methyl pyrazines from 5:222 Tetramorium impurum 5:235,254 2,5-dimethyl-3-e thyl-p yrazine s from 5:223 2,5-dimethyl pyrazines from 5:222 methyl pyrazines from 5:222 Tetramycines A,B 6:261 relative configuration 366 ofallyl glucoside 8:365,366 ofallyl rhamnoside 8:365,366 of (+)-baiyunol 8:362 of cholestanol 8:365,366 of cholesterol 8:361 Thermal model ofnociception 30:205 analgesic effect in 30:205 Thermal rhamnosidation 8:359 Thermally-induced rearrangement 6:468 of ~-hydrastine N-oxide 6:468 of c~-narcotine N-oxide derivative Thermococcus tadyiricus Thermolytic cyclization 6:429 ofalkenyl azides 6:429 of azides 7R*)-4-Thioc yanato-9-cadinene 28:660 X-ray analysis of 28:660 2-Thiocyanatoneopupukeanane Thiodepsipeptide thiocoraline 25:841 5-Thio-D-glucose ->4) linkage 8:329 1,2-trans 1-Thiodisaccharides 8:317, 318 1-Thiodisaccharides ->6) linkage 8:340 5-Thio-D-mannopyranose 6:351 5-Thio-D-mannose 28:715 as naturally occurring 5-thiosugar Thioesters 4:554 acylation of phosphonium ylides 4:554 3 208 of nucleosides 19:516 y-Tosyl-N-isobutylcrotonamide 21:383 c0-Tosyloxy-c~-phenylthiocrylontriles 6:540 Total fatty acids 24:1009-1015 fatty acid derivatives )-22-methyl-5,9-octacosadienoic acid 26:87 of (R)-2-methoxyhexadecanoic acid 26:78 of (Z)-2-methoxy-5-hexadecanoic acid 26:77 of 10 (E)-hexadecenoic acid 26:71 of 7-methyl-6-octadecenoic acid 26:72 of 9 of methyl (Z)-2-methoxy-6-hexa decenoate 26:75 of Mniopetals 29:148 ofnagilactone F 28:502 of Na-Methyl-D ~ 8-isokoumidine 15:493 ofparaherquamide A 28:331 6 a, 16fl-Trihydroxy-9fl,19-cyclolanost-24-oxo 25S,26-Trihydroxy-cholecalciferol 10:69 synthesis Trihydroxyethylated rutoside 22:320 1 [3,4c~,6ot-Trihydroxy-eudesm-11 -en-6o~ 8-Trihydroxyindolizidine 12:348 from methyl 2-azido-4,6 25-Trihydroxyvitamin D3 9:521 6 Trijugin A 2:267,268 Trillium glycosides 2:443 antifungal activity Trillium grandiflorum 2:443;23:343 Trillium smalii 21:662 Trillium tschonoskii 2:443 Trilobatin 15:31 Trimer 5:754 of plumbagin 5:754 ofplumbazeylanone Trime tho x y b enzyl)-3-(3 ',4 '-ethylene dioxyenzyl) butyrolactone 26:192 3,4,6-Trimethoxy phenyl-O-glucoside Trimethyl decalone 6:19,20 by Robinson annulation 6:19,20 from ethyl vinyl ketone 6:19 from 2-methyl-1,2-cyclohexadione 6:19 Trimethyl orthoacetate 14:725 corynan-17-oic acid methyl esters from Trimethyl orthoformate 1:448,449 methylation with 1:448 10-dodecatrienyl)-2-metho xy 10-dodecatrienyl)-hydroquinone 15:294 (2E,6E)-3,7,11 -Trimethyl-2,6-dodecadien-1 604 2-(Trimethylsiloxy) furan (TMSOF) 11:451,453 2-Trimethylsiloxyfuran 3:167 3-exo-Trimethylsilyl camphor 4:663 Trimethylsilyl cyanide 1:156 in glycosylcyanide synthesis Trimethylsilyl derivative 4:223 in nucleosides synthesis Trimethylsilyl esters 4:564 acylation of phosphonium ylides 4:564 Trimethylsilyl intermediates 4:394 in prenylation methods 4:394 N-Trimethylsilyl iodohydrin 1:277 Trimethylsilylmethylation 2-Trimethylsilyl-1,3-dithiane 12:156 2-(Trimethylsilyl)oxy] butadiene 12:377 Trimethylsilylated compound 30:239 NMR spectrum of Trimethylsilylation 1:272 Trimethylsilyldiazomethane 4:91 Trimethylsilylisocyanate 3:309 N-acylation of indoline 3:309 Trimethylsilylmethylation Trimethysilyl iodide 21:746 Trimusculus reticulatus 17:27 Trimyristin 5:753 4,6-Tri-O-acetyl-1,2-0-cyanoarylidene-cz-D-galactose 14:224 3,4,6-Tri-O-acetyl-1,2-Ocyanoethylidene-c~-D-mannose 14:229 2 6-Tri-O-acetyl-D-glucal 8:343,344 2,3,4-Tri-O-acetyl-ot-D-glucopyranosyl bromide 6-Tri-O-ac etyl-[3-D-gluc op yrano s yl chloride 6-Tri-O-benzoyl-2-phthalimido-2-deoxy-c~-D-glycosyl bromide 14:242 1,2,3 -Tri-O-benzo yl-4-O-triflyl-Larabinose Bolbostemma paniculatum) tubeimoside I from 7:143 Tuberostemonine 21:769 Tuberous sclerosis 30:374 autistic features Tubifolidine 1:67 synthesis of Tubifoline 1:41,45 Tubipora musica 24:119 Tubocurarine 13:631 ;21:52,102 from Chondodendrum tomentosum Tubotaiwine-N4-oxide 5:125 Tubulanus punctatus 18:725 Tubules 29 X-ray crystal analysis Tulipa gesneriana 19:247 Tulipinolide 7:231 Tulirinol 558 Tumor 28:532;30:61 effect of lipid A on Me)2-Phe-NHCH3 30:812 energy map of 30:812 ~25 1-Tyr2, Ala 16-systemin 25:373 Tyramine 6:525,529 -Glc(OAc)4]Tyr-Pro-Ser-NH2 30:815 receptor binding properties of (deltorphin C) 30:815 receptor binding properties of OAc)4]-Val-Val-Gly-NH2 30:815 receptor binding properties of receptor binding properties Tyr-Pro-Ser-NH2 (deltorphin C) 30:815 receptor binding properties of -D-Glc)-Gly-NH2 30:815 receptor binding properties of receptor binding properties -D-Glc)-Tyr-Proser-NH2 30:815 receptor binding propertxes of -D-Glc)-Val-Val-Gly-NH2 30:815 receptor binding properties of 30:815 d-Tyr(Me)z-Phe-G-V-V-NH2 30:813 binding bioactivity of 30:813 functional bioactivity of 30:813 d-Tyr(Me)z-Phe-NH2 30:813 binding bioactivity of 30:813 functional bioactivity of Uang synthesis 12:26,27 of avermectin oxahydrindene subunit Uca pugilator 19:628 UCF 1-A,B and C 21 UDP-GaIN) 25:461 UDP-GlcNAc 1:417 distribution of metabolism U-endo-fl-l,4 galactanase 25:436 Ueno method 10:322 Ulapualides A 19:609 antifungal activity Ulbelliferae 7:115,119 Ulbelliferone 7:224 Uleine 1:56-58 synthesis of Ullmann macrocyclization 20:308 Ulmann reaction Ulmus thomasii 17:338 Ulosonic acid 30:422,432,433,438 acylation reactions for 30:438 chemical synthesis of 30:432 strategies towards 30:438 synthesis of 30:422 treatment of enolpyruvate 30:432 Ulosonic acid synthesis 30:451-458 alternative approach to 30:452 from glycals Ulosonic ester halides 30:467 glycosylation reactions of Ultra-turrax-type homogenizers UV) 5:621,622 of flavonoids 5:621,622 of flavonols 5:622 of 3-methoxyflavones 5:622 2'-substituted flavonoids 5:622 of 2',4',5'-trisubstituted flavonol-3-methyl ether 5:630 Ulva lactuca 7:338 Ulva perfusa 21:305 Ulva sp Umbelliferae genera from Pleisopermium alatum Umbellifolide 7:215,237 from Artemisia umbellijbrmis Umbelliprenin epoxide 1:661 cyclization of Umbilicaria angulata 5:311 Umbilicaria caroliniana 5:311 Umbilicaria polyphylla 5:311 Umbraculum mediterraneum Umbrosin A 15:175 from Rabdosia umbrosa 15:175 from Rabdosia umbrosa var Addition 8:46 Uncaria genus 17:122 Uncaria guaianensis 17:116,124 Uncaria rhyncophylla 22:534 for convulsions in children 22:534 Uncaria tomentose Undec-8-ene-2,5-done 19:161 Undecane 21:600 N-Undecane 6:453,454 as alarm pheromone 3-Unsaturated nucleosides 4:223 1,3-intramolecular shift of 4:223 2-Unsaturated nucleosides 4:225 Unsaturated nucleosides ALUnsaturated sterols 25:56 schottenol 25:56 spinasterol 3-Unsaturated c~-C-glycopyranosylarenes Unstable D-mannose derivative 30:462 Unsubstituted 2-oxazolidone derivative 12:164,166 low [3-selectivity of 12:166 with 4-acetoxy by asymmetric aldol reaction 12:162 by asymmetric hydrogenation 12:162 of [3-keto amide 12:162 of (x Unsymmetrical onoceranoid triterpene 1:543 synthesis of Uoamine B 28:644 3-thiomethylacrylate ester group of 28 by Knoevenagel condensation 6:67,68 by vinylation 6:67,68 by Wittig reaction 6:68 synthesis of 6 U-plasminogen activator (u-PA) 30:844 Uptake blocker 21:84 Uranium (IV) hexafluoroacetylacetonate 8:466 Urdamycin A 11:134 antifungal activity of 11:134 antitumor activity of 11:134 from Streptomyces fradie Urdamycin B 11:134 urdamycinone B from Urdamycins 5:596 Uric acid 25:930 Uridine Uridine 5'-triphosphate 27:820 Uridine diphosphate Nacetylglucosamine Uridine diphosphate-galactose (UDPgal) 10:468 synthesis Urine retention 30:194 as opioid's side effect Uronide elicitors 25:488 Uronolactones 14:192 Uroporphyrinogens Urospora penicilliformis Uroterpenol 29:83 activity in mare-2 assay system 29:83 activity in RAS assay system Ursane 22:94 Ursane triterpene 29:585 effect on CHY Ursolic acid 2:129 358-360;364;30:146 from anacardic acid 9:341 ozonisation of Usnea rubescens 5:310 Usnea sp Ustilago maydis 22:263;25:389 Ustilago sp Uterine tumor 30:27 effect of pironetin derivatives of (+)-N-formylovigerine 30:582 of 7-formyldehydroovigerine 30:581 of ernamymphine 30:582 ofherveline A 30:583 UV irradiation 30:486,489 ofprovitamins 30:486 of provitamin D derivatives 30:489 UV spectroscopy 9:164,173 of indole alkaloids 9:164,173 UV spectrum 30:570 Uvaria narum 18:221 isodencetyl uvaricin Uvaria pauciovulata 28:422 Uvaricin 17:271 from Uvaria Vaccaria segetalis 26:50 imunomodulatory effect Vaccaroside D 26:29,30 enzymatic hydrolysis of 26:30 COSY of 26:29 HMBC/HSQC correlations of 26:29 HOHAHA spectrum of 26:29 843 phase-sensitive NOESY spectrum Vaccaroside F 26:29,30 1H and 13C spectra of 26:30 acid induced rearrangement of 26:31 alkaline and enzymatic hydrolysis of 26:30 FAB-MS of 26:30 HMBC/HSQC correlations of 26:29 IR spectrum of 26:30 Vaccination 30:408 for respiratory infection Vaccinium angustifolium 23:782 Vaccinium corymbosum 29:585 Vachanic acid (illicic acid Valencene 25:125 Valepotriates 13:660 from Valeriana officinalis 13:660 n-Valeraldehyde Valeriana hardwickii 22:534 for epilepsy 22:534 for hysteria 22:534 for hysteroepilepsy 22:534 Valerianajatamansi 270 for epilepsy 22:534 for hysteria 22:534 for hysteroepilepsy 22:534 (+)-l-hydroxypinoresinol from 26:270 monoterpene alkaloids from 6:524 (+)-pinoresinol-[3-D-glucoside from ~H-NMR spectrum of 5:137,138 COSY-45 spectrum of 5:138 IR spectrum of 5:137 mass spectrum of 5:137 UV spectrum of 5:137 Vallesamine 5:87 N-alkylhomovanillamides as 30:201 N-vanillyl-N-benzylureas as 30:201 N-vanilly-N-(3-acyloxy-2-benzylpropyl)-thioureas as 30:201 resinifeonoids as 30:201 Valoneanic acid 20:272 Valoneoyl group 23:400,403,415 in olegomers 23:403 Valproic acid 22:507 Van Deemter curve 9:458 Van der Waals effects Vancoresmycin 28:150 activity against gram-positive bacteria Vancouveria hexandra 29:788 Van de Walle (iridoids) 8:139 Van de Walle approach 6:16 in [3-dictyopterol synthesis 6:16 in dictyopterone synthesis Vandrikidine 9:193 Vanilla planifolia 25:126 Vanillic acid 23:750 Vanillin 7:88,457 Vanillin assay 21:502 Vanilline phosphoric acid 22:129 Vanilloid receptor agonist 30:202 olvanil as 30:202 capsaicin as 30:201,202 structure of Vanillomopis arborea 29:89 Vanilloyl imidazole Vantanea peruviana 29:708 Varacin 23:236,237 thiomethyl derivative Varicella-Zoster virus 30:394 cause of Varicinal A 23:56 Varroajacobsoni 28:387 honey bees tolerant to 28:387 toxicity of Varroa mites 28:383,384,392 as honey bee parasites 28:384 biological activity Vascular dilatation activity 23:139 Vascular physiological action 30:55,69 of natural products Vasicine 5:751,752 from vicinal tricarbonyl Vasodilating activity 21:379 Vasodilator 23:358 scoparone as 23:358 Vasodilator activity 23:358 of scoparone 23:358 Vasodilator effect 25:595 of acetylcholine Vasodilatory activity 30:275 ofSatujera obovata 30:275 Vasopressin 22:25 Vasoprotective agent 22:443 Vasoprotective effects 28:302 of green tea 595 activity in human cancer cell line 30:589 activity in murine cancer cell line 30:589 as platelet aggregation inhibitor 30:594 cytotoxic effect of 13C-NMR data of 23:544 ~H-NMR data of 23:544 mass fragmentation Vaticaphenol A 23:533,538 Veatchine 3:435 Vegetable phenolics 23:752 in artichoke 23:752 in asparagus 23:754 in broccoli 23:756 in cabbage 23:756 in carrot 23:754 in cauliflower 23:756 in celery 23:755 in chicory 23: 758 in chive 23:758 in crucifferae 23:756 m cucumber 23:757 in cucurbitaceae 23:757 in eggplant 23:757 in endive 23:758 m garlic Vellozia candida 20:474 rosane diterpenoids Velocitermes velox 14:451,452 Velutin 7:228 Velutinal 26:461 Venetian lagoon 28:702 Venom gland alkaloids Venturia inequalis 21:217 Vepridimerine E 2:128 Vepridimerines Veprisine 2:127,128 dimerization of 2:121 Verapamil 25:534,673;26:1063 as Ca2+-channel blocker Veratraldehyde 6:334 Veratrate 5:725,726 of epoxyj aeschkeanodiol 5:725 Veratrum album 23:569 Veratrum alkaloids 7:16 Veratrum califormicum 7:16 Veratrum sp. 21:97 Veratryl alcohol 26:1013 Verbascoside Versicoside A 7:288,293 from Arterias amurensis versicolor Vertebrate toxicity Verticillane 12:182,183 Verticillium alboartrum 25:299 Verticillium balanoides 27:868 Verticillium biguttatum 21:205 Verticillium dahliae 21:205,239 Verticillium lecanii 28:404 Verticillium sp Vertinolide 16:700 synthesis of 16:700 Vesicant activity 1:365 Vesicular glutamate transporters 25:538 Vesicular monoamine transporter type 2 (VMAT2) inhibitor Vesicular stomatitis virus (VSV) 26:223;30:743,752 replication of Vesiscular stomatitis 25:779 Vesititol 28:224 anti-microbial activity Vestitol 28:243 anti-Helicobacter pylori activity of 28:243 Veterinary medicine 28:383 for ectoparasites control 28:383 Vetiver grass 28:399 for controlling ticks 28:399 phetchabun as 28:399 'Si Sa Ket' as 28:399 Vetiver oil sesquiterpene 15:273 Vetiveria zizanioides Vibrio sp Vibrio valnificus 25:718 Vibsanol 26:255 Vibumium dilatatum 4:712 Viburnum awabuki 26:255 9 Viburnum suspensum 25:251,257,259 Viburtinal 7:458,459 from Viburnum tinus 16:302 from Viburnum opulus Vicia angustifolia Vicia sativa 25:93;29:591 Vicinal oxyamination reaction 11:61 1,2,3-Vicinal tricarbonyl unit Vicoa indica 29:89 Vicolides 29:89 activity in CTN bioassay system Vietnamese ginseng 21:672 Vigabatrin Vigna angularis 25:93 Vigna radiata 18:522 23-O-[3-D-gl ucop yrano s y 1 brassinolide Vigna unguiculata 25:93 Villagorgia rubra 21:260 Villagorgins 21:260 Villamine synthesis of 13:405 X-ray analysis Vilsmeier formylation 1:507,508 Vinamidine 2:389 Buchi's synthesis of 14:868,869 from catharanthine 14:854-858 from Catharanthus roseus 8:283 Gorman's synthesis of Kuehne's synthesis of Kutney's synthesis of Magnus's synthesis of Potier's synthesis of Schill's synthesis of 14:861,862 synthetic approaches to Buchi's synthesis of 14:868,869 deacetylvindoline from 14:862, 863 first synthesis of 4:32 from anhydrovinblastine 14:820 Kuehne's synthesis of Kutney's synthesis of Magnus's synthesis of Potier's synthesis of Schill's synthesis of 14:861,862 synthesis of 5:185-187 synthetic approaches to Vinca major elegantissima 1:124 Vinca minor 2:370 Vinca rosea (Catharanthus roseus Vincadiffine 5:125 9 115 derivatives of 19:115 enantioselective synthesis of 4:40,41 from Vincadifformis 19:90 preparation of 19:101 synthesis of 14:635,636 total synthesis of 19:93 transformation of Vincadifformine-type alkaloids 5:92 apodine 5:92 apodinine 5:93 cylindrocarpidine 5:93 O-demethylpalosine 5:92 (+)-demethylaspidospermine 5:92 desoxoapodine 5:92 10-hydroxy' 11-methoxytabersonine 5:93 12-demethoxycylindrocarpidine 5:92 12-hydroxyvincadifformine 5:92 14,15-dihydroxyvincadifformine 5:92 5-oxo-cyclindrocarpidine 5:93 haxuntine 5:93 hazuntinine 5:93 homocylindrocarpidine 5:93 lochnericine 5:92 mehranine 5:90,92 (+)-minovincine 5:92 (+)-3-oxo-minovincine 5:92 tabersonine 5:92 (+)-vincadifformine 5:90 183 ( +)-V incamine 14: 726 from Oppolzer's aldehyde 14:726 synthesis of 14:726 16-epi 89 from Vinca minor 8:283;13:660 synthesis of 1:117,118 Vincamine-related alkaloids 8:266 synthesis Vincaminoreine 14:635,636 synthesis of 14 Vincanicine 1:36 Vincanidine 1:36 Vincristine 2:390,398 from Catharanthus roseus 8:283 Gorman's synthesis of Kuehne's synthesis of Kutney's synthesis of Magnus's synthesis of Potier's synthesis of Schill's synthesis of 14:861,862 synthetic approaches to 14:805-884 synthesis of fi Vindolinine 2:377 Vindorosine 4:34 Vineomycin A~ 11:113 antibacterial 11:113 antitumour from Streptomyces matensis Vineomycin A1 5:594,595 from Streptomyces matensis subsp, vineus 5:593 Vineomycin B2 10:370 synthesis antifungal agent 16:565 synthesis of trans-g-Viniferin 26:560 (+)-c~-trans-g-Viniferin 26:560 cis-~-Viniferin 26:567 1,2-Viniferin 27:767 e-Viniferin Viniferin 27:855 ~-Viniferin diol 26:569 Viniferins 27:770,766 in spermatophytic plants species Vinoxine 1:62 total synthesis of Vinrosidine 14:857 Vinyl 4H-1,2 dithiin 23:4593-Vinyl 4H-1,3 dithiin 23:4592-Vinyl acetate 1:562,563 reaction with methyl lithium 1 Vinyl acetate 1:562,563 reaction with methyllithium 1 Vinyl azides 1:165 preparation of Vinyl carbanions 11:440,441 nucleophilic addition with 11 Vinyl carbene 3:27 (Z)-Vinyl chromium 30:10 Vinyl cuprate addition 3:189,190 6-Di-Oisopropylidene D-glucose 12:41 from D-ribose 12:50 palladium-catalyzed coupling reaction of 30:8 (Z)-Vinyl iodide 30:20 oxidation of 30:20 condensation of 30:20 Vinyl palladation 16:371 of 4-cyclopentene-1,3-diols 16:371 Vinyl radical cyclization 12:24 Vinyl stannane 1:490 synthesis of 1:490 from tributyltin/acetylene 1:490 Vinyl sulfoxides Vinyl tricarbonyl hydrate 8:267-272 2-Vinyl-4H-1,3-dithiin 23:469 Vinylacetyl chloride 14:453,454 condensation of 14:453 Vinylallenes 4:522 sigmatropic rearrangement 4:522 Vinylation 6:86,87 in 7,20-diisocyanoadociane synthesis Vinylcyclobutane 3:465 Vinylcyclopropanes 3:38,44,47 from 1,4-dienes 3:38,44,47 pyrolysis of 3:34 via allylic SN 2 process 3:47 Vinylcyclopropylcarbene 14:627 6-Vinyldihydropiran-2-carboxylate template Vinylic anions 4:497 inversion of 4:497 Vinylic ethers 4:116 hydroboration Vinylic sulfoxides 4:501,502 for synthesis of esterone 4:501,502 for synthesis of vitamin Vinylketene acetals 14:503,504 asymmetric Diels-Alder reaction of 14:503 Vinylogous amide susbtrates Vinylogous urea substrates 18:363 Vinylogous urethane 25:10 synthesis of dihydrofurans Vinyloxyborane-imine reaction 4:465,466 carbapenem precursors by 4:469 stereochemistry of Vinylpicoline 14:437,438 bis-annelating agent 14 Vinylpyridine 14:438 Vinylsilane 8:242 A1C13 catalyzed Friedel-Crafts acylation 8:242 synthesis of Vinylsilane-medicated bicyclization 13:615 Violanin 5:646 Violaxanthin 20:575,727;30:530 Violer~hrin 30:518,519 structure of Viral 2'-deoxythymidine kinase 30:395 Viral adhesion 16:113 Viral diseases 30:732 Viral DNA 30:226 integration of Viral DNA polymers 30:395 for herpes simplex virus 30:395 for varicella-zoster virus 30:395 phosphorylation of 30:395 Viral envelope glycoproteins 30:404 natural sulphated polysaccharide (PS) 30:404 Viral glycoprotein 27:109 haemagglutinin Viral glycoproteins 25:388 Viral infections 30:394,742 therapy of 30:394 Viral mutation 30:407 Viral proteins Viral sialidase 16:112 Virantmycin 29:339 antifungal activity of 29:339 antiviral activity of 29:339 effects on lipids peroxidation 29:339 inhibition of glutamate toxicity Virenamide A 23:244;28:644 as cytotoxic linear peptides as cytotoxic linear peptides as cytotoxic linear peptides Virgilia 26:1157 Virginiamycin 5:606 Viridifloric acid 1:260,261 enantioselective synthesis of 1:260 Viridiflorine 1:267 synthesis of Viridin antibiotics Viridiofungins 21:191 186 Virola surinamensis 26:230 grandisin from 26:230 veraguensin from 26:230 Virosecurinine 21:69 Virucidal activity 21:665 Virucidal agents 30:627 hypericin as 30:627 pseudohypericin as 30:627 Virus 30:393,394 adeno-30:393 herpes-30:393 pox-30:393 replication of 30:394 Virus replication Virus-cell binding inhibitors 30:398 inhibition of Virus-specific treatment 30:407 Virustatic pharmaceuticals 17:421 Viscidulin 1 5:678 316,320 Vulgarol 7:209 from Artemisia vulgaris Wacker process 11:238,241,246 Wadsworth-Emmons condensation 1:52,60 Wadsworth-Emmons reaction 1:176, 177 Wallenberg's procedure 6:298,299 warburganal 6:108 WALTZ sequence 845 Warburganal 29:87 activity in skin-1 assay system Warbugia stuhlmannii 17:234 Warbugia ugandensis Warburgia stuhlrnanii 4:403,427 Warburgia ugandensis 4:403,427 Warfarin 23:359 Warren procedure 3:257 Warts Watersipora subtorquata 28:620 5,7-dihydroxy-6-oxo-6H-anthra[ 1,9-bc]thiophene-1-carboxylic acid from Water-soluble polymers 30:395 biopolymers in 30:395 Watt synthesis 14:678-681 of taxodione Wax esters 9:452 Wedelia asperrirna 20:8 Wedelia glauca 20:8 Wedelia paludosa 26:810 ent-kaura-16-en-19 Wedelia scaberrima 7:427 Wedeloside 20:8 Weight loss 30:56 due to cancer drugs chemotherapy Weiler's reaction 11:115 Weinerb reaction 26:1239 Weinreb's amide 30:473 synthesis of Weisiensin A 15:112,120 13C-NMR of 15:134 from Rabdosia calcicolus 15:171 from Rabdosia nervosa 15:173 from Rabdosia weisiensis Welch synthesis 6:17 of isozonarol 6:17 of zonarol Wender synthesis 13:445 Wender's [4+4] cycloaddition strategy Wenkert's enamine 1:113;14:727 synthesis Weolignans 27:765 biological activity Western blotting analysis 15:449 Wharton reaction 10:47 Wharton rearrangement Wheat cystatins 29:594 effects on cathepsin B 29:594 effects on cathepsins 29:594 effects on chymopapain 29:594 effects on cysteine proteases 29:594 effects on ficin 29:594 effects on papain 29:594 Wheat flour 28:259 vanillic acid in 28:259 syringic acid White synthesis 12:15,27,28 of avermectin B la aglycone 12:15 Whole insect assays 29:29 20E 22-O-benzoate tested in 29:30 cyasterone activity in 29:30 24(28)-dehydromakisterone A activity in 29:30 2-deoxy-20-hydroxyecdysone activity in 29:30 20E 2,25-dibenzoate tested bioactive terpenes from Wiesnerella denudata 2:280 Wighteone 28:226,229 anti-human immunodeficiency virus (HIV) activity of 28:226 biological activity of Wilcoxon test 2:434 Wild plasmodium constituents 29:236 6-alkyl-4-methoxypyran-2-one s ceratiopyron A as 29:237 ceratioflavin A as Wilforic acid A 30:676 13C-NMR spectra of 30:677 ~H-NMR spectrum of 30:676 IR absorption bands of 30:676 structure of 30:677 UV absorption bands of 30:676 Wilforic acid B 30:639 HREIMS spectrum 30:639 structure of 30:639 Wilforic acid C 30:640 ~3C spectrum of Williams approach 12:28-30 for avermectin oxahydrindene subunit Salix species) 30:192 analgesic properties of 30:192 anti-inflammatory properties of Wisterlasaponm A 21:642 Wistarlasaponln Wistarlasaponm Wistarlasaponln Wistariasaponm Wistarlasaponm Wistariasaponln Wistanasaponm Wistariasaponin YC2 25:96 Wistariasaponins 25:222 Wistarin 6:8 from Ircinia wistarii Withania ashwagandha 22:535 Withania coagulans Withanolide 19:463,470 antitumor activity of 19:470 biological activities of 19:470 insect antifeedant properties of 19:470 novel structure 139 Withanolide glycosides Withaphysalins A 20:189 from Physalis minima from Physalis minima Withaphysalins C 20:189 from Physalis minima 20:189 Withasomniferol 20:181 Withasomnine 1:343 synthesis of 1:343 Witkop photocyclization 1:52 Wittig condensation Wittig cyclopropanation 21:397 Wittig homologation 3:268,269;11:100, 101 Wittig olefin 30:443 formation of )-5-methyltetradec-4-enal 26:72 of 12-hydroxy-2-methyldodecanal 26:70 of 6-methyl-2-heptanone 26:65 of 7-methyl-2-heptanone 26:65 of 5-methyl-2-hexanone 26:66 of 5-pentadecenal Wittig reduction 21:397 Wittig ylide 6 Wittig-methylenation 10:413 of L-mannose Wittig-type methodology 21:383 Witting olefination 30:443 of sugar aldehydes 287 anti-inflammatory action of 30:289 structure of 30:287 Wolff rearrangement 19:18;21:438 of diazoketone 10:593-595 oxetane ring formation 684 Huang-Minlon modification Woodward reagent K 6:238 Wounding-Induced Protein Kinase 26:946 Writhing test 30:207 activity of 13-narin-II8-4'-Omeeridictoyol in 30:207 role of biflavonoid in 30 Wurmbea sp. 6:158 xanthophils from 6:158 Wurtz Wyeronic X14766A 29:317 against gram-positive bacteria 545 6-acetyl-mannose in 29:545 as exocellular polysaccharide gum 29:545 glucose in 29:545 glucuronic acid in 29:545 mannose 6-pyruvate mannose in 29:545 rheological properties Xanthate 1:452,453 formation 1:452,453 rearrangement to dithiocarbonate 1:452 Xanthine oxidase 30:224 interaction with Xanthium spinosum 25:781 Xanthium strumarium Xanthoangelol 22:432 Xanthoangelo113 30:74,77 inhibitory mechanism of 30:74,77 effect on phenylephrine-induced vasoconstriction Xanthoangelol E 30:76 effect on phenylephrine-induced vasoconstriction Xanthobaccin A 28:140 as fungitoxic metabolite as fungitoxic metabolite as fungitoxic metabolite Xanthocephalum linearifolium 25:251 Xanthoceras sorbifolia 7:139,141 Xanthochymol 22:658 Xanthocidin 14:602 928 Xantholignans Vitians 26:596 Xanthomonas compestris pv Xanthomonas fragariae 26:596 Xanthomonas hortorum campestris pv Xanthomonas maltophilia 23:474 Xanthomonas oryzae 12:398 Xanthone hypothesis 25:351 Xanthone a-mangostin 25:531,536 inhibitor of CaZ+-ATPase Xanthones 5:495,595,705 Claisen rearrangement of 4:368, 370-372 derivative of 5:759 from heartwood 30:622 from umbelliferone Xanthonoids 5:758 Xanthonolignans 5:5 Xanthonolignoid kielcorin 22:662 Xanthoperyl methyl ether 14:673 Xanthopurpurin 3-methylether 26:665 Xanthopurpurin 26:657 Xanthoxyletin 2:118 Xanthoxylon hostile 22:535 for epilepsy 22:535 Xanthurenic acid 19:649;23:268; 26:966,991 microbial transformation of :749 and cooxidation 9:582,583 oxidation of 27:749 Xenochemicals from Xenorhabdus nematophilus 15:389 introduction of 15:381 Xenopus laevis 8:435 Xenopus oocyte 15:451 Xenopus-derived Xenorhabdus nematophilus 15:389 xenocoumacins from Xestocylamine activity 24:573 inhibition of protein kinase C 24:573 Xestomycin 25:826 Xestoquinol 17:62 total synthesis of 17:62 CD and absolute stereochemistry Xestospongia ashmorica 21:262 Xestospongia carbonaria 25:861 267 xestospongin A from 21:267 xestospongin B from 21:267 xestospongin C from 21:267 xestospongin D from Xestospongia genus 25:861 Xestospongia sapra 15:312 535 for convulsions in children 22:535 Ximenia caffi'a 22:535 for epilepsy Xindongnin A 15:116 13C-NMR of 15:130 from Rabdosia dawoensis 15:171 from Rabdosia rubescens 15:174 ~H-NMR 13C-NMR of 15:133 from Rabdosia rubescens 15:174 IH-NMR of 15:126 Xiphidium Xiphimena diversicaudatum 26:460 X-ray absorbance spectroscopy (XAS) X-ray absorption fine spectroscopy (EXAFS) of (+)-isoconcinndiol 6:26 of (+)-aristoserratine 11:296 of (+)-aristoteline 11:278 of(+)-retigeranic acid A 13:22 of (22R,23,R)-22,23-methyenecholesterol from 9:36 nargenicine 17:296 of ascidiacyclamide 4:93 of azadirachtin 9:94,103,105 ofcadlinolide A 9 Xuxuarines El3 30:682,683 13C-NMR spectra of 30:682 IH-NMR spectra of 30:682 CD spectral of 30:683 FAB-MS of 30:683 ROESY of 1156 Xylerithrin 29:298 biosynthesis of 29:298 Xylerythrins 29:293,299 5-O-methylxylerythrin as 29:293 peniophorinin as 29:293 peniosanguin as Xylitol pentaacetate 4:509 synthesis of Xylocarpus grantum 7:190 Xylocarpus moluccensis 7:176,191 191 D-Xylofuranose 6:359 C3-P bond analog Xylomollin 7:185 from Xylocarpus moluccensis Xylopia aromatica 21:600 Xylopia longifolia Xylosidase 7:58,70 352 Xylosides 8:362 synthesis of -Xylo syl-( 1 -->3 )-thio gluc o fur ano s e thiodisaccharide Xylotheca tettensis var. fissistyla 22:535 in convulsions Yamaguchi method 11:154 Yamaguchi reagent 11:157 Yamamoto condensation 12:24 of propargylic titanium reagent 12:2 regioselective 12 29:210 triptolide synthesis by 29:210 Yangambin 24:741 anti-platelet aggregation activity of 24:741 (+)-Yangambin 26:242,243,264 as PAF-induced inhibitor Yarrowia lipolytica (Candida lipolytica) 13:308 595 activity against A549 (human lung adenocarcinoma) 30:588 activity against HT-29 (human colon carcinoma) 30:588 activity against KB-16 (human oral epidermal carcinoma) 30:588 activity against P-388 (murine lymphocytic leukemia) 30:588 activity in human cancer cell line 30:589 activity in murine cancer cell line 30:589 as platelet aggregation inhibitor 30:594 cytotoxic effect of 26:213 Yeast glycogen phosphorylase 27:821 Yeast kex 2 protease (Kexin) 25:387 Yeast mutant 30:171 fusion of 30:171 Yeast reduction 1:482;13:560 Yeasts 1:689 for asymmetric reduction 1:689 "Yellow pigment analogues of 28:653 in diarrhetic shellfish poisoning (DSP Ylidene-1,4-dioxalan-4-one intermediate -5-Ylidenepyrrol-2-(5H)-one 21:416 y-Ylidene-y-butyrolactone structure 26:363 Ylides Yohimbine 14:566,567 enantioselective synthesis of 14:566,567 from piperdine derivative 14:566,567 (+)-Yohimbine 14:566,567 enantioselective synthesis of 14:566 Yohimbine precursor 3:435 synthesis of activity in iNOS assay system 29:87 activity in NO assay system 29:87 systems 29:87 Yoshikawa 29:481 validamine synthesis by Zahavin A 29:103 activity in AOS bioassay system 29:103 from marine soft Zahna africana 21:657 oleanane saponins from Zaitev reaction 1:318 Zalcitabin 24:474,486,488 as anti-viral agent 24:474 Zalerion arboricola 22:69,248 473 carbaaldopyranoses synthesis by Zanthoxyllum naranjillo 26:799 Zanthoxylum ailanthoides 10:152 Zanthoxylum holtzianum 22:535 in convulsions Zanthoxylum integrifolium 27:167 Zanthoxylum liebmannianum Zanthoxylum punctatum 27:159 Zanthoxylum simulans 22:536;27:863 Zanthoxylum sp. 27:164 Zanthoxylum spinosum 27:170 Zanthoxylum tessmanii 27:159 Zanthoxylum usambarense 27:160 Zanthoxylum xanthoxyloides Zaragozic acid A 23:344 Zaragozic acids 21:192 Zea luxurians 29:600 Zea mays 27:215 allelopathic interaction Zearalenone 6:213,214 6-epoxidation of 30:521 absolute configuration of 7:360 allenic carotenoids from 6:139 C-3 hydroxylation of Physalis alkekengi 7:360 functions of 30:523 in biosynthesis 6:139 Zeaxanthin disulphate 30:528 from zeaxanthin 30:528 synthesis of Zemplin conditions 6:409 Zemplin de-O-acetylation Zemplin transesterification method 21:163 Z-Enediones 16:648 Z-Enolate Zeralenone 8:176,177 from 0~-iodoalkyl-2-phenylthiomethyl-4,6-dimethoxybenzoate synthesis of EBV assay system Zeylasterone-2,3-dimethyl ehter 18:765 (+)-Zeylenol 23:841 Z-homoallylalcohol 30:41 Lindlar's catalyst 487 as anti-viral agent 24:474 steganes synthesis by Zinc (II) iodide 12:164 Zinc amalgam 30:222 Zinc borohydride 1:261;4:348 reduction with 1:261;4:348 Zinc bound alkoxide 17:481 Zinc clathridine Zinc-copper couple 4:424 in deoxygenation 4:424 in reductive elimination 4:165 Zinc-dust 12:166 in deoxygenation Zincke's salt 19:38 Zincophorin 3:276 Zingiber off~cinarum 17:378 Zingiber ottensi 22:536 for convulsions Zingiberene 8:45 from R-(+)-citronellal 8:45 synthesis 168 Zirconium derivatives 9:453 as fluorescence-inducing reagent Wittig rearrangement of 3:249 Z-Isomers 30:441 by transesterification Zizaane sesquiterpenoids 16:125 ent-Zizaenes Zizanoic acid 4:674 48 jujuba saponin II from 27:41 jujuboside B from 27:41 saponin I-III from 27:42 ziziphin from Zizyphus spinachristi 21:666 christinin A from X-ray crystal structure of 9 25:711;28:646 sphingolipid hariamide from 28:646 zoanthid A from 28:646 Zoapatanol 10:210 total synthesis of 10:210 Zoapatline 19:389 isolation of Williams enantioselective synthesis of 6:15 Zonaric acid 15:297 Zonarii Rau synthesis of 6:17 synthesis of 6:17 Zoobotryon verticillatum 17:85 Zooecdysteroids 29:10 biochemical roles of 29:10 classification of 29:10 20,26-dihydroxyecdysone as 29:10 hydroxyecdysonoic acid as Zoogloea ramigera 1:689 Zwitterionic anthocyanins 5:664 Zwitterionic aza-Claisen 246 ascomycetes from 22:246 Zygomycotina Zymogen activation 25:391 Zymosan 26:342;30:778 from yeast 5:224-227,229, 245,247,254 Mesoponera castaneicolor 229, 245, 257, 245, 247, 254 Mesotetro 19:363 (+)-Mesquitol (3,7,3',4'-tetrahydroxyflavan) 2, trihydroxy-indolizidine 12:325 Mesylate elimination 1:477 Mesylation 4:16, 126, 442; 6:9, 10, 71, 76, 77, 229, 289, 290, 390, [548] [549] [550] 10:322, 323; 19:147 (Z) -T-Mesyloxy-c~, [3-enoates 10:411 (E) , (Z) -T-M es ylo xy-~-alkyl-ot, [3- 15 :484 Na-Methoxy-19(Z)-anhydrovobasinediol 15:466, 318, 324, 325, 332, 333, 8:21, 29; 10:13, 17, 25; 13:33 Methylenation 8:26, 29, 30 with 13:387 Methylmalonyl CoA 11:194, 195 hypothetical incorporation of 11:195 with macrolide antibiotic 11:195 Methylmalonyl CoA 11:194, 195 with macrolide antibiotic 196 from propionyl CoA 11:195, 11:198,1996biosynthesis of 11:198,199 by Penicillium patulum 11:198, 199 3-Methylsampangine 23:6 N-Methylschumannificine 21:140,141, 143,145 N-Methylschumanniophytine 21:152 Methylseleno acetal 8:6 reaction with n-butyllitium 8:6 reaction with 14-dibromopentane 8:62-Methylseleno-2-phenyl-6-heptene 8:12,13 from 1-methylseleno-1-phenylethyllithium 8:7 from 5-bromo-l-pentene 8:7 synthesis of 8:7 transformation of 8:7, 7:324,325,327,329-331,340-343,346-349,351,352,357, 358,:360,361,363 ;11:200;13:553; 21:207,721 ; (1, 18:315, 329, 334, 339, 369 c~, 182; (6) (7) 74, 75 ; 8:224, 277 ; 9:343, 347; 10:61, 164, 183, 412; 11:96, 97, 123 ; 14:5, 37, 39, 42, 118, 274; 15:272; 16:30, 155, 424, 582, 700; 18:10, 63, 81, 333, 343, 355, 374, 369, 378; 22:278, 285 6:70,71;9:435,437, 516;11:31,38,39,41,42;13:29,30,180, 398,404-406,417,418,437,440,448, 458,609,618;16:494 1:695, 697, 698; 4:449, 459; 6:553, 554 ; 13:499, 502; 18:7, 237, 246, 259, 281, 470, 893, 903 Mitsunobu procedure 1:456; 14:182 ring closure by 11:10 Mitsunobu reaction 1:205;4:86,456,457, 478,515,519;6:294,295 ;10:603; 11:404 ;12:305,312,319,468; 13:201, 443,485;14:15,275;16:79,350; 18:174,217,235,471 ;22:283; 24:36-37;26:1236;30:20, 1:632,637;3:6,8,11,16,24, 61 ;13:37-39 5:343;6:110;7:95,98,106-109,112,114-118,120,124,126,427; 8:220 12:456,457; 18:43-109;21:20, 72,488;22:5 ;26:820;30:193,195,200 activity of (-)-deoxypodo phyllotoxin in 30:589 activity of (-)-hernone in 30:590 activity of (-)-nymphone in 30:590 activity of (-)-yatein in 30:590 activity of (+)-corytuberine in 30:589 544 activity of (+)-epiaschantin in 30:590 activity of (+)-epimagnolin in 30:590 activity of (+)-epiyangambin in 30:590 activity of (+)-hernovine in 30:589 activity of (+)-laurotetanine in 30:589 activity of (+)-magnoflorine in 30:589 activity of (+)-malekulatine in 30:590 activity of (+)-N-hydroxyhemangerine in 30:589 activity of (+)-N-formylnornantenine in 30:589 activity of (+)-N-formyldehydroovigerine in 30:589 activity of (+)-N-formylovigerine in 30:589 activity of (+)-ovigerine in 30:590 activity of (+)-ovihernangerine in 30:590 activity of (+)-vateamine-2'13-Noxide in 30:590 activity of 7-formyldehydrohernangerine in 30:589 activity of 7-formyldehydronomantenine in 30:589 activity of 7-formyldehydroovigerine in 30:589 activity of 7-hydroxy-6-methoxy- [3,3 [3,14a-trihydroxy-5 [3- cholest-7-en-6-one activity in 29:28 213,3 [3,14c~-trihydroxy-5 [3- cholest-7en-6-one 2,3-acetonide activity in 29:28 2 ~,3 [3, 14 2:129;7:134,154,189, 429,430,432,434;9:51,55,57,293; 20:6;21:651,656,665 ;24:132;25:59, 61,107,541 ;29:575;30:697,718 5:135,140-144,150,152, 153,165,167,169,176,178 7:190; 13:233, 234; 21:182, 187, 197, 199, 202, 205, 219, 220, 229, 213, 223, 238; 22:459, 489, 499; 26:404, 189, 194, 195 Rhizophora mangle 7:175 Rhizophora mucronata 7:176,180,188, 189,192,194,195 Rhizophora sp. 7:176 Rhizophora stylosa 193 Rhizophoraceae 22:718, 720 Rhizophorine 7:192 12:175 Rutin 7:228; 22:166, 317, 323, 424, 645; 23:747; 25:469, 608, 610, 613, 615; 26:314, 666, 747, 762, 763, 768, 769; 29:573 ; 30:208 21 Serotonin 21:10, 17, 19, 50, 68, 84, 91, 95, 101, 104, 108; 22:111, 668, 669, 673; 26: 267 ; 30:367, 368, 369, 376, 377, 378, 379, 381, 384 516 3, 7, 11, 6, 10, 7:193 Tetradecyl acetate 7:193 3, 4, 5, 8, 7', from Asterias rubens 6:152, 161 Tetradehydroastaxanthin 6:153 stereomutation studies of 6:15 ( 3 S, 8, 7', :159 synthesis of 6:157 Tetradehydroastaxanthin diacetate 6:154 Tetradehydroglaucine 3:428 3, 4, 5, 4, 5, 126 2, 3, 13, 3, 13, 1:702; 28:424, 425 2, 3, 4, 318 synthesis of 8:316, 318 2, 3, 4, 339 2, 3, 4, 326 1, 2, 4, deoxy-ot-D-threohexopyranose 14:173 synthesis of 14: 173 1, 2, 4, lyxo-hexopyranose 14:173 synthesis of 14: 173 1, 2, 3, 3, 4, 21, 22, 3, 4, 2, 5, 4, 5, 3, 4, 3, 4, 361 thermal glycosidation with 8:360,361 1,2,3,6-Tetra-O-galloyl-13-D-gluco se (galloyl ester) 29:589 effects on PEP 29:589 Tetraol 12:237 Tetraol derivative 6:291, 292 2, 6, 8, ~, 6, 117 3, 5, 8, N, N', N 5 , N: o 5:355,364;21:393;414; 25:714,715,771,772,775,878,884, 892,900;26:1175,1176,1179,1181, 1184,1188,1193,1198-1200,1212, 1217;28: Three-carbon almulations 6:42,49,50, 52,74,75 in (+_)-A 9(12) capnellene synthesis 6:42 in capnellenol synthesis 6:48,50 in dolasta-1 (15), 7,9-trien-14- Threo ethyl [3-hydroxy-[3-(2-piperidyl) propanooates 12:279 from ethyl [3-hydroxy-13-(2pyridyl) in D-glycero-D-mannoheptose synthesis 137, [143] [144] [145] 149; 16:4, [7] [8] [9] Threonine kinases 27:824 D- 1 -hydroxy-10-vinyl-2cyclodecene 8:196,197 synthesis of 8:196,197 (Z)-Trans- 1-hydroxy-10-vinyl-2cyclodecene 8:196,197 synthesis of 8:196,197 8:352;21:197, 198,199,201,213,214,227,223,225 5:368;7:406;21:191, 196-198,202,203,212,213,215,221, 223,224,226,227 ;25:155 :3,38-41;7:124,131-174; 6:110;15:281,282;18:757-769;17:80; 21:237;23:494;24:241-249,285,799; 25:478;27:702 796-802;23:137, 473 ;24:818,819;26:230,673,787,788, 792,793,797,799,801,802,813,819, 822,828;28:148;29 Trypanosoma spp. 2:301-310;26:786, 779,780,785,786,797,800,803,806-808,810,822,824,828 13:195, [223] [224] [225] [226] [227] [228] 195, 198; 29:486 as neuraminidase inhibitors 29:487 as c~-amylase inhibitor 29:486 c~-glucosidase inhibitors of 7:46;10:518 by [2, 3]